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Abstract
UK FASHIoN: feasibility study of a randomised controlled
trial of arthroscopic surgery for hip impingement compared
with best conservative care
Damian Griffin,1* Peter Wall,1 Alba Realpe,2 Ann Adams,2
Nick Parsons,3 Rachel Hobson,1 Juul Achten,1 Jeremy Fry,4
Matthew Costa,5 Stavros Petrou,5 Nadine Foster6 and Jenny Donovan7
1Division of Health Sciences, University of Warwick, Warwick, UK
2Division of Mental Health and Wellbeing, University of Warwick, Warwick, UK
3Department of Statistics and Epidemiology, University of Warwick, Warwick, UK
4Patient representative
5Warwick Clinical Trials Unit, University of Warwick, Warwick, UK
6Arthritis Research UK Primary Care Centre, Keele University, Staffordshire, UK
7School of Social and Community Medicine, University of Bristol, Bristol, UK
*Corresponding author damian.griffin@warwick.ac.uk
Background: Femoroacetabular impingement (FAI) is a syndrome of hip or groin pain associated with
shape abnormalities of the hip joint. Treatments include arthroscopic surgery and conservative care. This
study explored the feasibility of a randomised controlled trial to compare these treatments.
Objectives: The objectives of this study were to estimate the number of patients available for a full
randomised controlled trial (RCT); to explore clinician and patient willingness to participate in such a RCT;
to develop consensus on eligibility criteria, surgical and best conservative care protocols; to examine
possible outcome measures and estimate the sample size for a full RCT; and to develop trial procedures
and estimate recruitment and follow-up rates.
Methods: Pre-pilot work: we surveyed all UK NHS hospital trusts (n= 197) to identify all FAI surgeons and
to estimate how much arthroscopic FAI surgery they performed. We interviewed a purposive sample of
18 patients, 36 physiotherapists, 18 surgeons and two sports physicians to explore attitudes towards a RCT and
used consensus-building methods among them to develop treatment protocols and patient information. Pilot
RCT: we performed a pilot RCT in 10 hospital trusts. Patients were randomised to receive either hip arthroscopy
or best conservative care and then followed up at 3, 6 and 12 months using patient-reported questionnaires
for hip pain and function, activity level, quality of life, and a resource-use questionnaire. Qualitative recruitment
intervention: we performed semistructured interviews with all researchers and clinicians involved in the pilot
RCT in eight hospital trusts and recorded and analysed diagnostic and recruitment consultations with
eligible patients.
Results: We identified 120 surgeons who reported treating at least 1908 patients with FAI by hip
arthroscopy in the NHS in the financial year 2011/12. There were 34 hospital trusts that performed ≥ 20
arthroscopic FAI operations in the year. We found that clinicians were positive about a RCT: only half
reported equipoise, but most said that they would be prepared to randomise patients. Patients strongly
supported a RCT, but expressed concerns about its design; these were used to develop patient information
for the pilot RCT. We developed a surgical protocol and showed that this could be used in a RCT. We
developed a physiotherapy-led exercise-based package of best conservative care called ‘personalised hip
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therapy’ and showed that this was practicable. In the pilot RCT, we recruited 42 out of 60 eligible patients
(70%) across nine sites. The mean duration and recruitment rate across all sites were 4.5 months and one
patient per site per month, respectively. The lead site recruited for the longest period (9.3 months) and
accrued the largest number of patients (2.1 patients per month). We recorded and analysed 84 diagnostic
and recruitment consultations in 60 patients and used these to develop a model for an optimal recruitment
consultation. We identified the International Hip Outcome Tool at 12 months as an appropriate outcome
measure and estimated the sample size for a full trial as 344 participants: a number that could be recruited
in 25 centres over 18 months.
Conclusion: We have demonstrated that it is feasible to perform a RCT to establish the clinical effectiveness
of hip arthroscopy compared with best conservative care for FAI. We have designed a full trial and developed
and tested procedures for it, including an innovative approach to recruitment. We propose that a full trial
be implemented.
Funding: The National Institute for Health Research Health Technology Assessment programme.
ABSTRACT
NIHR Journals Library www.journalslibrary.nihr.ac.uk
vi
Contents
List of tables xi
List of figures xiii
List of boxes xv
List of abbreviations xvii
Plain English summary xix
Scientific summary xxi
Chapter 1 Introduction 1
Management of hip pain in young adults 1
Femoroacetabular impingement 1
Open surgery for femoroacetabular impingement 1
Arthroscopic surgery for femoroacetabular impingement 1
Likely difficulties in recruitment to a trial of treatment for femoroacetabular impingement 2
Purpose of this study 3
Chapter 2 Pre-pilot study 5
Objectives 5
Hip arthroscopy for femoroacetabular impingement in the NHS in the UK: a workload survey 5
Introduction 5
Objective 5
Materials and methods 5
Results 6
Discussion 12
Clinicians’ attitudes to randomisation of femoroacetabular impingement patients 13
Introduction 13
Objectives 13
Methods 13
Results 13
Discussion 15
Develop eligibility criteria for a randomised controlled trial and design an operative protocol 16
Introduction 16
Objectives 16
Methods 16
Results 16
Discussion 17
Design of a best conservative care treatment protocol for femoroacetabular impingement 18
Introduction 18
Objectives 18
Methods 18
Results 20
Developing an exercise template and testing the protocol 25
Discussion 25
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
vii
Possible outcome measures and sample size for a full randomised controlled trial 26
Patients’ attitudes towards randomisation and design of patient information material for
a randomised controlled trial 27
Introduction 27
Objectives 28
Methods 28
Results 28
Patient information sheet assessment 29
Discussion 30
Chapter 3 Pilot study 31
Objectives 31
Methods 31
Design 31
Participants 31
Recruitment 32
Treatment allocation 32
Interventions 32
Outcome assessment 33
Concealment of treatment allocation 33
Consent 33
Sample size 33
Adverse events and serious adverse events 34
Fidelity of treatments 34
Economic analysis 35
Statistical methods 35
Summary of changes to the project protocol 35
Results 36
Trial approval and procedures 36
Recruitment 36
Follow-up 36
Procedures to ensure fidelity of interventions 40
Economic analysis 40
Discussion 41
Chapter 4 Qualitative recruitment intervention 43
Objectives 43
Overview of methods 43
Patient pathways 43
Methods 43
Results 43
In-depth interviews with members of the Trial Management Group 46
Methods 46
Results 46
In-depth interviews with surgeons, physiotherapists and research associates at
participating sites 47
Methods 47
Results 48
Recordings of diagnostic and recruitment consultations 50
Methods 50
Results 51
CONTENTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
viii
Step 1: explain what femoroacetabular impingement is to the patient 54
Step 2: reassure the patient that they will receive treatment 54
Step 3: explain that there is uncertainty about which treatment is the best 55
Step 4: explain the purpose of the study 55
Step 5: give the patient a balanced view about the pros and cons of each of the
two treatments 55
Step 6: explain the study procedures 56
Task 1: respond to patients’ concerns and questions 56
Task 2: show confidence and a relaxed manner 56
Study documentation 57
Evidence base for the trial 57
Qualitative recruitment intervention feedback to chief investigator and trial
management group 57
Discussion 58
Chapter 5 Discussion and conclusion 61
Acknowledgements 63
References 65
Appendix 1 Anonymous patient cases and clinician interview schedule 71
Appendix 2 Detailed results of patient interviews 77
Appendix 3 Detailed results of clinician interviews 89
Appendix 4 Database of exercises to accompany personalised hip therapy protocol 101
Appendix 5 Pre-pilot patient interview schedule and patient information
sheet questionnaire 125
Appendix 6 Final patient information sheet 131
Appendix 7 Outcome questionnaire 141
Appendix 8 Hip arthroscopy surgery vignettes 159
Appendix 9 Site research and development approval 163
Appendix 10 Pilot: qualitative recruitment intervention study – trial
management group and recruiter interview schedule 165
Appendix 11 Examples of feedback letters to principal investigators and
research associates 169
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
ix

List of tables
TABLE 1 Femoroacetabular impingement surgeons and their reported activity
across the NHS 7
TABLE 2 Workload by FAI surgeon 7
TABLE 3 Prevalence rates for FAI surgery 9
TABLE 4 Summary of workload for hospital trusts 9
TABLE 5 Hospitals/trusts performing ≥ 10 hip arthroscopies for FAI per 12 months 10
TABLE 6 Conservative care protocol proposed by Emara et al. and used as starting
point for consensus building 18
TABLE 7 Level of agreement with the Emara et al. protocol (initial protocol) 20
TABLE 8 Summary of additional comments made with respect to the Emara et al.
protocol (initial protocol) 20
TABLE 9 Total sample sizes (n of participants) for MCID= 6.1 27
TABLE 10 The 95% CIs for recruitment based on sample sizes of 15, 30, 60, 90
and 120 34
TABLE 11 Site recruitment data 37
TABLE 12 Patient characteristics by treatment group at recruitment 38
TABLE 13 Completeness of economic questionnaires 40
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xi

List of figures
FIGURE 1 Overview of the feasibility study design 4
FIGURE 2 Distributions of caseload by surgeon for open and arthroscopic surgery 7
FIGURE 3 Choropleth map of arthroscopic surgery for FAI 2011/12 8
FIGURE 4 Choropleth map of open surgery for FAI 2011/12 8
FIGURE 5 Recruitment during the pilot RCT 37
FIGURE 6 Box plots of functional hip scores 38
FIGURE 7 The CONSORT diagram for pilot RCT 39
FIGURE 8 The FASHIoN pathway through eligibility and recruitment 44
FIGURE 9 The FASHIoN model of a good recruitment consultation: a six-step
approach 53
FIGURE 10 UK FASHIoN: time in days to R&D approval 163
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xiii

List of boxes
BOX 1 Final best conservative care protocol: PHT 23
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xv

List of abbreviations
3D three-dimensional
AE adverse event
BHS British Hip Society
CDC Consensus Development
Conference
CI confidence interval
CONSORT Consolidated Standards of
Reporting Trials
CSP Chartered Society of Physiotherapy
EQ-5D European Quality of Life-5
Dimensions
FAI femoroacetabular impingement
FASHIoN Feasibility of Arthroscopic Surgery
for Hip Impingement compared
with Non-operative care
GCP good clinical practice
HES Hospital Episode Statistics
HTA Health Technology Assessment
IBM International Business Machines
iHOT-33 International Hip Outcome Tool
MAHORN Multicenter Arthroscopy of the Hip
Outcomes Research Network
MCID minimum clinically important
difference
MRC Medical Research Council
MRI magnetic resonance imaging
NAHS Non-Arthritic Hip Score
NGT nominal group technique
NIHR National Institute for Health Research
ONS Office for National Statistics
OPCS-4 Office of Population Censuses and
Surveys Classification of Interventions
and Procedures-Fourth Edition
PHT personalised hip therapy
PI principal investigator
PIS patient information sheet
PPI patient and public involvement
QRI qualitative recruitment intervention
R&D research and development
RCT randomised controlled trial
REC Research Ethics Committee
RIAS Roter Interaction Analysis System
SAE serious adverse event
SD standard deviation
SF-12 Short Form questionnaire-12 items
TMG Trial Management Group
UCLA University of California,
Los Angeles
UHCW University Hospitals Coventry and
Warwickshire
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xvii

Plain English summary
Some people develop hip pain because of a condition called hip impingement. In people with thisproblem, the ball and socket of the hip joint do not fit together properly, so that they rub and damage
the smooth lining of the joint. These people have pain that may stop them playing sport, going to work
or doing everyday things such as driving, housework and looking after children.
Conservative treatment includes not doing the activities that hurt, taking painkillers and doing hip
exercises, often guided by a physiotherapist. Recently a new treatment has been developed, using keyhole
surgery to repair and reshape the hip so that the ball and socket fit together better. This operation seems
to work well, but we do not know if it is better than conservative treatment.
In this research, we discovered that patients and their doctors and physiotherapists would be keen to
take part in a study to find out whether or not the keyhole surgery really does work and is better than
conservative treatment. We designed and performed a study to test this in the real situation. We found
that two-thirds of the patients who were being treated for hip impingement agreed to join the study and
to be treated either by conservative care or by keyhole surgery.
This prepares the way for a larger study that will involve 25 hospitals over several years. When it is finished
we will know whether people with painful hip impingement should be offered keyhole surgery or
conservative care.
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
xix

Scientific summary
Background
The human hip is a ball and socket joint in which the femoral head (the ball) articulates with the cup-shaped
acetabulum (the socket). However, the femoral head is not always spherical and the acetabulum is sometimes
too deep. During movement, hips with these features impinge, a condition called femoroacetabular
impingement (FAI). FAI can damage the cartilage that lines the hip joint. FAI typically causes groin pain, which
many patients describe as severe and distressing, and which interferes with sport, work and everyday activities.
Recent research shows a likely association between hip impingement and the subsequent development of
osteoarthritis of the hip.
A conservative approach to treating FAI includes using analgesia, modifying activities to try to prevent
impingement and regimes of exercise and physiotherapy. There are a few observational case series
reporting that this conventional treatment method can alleviate the symptoms of FAI.
Recently, there has been a rapid growth in the technology and enthusiasm for surgical treatment of FAI.
Open surgery has been used, but arthroscopic (keyhole) surgery has rapidly grown in popularity. During
hip arthroscopy, under general anaesthesia, the surgeon passes a small telescope into the hip joint and
uses long, thin, powered burrs to reshape the hip joint. Case series (without controls) have been reported
which suggest that patients experience an improvement in pain and function. Some surgeons now suggest
that arthroscopy is superior to conventional non-operative treatment strategies.
We performed a feasibility study to establish whether or not a randomised controlled trial (RCT) of hip
arthroscopy compared with best conventional care in patients with FAI was possible and to inform the
design of such a study. Our main concern was whether or not patients could be recruited and we focused
on this in the design of the feasibility study, including a pilot RCT.
Aim and objectives
The aim of this study was to assess the feasibility of a RCT of hip arthroscopy compared with best
conventional care in patients with FAI.
The objectives of this study are listed below:
l to estimate the annual number of patients offered hip arthroscopy for FAI in the UK
l to explore clinicians’ and patients’ attitudes to recruitment into a RCT of FAI treatments
l to develop a consensus for eligibility criteria, an operative care protocol and a best conservative care
protocol among clinicians who manage patients with FAI
l to consider possible outcome measures and estimate the sample size for a full RCT
l to develop trial procedures and patient information material to maximise recruitment rate
l to estimate recruitment rate to a full RCT
l to test trial procedures and to ensure acceptability of the trial to ethics and research and development
(R&D) committees
l to test measures of treatment fidelity, for both arthroscopy and best conservative care
l to understand the recruitment process so that any difficulties related to design or conduct can be
addressed in a full trial.
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xxi
Methods
The feasibility study was divided into three parts: pre-pilot work, a pilot study and a qualitative recruitment
intervention (QRI).
Pre-pilot work
Workload
A list of orthopaedic clinical directors of NHS health care boards and trusts was established. These directors
were then contacted to identify all FAI surgeons working within their departments. We asked each FAI
surgeon for details of their own FAI surgical workload data for the financial year 2011/12.
Clinicians’ attitudes to randomisation
Semistructured interviews were carried out with a sample of orthopaedic surgeons, sports physicians and
physiotherapists. The interviews were analysed and relevant elements of clinical decision-making in relation
to RCT participation were identified.
Developing eligibility criteria for a randomised controlled trial and designing
an operative protocol
Draft eligibility criteria and an operative protocol were prepared. Internationally recognised expert surgeons
in this field were invited to comment on these provisional documents. The feedback they provided was
used to modify the two documents, which were then recirculated for further comment.
Design of a best conservative care treatment protocol for
femoroacetabular impingement
An international and UK sample of physiotherapists who treat FAI was recruited by identifying and
advertising to relevant networks of physiotherapists. We used evidence from a systematic review of
non-operative care for FAI and a number of consensus-gathering methods to develop a protocol of best
conventional care.
Patients’ attitudes towards randomisation and design of patient information
material for a randomised controlled trial
We purposively sampled patients who had been treated for FAI and used semistructured interviews to
explore their attitudes towards participation in a RCT. We also worked with them to develop patient
information for the RCT, seeking to ensure optimum recruitment.
Consideration of outcome measures and sample size for a full randomised
controlled trial
We reviewed the available literature on outcome measures for FAI treatment and explored which to use in
our interviews with surgeons. We used information on minimum clinically important difference, estimated
effect size and standard deviation to estimate sample size.
Pilot study
A multicentre pilot RCT was performed in 10 NHS hospitals.
Patients were included if they met the inclusion criteria: aged ≥ 16 years; symptoms of hip pain;
radiographic evidence of FAI on plain radiographs and cross-sectional imaging; treating surgeon believes
that they would benefit from arthroscopic FAI surgery; and able to give written informed consent and able
to participate fully in the interventions. Patients were excluded if they had previous significant hip pathology
such as Perthes’ disease, slipped upper femoral epiphysis or avascular necrosis; previous hip injury such as
acetabular fracture, hip dislocation or femoral neck fracture; previous FAI surgery (shape-changing surgery)
on the side being considered for treatment; or existing osteoarthritis, defined as Tönnis grade of > 1,
or more than 2-mm loss of superior joint space width on anteroposterior pelvic radiograph.
SCIENTIFIC SUMMARY
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Eligible patients were identified by research associates and surgeons taking part in the trial. The consultations
between the patient and surgeon were recorded (the diagnostic consultation). Eligible patients who were
then approached to take part in the trial also had the recruitment consultation recorded, a process that was
typically undertaken by a trained research associate. Patients were randomised 1 : 1 to receive either hip
arthroscopy or best conservative care.
Patients were followed up at 3, 6 and 12 months after randomisation using patient-reported outcome
measures for hip pain and function [Non-Arthritic Hip Score and International Hip Outcome Tool (iHOT-33)]
and quality of life (Short Form questionnaire-12 items and European Quality of Life-5 Dimensions). Patients
were also asked to report any medical complications they experienced during the trial and to record any
expenses experienced as a result of their treatment.
Qualitative recruitment intervention
A QRI observed recruitment as it happened through analysis of recordings of diagnostic and treatment
consultations. It was used to understand potential or actual obstacles to recruitment and to inform a plan
to address them. The nature of the IQR meant that the research moulded itself around the needs of the
trial as it progressed and was completed when theoretical saturation was reached (i.e. new data collection
did not materially add to the findings).
Results
Pre-pilot work
Workload
There are at least 120 substantive NHS consultant surgeons treating FAI. Collectively these surgeons
performed 2399 operations for FAI in 2011/12; 1908 were performed by hip arthroscopy, compared with
491 by open surgery. Thirty-four hospital trusts had a workload of 20 or more hip arthroscopies for FAI in
a year.
Clinicians’ attitudes to randomisation
We interviewed 18 of the highest-volume surgeons to explore their views about a trial comparing hip
arthroscopy and best conventional care in patients with FAI. One surgeon declined to participate in the
trial owing to lack of equipoise, five had a bias towards surgery but recognised the need for a trial and
were prepared to randomise patients, and 12 expressed equipoise and were keen to take part in a trial.
Developing eligibility criteria for a randomised controlled trial and designing
an operative protocol
The eligibility criteria and operative protocol were initially designed by the investigators and then refined in
collaboration with an international group of 16 expert surgeons specialising in arthroscopic FAI surgery.
The criteria and protocol were modified after discussion with a further sample of 14 UK specialist hip
surgeons who had experience of treating patients with FAI and were likely collaborators for a full RCT.
Design of a best conservative care treatment protocol for
femoroacetabular impingement
Our survey of physiotherapists showed that there is no currently accepted ‘best’ physiotherapy practice
for patients with FAI, in the UK or internationally, and current practice varies widely. We developed a
new protocol for the physiotherapy-led intervention. Many patients had previous conservative care
(including some form of physiotherapy treatments) prior to considering surgery and attending a
consultation with a surgeon, so we developed a conservative care protocol that was sufficiently different
(in terms of number of treatment sessions, length of treatment period overall and the content of the
treatment) for patients to consider it a new treatment. Recruiting patients from surgical settings to a
randomised trial comparing surgery with a non-surgical intervention is known to be challenging and so it
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was important that the conservative care intervention in this trial was considered by both participating
clinicians and patients to be a credible alternative to surgery. We developed a protocol with four core
components: (1) a detailed patient assessment; (2) education and advice about FAI; (3) help with pain relief
(which may include up to two radiography- or ultrasonography-guided intra-articular steroid injections if
pain prevents performance of the exercise programme); and (4) an exercise programme that has the key
features of individualisation, supervision and progression. It is delivered over a minimum of 12 weeks and
includes a minimum of six physiotherapy-led, one-to-one treatment sessions. We used a patient focus
group to choose the most acceptable name for this protocol of best conventional care. The group made it
clear that we should express that this was a coherent and valid alternative to surgery and different from
physiotherapy likely to have been received already, and recommended the name personalised hip therapy
(PHT). In the development of PHT we struck a balance between the need for a meaningful comparator for
hip arthroscopy, the need to ensure PHT is different from previous physiotherapy that FAI patients may
have experienced and the need for PHT to be deliverable in the NHS outside a trial. UK physiotherapists
and patients felt that PHT was ‘best’ in that not all patients currently receive such a comprehensive
package, but ‘conventional’ in that all its elements are widely used and the package is deliverable within
usual constraints in the NHS.
Patients’ attitudes towards randomisation and design of patient information
material for a randomised controlled trial
Our sample included 18 patients who had been treated for FAI. Fourteen had received arthroscopic
surgery, four had received physiotherapy and steroid injections and one had both. Symptoms of FAI had
affected their work, recreation and day-to-day activities and many reported a great sense of relief when a
diagnosis was made. Patients said that both surgical and conventional care would be acceptable. Patients
were enthusiastic about research in this field and about being involved, but had reservations about some
of the language involved. To them, ‘trial’, ‘random’ and ’50 : 50 chance’ implied a lack of personalised
care. All of these patients said that they would have been prepared to take part in a RCT as long as the
treatment options and uncertainty around them had been fully explained, the treatment they received had
been personalised for them and they were assured that their care would be continued whatever happened
in the research.
Consideration of outcome measures and sample size for a full randomised
controlled trial
The iHOT-33 was the preferred outcome measure because there was extensive patient involvement in item
generation, a minimum clinically important difference (MCID) has been independently determined and this
instrument has been chosen as the principal outcome measure for the UK Non-Arthritic Hip Registry
mandated by the National Institute for Health and Care Excellence. We estimated that 292 participants
would be required for analysis to detect an effect difference equal to the MCID (standardised effect
difference of 0.38) with a power of 90%. Assuming a follow-up rate of 85%, this implies a sample size of
344 participants.
Pilot study
Ten clinical centres participated in the pilot trial, nine of which opened to recruitment within 6 months.
At one site, local R&D approval was delayed until just before the end of the pilot, so no patients
were recruited.
Of 144 potentially eligible patients with hip problems identified at pre-clinic screening of referral letters,
60 met the inclusion criteria after assessment and were approached for randomisation. The most frequent
reasons for exclusion were a diagnosis other than FAI (53/84) and a judgement that the patient would not
benefit from arthroscopic surgery (21/84). Forty-two patients (70% of those eligible) consented to take
part in the pilot RCT. Among those who declined (18), the most common reasons were a preference for
surgery (11/18) and a preference not to have surgery (3/18). The mean recruitment rate was one patient
per centre per month.
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Two patients declined their allocated intervention (1/21 surgery and 1/21 PHT) while one patient (1/21)
allocated to PHT decided to have an operation following randomisation, but prior to starting their
allocated treatment. Follow-up rates at the time of writing were 39 out of 42 (93%), 38 out of 42 (90%)
and 31 out of 32 (97%) at 3, 6 and 12 months; follow-up will continue to 12 months for all patients.
Measures of fidelity of both hip arthroscopy and best conservative care were practicable and gave
confidence to clinicians and researchers in the fidelity of the interventions.
Qualitative recruitment intervention
We recorded and analysed 87 diagnostic and recruitment consultations with 60 new patients during the
pilot trial. We identified structural features associated with successful recruitment, such as running targeted
clinics, having a dedicated research associate in attendance and ensuring referred patients arrived with
expectations of receiving treatment for FAI rather than being told they had been referred for surgery.
Common difficulties with recruitment that were identified included poorly balanced presentations of
treatment options (when surgery was presented at greater length and more favourably than PHT); graphic
descriptions of surgery that may have put patients off that option or discouraged participation; presenting
trial information in an order that was confusing for patients; and surgeons going beyond their protocol
brief, to explain the trial rather than referring patients to the trial recruiter for this information. We
identified where improvements could be made in presenting trial information and in engaging patients to
consider participation. We targeted sites where recruitment rates were lower and provided individual
confidential feedback for recruiters on good practice and areas for improvement, and with anonymised
findings being fed back to all sites.
Conclusion
In a comprehensive feasibility study and multicentre pilot trial, we demonstrated that a RCT of hip
arthroscopy compared with best conventional care in patients with FAI is feasible and would be welcomed
by patients and clinicians.
Most critically, we showed that recruitment can be successful, with a recruitment rate of 70% of eligible
patients on average across nine hospital sites. We have developed the procedures for such a trial and
shown that they are practicable.
This feasibility study and pilot trial have enabled us to design a full RCT in 25 sites in the UK with a
recruitment period of 20 months and a total sample of 344 participants. Such a trial will answer the
pragmatic question of whether or not arthroscopic surgery provides benefit in patients with hip
impingement, compared with best conservative care.
We propose that such a trial be initiated.
Funding
The National Institute for Health Research Health Technology Assessment programme.
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Chapter 1 Introduction
Management of hip pain in young adults
Until recently, the management of hip pain in young adults has been largely conservative. A minority of
such patients had established osteoarthritis, inflammatory arthritis, avascular necrosis or fractures, and
their care sometimes included surgery. However, the majority had no specific diagnosis and received
multidisciplinary non-operative care, provided by a combination of physiotherapists (probably the largest
contribution), rheumatologists, orthopaedic surgeons, sport and exercise medicine physicians and
general practitioners.
Femoroacetabular impingement
In the last few years there has been increasing recognition of the syndrome of femoroacetabular impingement
(FAI), which seems to account for a large proportion of the previously undiagnosed cases of hip pain in young
adults.1,2 Subtle deformities of the hip combine to cause impingement between femoral neck and anterior rim
of the acetabulum, most often in flexion and internal rotation.2 The deformities may include asphericity of
the femoral head, widening of the femoral neck, overcoverage of the anterosuperior acetabular wall and
abnormal version of the femur or acetabulum.2 Excess contact forces between the proximal femur and
the acetabular rim during terminal motion of the hip lead to lesions of acetabular labrum and the adjacent
acetabular cartilage.2 FAI seems to be associated with progressive articular degeneration of the acetabulum,
usually starting from the anterosuperior rim and accelerating medially and posteriorly.1–3
Open surgery for femoroacetabular impingement
In 2001, Ganz et al.4 described a surgical technique to dislocate a hip joint without damaging the blood
supply to the femoral head. This allowed the development of surgical techniques to correct the shape
abnormalities of FAI. The technique involved a major operation, with a trochanteric osteotomy and a
prolonged period on crutches. Ganz et al.4 described a total of 213 surgical hip dislocations, in 164 cases
of which the indication was FAI. Subsequently, there was a gradual development of interest in the
international orthopaedic community in the problem of hip pain in young adults and an increasing
recognition of FAI. Improved imaging, especially magnetic resonance imaging (MRI)/magnetic resonance
arthrography, allowed more confident diagnosis of FAI,5,6 and surgeons began to visit Ganz to learn the
technique. Observational case series have been published describing good clinical results in terms of pain
and function for surgical dislocation for FAI;7 however, only a few centres began to offer this treatment for
patients, perhaps because the likely benefit, as perceived by surgeons and patients, was insufficient to
justify the invasiveness and risks of such an extensive surgical procedure.
Arthroscopic surgery for femoroacetabular impingement
Since the early 1990s there has been a slowly developing interest in arthroscopic surgery in the hip.
Confined to just a few centres around the world, it seemed to be only rarely indicated and of doubtful
clinical usefulness. In the early 2000s, a few surgeons, including one of the authors of this report (DG),
began to explore the possibilities of arthroscopic surgery in the management of FAI. Since then, numerous
authors have published observational case series reporting favourable outcomes in terms of pain and
function for the arthroscopic management of FAI.8–10 Overall, a recent systematic review of hip arthroscopy
judged the evidence to support this treatment of FAI only as ‘fair’.11 The feasibility team have conducted a
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Cochrane Review on surgery for the treatment of FAI and found no published randomised controlled trials
(RCTs) to help determine the efficacy and safety of surgery for FAI.12 Four ongoing trials [including the
Feasibility of Arthroscopic Surgery for Hip Impingement compared with Non-operative care (FASHIoN)
study] were ongoing that when complete may be eligible for inclusion in the review and help determine
the efficacy and safety of FAI surgery. The underlying message from systematic reviews is that better
evidence for any sort of surgery is needed, ideally a well-designed RCT. With the majority of current
literature focusing on the surgical management of FAI, there is little information about conservative
(non-operative) treatment, which might form the natural comparator to surgery.13
Likely difficulties in recruitment to a trial of treatment for
femoroacetabular impingement
Pragmatic multicentre RCTs are acknowledged to be the best design for evaluating the effectiveness of
health-care interventions as they provide robust evidence of effect, but they often encounter recruitment
difficulties.14–17 RCTs in surgery face particular challenges including that many surgeons have limited
experience of RCTs, there are often learning curves for particular procedures, surgeons sometimes adopt
idiosyncratic individual techniques, and the natural comparison might be a very different and more
conservative type of management.18,19 In order to participate in RCTs, all clinicians involved (surgeons and
physiotherapists) need to accept at least collective uncertainty or equipoise between treatments, including
the possibility that surgery is no more effective than best conservative care. For patients, the idea that
there is uncertainty over the comparative effectiveness of surgical treatments and conservative care can be
very difficult to accept. Lack of both clinician and patient equipoise could be major barriers to recruitment
to a trial of surgery versus conservative care for FAI, especially as many patients may well feel that they
have already had a period of conservative care. Trials comparing orthopaedic surgery with conservative
care show widely varying recruitment rates.
l A trial of surgery compared with conservative treatment for carpal tunnel syndrome found that
201 patients refused to enter any study and a further 207 refused to enter the trial but would enter an
observational study. A total of 116 patients were randomised. Therefore, the recruitment rate for the
trial was 22%.20
l A trial of vertebroplasty compared with conservative treatment in acute osteoporotic vertebral
compression fractures recruited 202 of 479 eligible patients (42%).21
l A trial of arthroscopic surgery compared with physiotherapy for osteoarthritis of the knee recruited
188 patients out of 219 (86%).22
Qualitative research methods can be used to understand recruitment difficulties and inform the
development of strategies to improve recruitment to RCTs.23–25 In the Health Technology Assessment
(HTA)-funded ProtecT (Prostate testing for cancer and Treatment) study, for example, the findings from an
integrated qualitative study led to the rate of randomisation of eligible participants rising from 30% to
70% over a 12-month period.23 The ProtecT trial was expected to be challenging for recruitment for
reasons including strong treatment preferences by patients and clinicians. The qualitative research
integrated within a feasibility study26 enabled a nuanced understanding of the recruitment process from
the perspectives of potential participants, clinicians and triallists, including reasons for treatment
preferences and unexpected misinterpretations of information.23 Strategies were developed that led to
improvements in levels of randomisation and informed consent. The research methods used in the ProtecT
study were then developed into a complex recruitment intervention,27 which has been applied to several
other RCTs in different contexts, leading to insights about recruitment issues and the development of
targeted recruitment strategies.24,25 This research is a major theme of the Medical Research Council (MRC)
Collaboration and Innovation in Difficult and Complex Randomised Controlled Trials methodology hub,
which specialises in working with RCTs likely to be challenging for recruitment, such as this study.
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Purpose of this study
Theoretical arguments have been made that surgery for FAI may prevent the development of
osteoarthritis,1,4 but there is little evidence for this. Surgery might be indicated to relieve symptoms, but an
equally strong argument can be made that a well-constructed regime of conservative care will reduce the
symptoms of FAI.
Femoroacetabular impingement surgery, including arthroscopic surgery, has evolved quickly, more quickly
than our understanding of the natural history of FAI,28–30 so it is now not clear whether or not surgery
offers real benefit over conservative care. A RCT of arthroscopic surgery compared with conservative care
for FAI is appropriate, prompting interest from the National Institute for Health Research (NIHR) HTA
programme in funding such a trial.
However, this is a rapidly developing field, currently practised by relatively few surgeon innovators and
specialists in conservative care; these groups may not be in equipoise, and this presents special problems in
the performance of a trial.18 In addition, patients are likely to have strong views about whether they would
prefer surgical or conservative treatment, raising questions about their preparedness to be randomised.
The research question for this feasibility study was whether or not a substantive RCT of hip arthroscopy
compared with conservative care for FAI could succeed and, if so, how best it might be designed. It
included a pilot RCT to test the proposed processes of a substantive trial and, crucially, to estimate the rate
of recruitment.
The research included several related studies, performed in two stages. Pre-pilot studies (see Chapter 2)
estimated the number and distribution of patients available for a full trial in the UK, explored clinicians’
and patients’ attitudes towards a trial, developed a consensus among clinicians who manage patients
with FAI for eligibility criteria, best conservative care and surgical protocols, examined possible outcome
measures and estimated sample size for a full trial, and worked with patients to develop patient
information for a trial. A pilot RCT (see Chapter 3) was then performed in order to estimate recruitment
rates for a full trial. During the pilot RCT, an integrated qualitative study (see Chapter 4) of both patients
and clinicians was performed to determine the barriers to, and develop solutions for, completing
recruitment to a full RCT. The feasibility study design is summarised in Figure 1.
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Pre-pilot work
FAI caseload
survey
Expert patient
interviews
Clinician
interviews
Agreement on
intervention
protocols
Consideration
of outcome
measures
Pilot study
Patient referred with possible FAI
Patient invited to have
recorded consultations
Unwilling
Unwilling
Unwilling
Key
Consents to randomisation
Surgeon makes diagnosis and offers
option of entry to pilot trial and IQR
Trial information consultation with research
 associate and invitation to participate
(n = 60)
1 : 1 randomisation
Consents to have recorded consultations
Observation of Trial 
Steering Committee 
and TMG
Monitoring of
recruitment flow
Record and review
diagnostic consultations
Record and review trial
information
Indicates part of IQR 
Best conservative
care
(n = ≈ 10)
Hip arthroscopy
(n = ≈ 10)
Loss to follow-up/
withdraw
Follow-up for 3, 6 and 12 months
after randomisation
FIGURE 1 Overview of the feasibility study design.
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Chapter 2 Pre-pilot study
Objectives
The objectives of the pre-pilot study were to:
l estimate the annual number of patients offered hip arthroscopy for FAI in the UK (see Hip arthroscopy
for femoroacetabular impingement in the NHS in the UK: a workload survey)
l explore clinicians’ (see Clinicians’ attitudes to randomisation of femoroacetabular impingement
patients) and patients’ attitudes (see Develop eligibility criteria for a randomised controlled trial and
design an operative protocol) to recruitment into a RCT of FAI treatments
l develop a consensus for eligibility criteria for eligibility criteria, an operative care protocol and a best
conservative care protocol among clinicians who manage patients with FAI (see Design of a best
conservative care treatment protocol for femoroacetabular impingement and Possible outcome
measures and sample size for a full randomised controlled trial)
l consider possible outcome measures and estimate the sample size for a full trial (see Patients’ attitudes
towards randomisation and design of patient information material for a randomised controlled trial)
l develop trial procedures and patient information material to maximise recruitment rate to a RCT of
arthrocopic surgery versus best conservative care for FAI section 2.7.
Hip arthroscopy for femoroacetabular impingement in the NHS
in the UK: a workload survey
Introduction
The prevalence in the general population of symptomatic FAI (FAI hip shape morphology and concurrent
hip symptoms) is not known. Similarly the proportion of these patients who require surgery is not known.
The published literature has an overwhelming focus on the surgical management of FAI.1,31,32 Obtaining an
understanding of the amount of surgery that is being undertaken for FAI would help to understand the
burden of symptomatic FAI and help to determine the likely pool of eligible patients for a RCT.
Objective
To estimate the frequency and types of FAI surgery being undertaken in the UK within the NHS.
Materials and methods
A list of all NHS hospital health boards and trusts within England, Northern Ireland, Scotland and Wales
was compiled using the NHS online resource: www.nhs.uk. All hospital trusts and health boards were
contacted by telephone to determine if they had an orthopaedic service and within each orthopaedic
service the number of orthopaedic departments that made up that service. Clinical directors for these
departments/services were then contacted by letter requesting the names and contact details of all FAI
surgeons within their department/service. Each FAI surgeon identified received a letter requesting the
following workload data for the financial year 2011/12:
l hip arthroscopies performed within the NHS over the last 12 months
l number of hip arthroscopies performed for FAI within the NHS over the last 12 months
l number of open surgical procedures performed for FAI within the NHS over the last 12 months.
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Clinical directors and surgeons were contacted repeatedly by letter, e-mail and telephone and through their
secretaries. When a consultant’s practice spanned less than 12 months, the results were not rescaled;
instead, conservative estimates were obtained for the full 12 months by keeping case numbers the same,
no matter the period of practice. When consultants provided a range, this was recorded and final
calculations were made based on the lowest figure. Each surgeon returning data was assigned a postcode
for their NHS practice and this was used to create a choropleth map of the workload data based on regions
within the UK. Prevalence rates for surgery were then calculated for each region per 100,000 population
using mid-2010 population estimates from the Office for National Statistics (ONS).33 Consultants who did
not consider themselves as FAI specialty surgeons were removed from the database. Consultants who
considered themselves to be FAI surgeons but were not currently performing this type of surgery within
their NHS practice were kept on the database, with reasons for this recorded (e.g. no current funding for
the procedure). Anyone who was considered a FAI surgeon but did not want to participate in the study was
removed from the database. Data collection was undertaken over a 6-month period between May and
October 2012.
In order to triangulate and validate the FAI surgical workload data obtained by survey, NHS Hospital
Episode Statistics (HES) data were obtained for procedures undertaken in 2011/12 using Office of
Population Censuses and Surveys Classification of Interventions and Procedures-Fourth Edition (OPCS-4)
codes within England. OPCS is a procedural classification for the coding of operations, procedures and
interventions performed during inpatient stays, day case surgery and some outpatient attendances in the
NHS. OPCS-4 is an alphanumeric nomenclature, with a four-character code system. The code system can
also be combined to provide further detail. Specific procedure codes for FAI surgery have not yet
been established.
In the absence of any established OPCS-4 codes for FAI surgery, the codes currently agreed and applied to
FAI surgery within University Hospitals Coventry and Warwickshire (UHCW) were used: Z843, which
represents surgery on the hip joint, combined with W844, endoscopic decompression of joint, or W802,
open debridement of joint.
Validation of the HES data was undertaken using an independently locally collected database for FAI
surgery at UHCW.
International Business Machines (IBM) Statistical Product and Service Solutions (SPSS) Statistics
(IBM Corporation, Armonk, NY, USA) version 21 for Windows was used for the statistical analysis.
Summary statistics including mean [with confidence intervals (CIs)] and median (with interquartile ranges)
values were reported for the data. Differences in workload data between arthroscopic and open surgery
were analysed using a Student’s t-test. The level of statistical significance (p-value) was set at 0.05.
Results
There were a total of 193 NHS hospital health boards and trusts in the UK. Of these, 27 did not have an
orthopaedic surgical department/service. A total of 2399 cases of surgery were undertaken for FAI over the
12 months. The breakdown of the workload data (both arthroscopic and open) for FAI surgeons who
responded to the survey is shown in Table 1.
Of the 100 surgeons returning workload data, 25 did not perform any arthroscopic surgery over the
12-month period and 55 did not perform any open surgery over the 12-month period. The distributions of
caseload by surgeon for open and arthroscopic surgery are shown in Figure 2 and the mean and median
numbers of cases of FAI surgery per surgeon are shown in Table 2.
PRE-PILOT STUDY
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Each surgeon returning data was assigned a postcode for their NHS practice and this was used to create a
choropleth map of the workload data based on regions within the UK. Figures 3 and 4 show the number
of cases of FAI surgery performed by arthroscopic and open surgery, respectively, in regions of the UK.
Prevalence rates for FAI surgery using mid-2010 population estimates from the ONS33 are shown Table 3.
Distribution of the numbers of cases per hospital trust is shown in Table 4, combining surgeons where they
worked in the same trust.
Trusts with a workload of ≥ 10 hip arthroscopies for FAI per 12 months are summarised in Table 5.
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FIGURE 2 Distributions of caseload by surgeon for open and arthroscopic surgery. (a) Individual surgeon workload
for FAI treated arthroscopically; and (b) individual surgeon workload for FAI treated with open surgery.
TABLE 2 Workload by FAI surgeon
Summary statistic
Arthroscopic FAI workload
per surgeon
Open FAI
per surgeon
Total FAI surgery workload
per surgeon
Mean (95% CI) 19 (15 to 24) 5 (7 to 3) 24 (17 to 31)
Median (IQR) 12 (0–30) 0 (0–4) 12 (0–34)
IQR, interquartile range.
TABLE 1 Femoroacetabular impingement surgeons and their reported activity across the NHS
Country
Hospital health
boards and
NHS trusts with
a FAI surgeon
FAI
surgeons
Surgeons not
responding (%)
Hospital health
board and NHS
trusts with no
funding for
surgery
Open FAI
surgery cases
over 12 months
Arthroscopic
FAI cases over
12 months
England 69 110 17 6 (8 surgeons) 444 1791
Scotland 2 2 0 0 38 62
Wales 2 6 3 0 9 55
Northern Ireland 2 2 0 2 0 0
Total 75 120 20 (17) 8 491 1908
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FIGURE 3 Choropleth map of arthroscopic surgery for FAI 2011/12. Number of cases of FAI surgery performed by
arthroscopic surgery.
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FIGURE 4 Choropleth map of open surgery for FAI 2011/12. Number of cases of FAI surgery performed by
open surgery.
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TABLE 3 Prevalence rates for FAI surgery
Region
Mid-2010
population
estimate33
Arthroscopic
FAI surgery
cases
Arthroscopic
FAI surgery
per 100,000
population
Open FAI
surgery cases
Open FAI surgery
per 100,000
population
Total FAI
workload
per 100,000
population
London 7,825,000 392 5.0 73 0.9 5.9
South East 8,523,000 326 3.8 3 0.0 3.9
West Midlands 5,455,000 250 4.6 64 1.2 5.8
South West 5,274,000 249 4.7 198 3.8 8.5
North West 6,936,000 198 2.9 6 0.1 2.9
East of England 5,832,000 178 3.1 51 0.9 3.9
Yorkshire and
Humber
5,301,000 103 1.9 4 0.1 2.0
North East 2,607,000 95 3.6 25 1.0 4.6
Scotland 5,222,000 62 1.2 38 0.7 1.9
Wales 3,006,000 55 1.8 9 0.3 2.1
East Midlands 4,481,000 0 0.0 20 0.4 0.4
Northern
Ireland
1,799,000 0 0.0 0 0.0 0.0
Total 62,261,000 1908 3.1 491 0.8 3.9
TABLE 4 Summary of workload for hospital trusts
Summary statistic
FAI surgeons
per hospital trust
Arthroscopy
per hospital trust
per 12 months
Arthroscopy for FAI
per hospital trust
per 12 months
Open surgery for FAI
per hospital trust
per 12 months
Mean 1.3 37.3 25.4 6.5
95% CI 1.2 to 1.5 25.1 to 50.1 17.6 to 33.3 2.5 to 10.5
Median 1 22 12 0
Interquartile range 1 45 41 5
Minimum and maximum 1 and 4 0 and 352 0 and 149 0 and 132
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TABLE 5 Hospitals/trusts performing ≥ 10 hip arthroscopies for FAI per 12 months
Hospital trust
Number of
surgeons
Hip arthroscopy
per 12 months
Hip arthroscopy for FAI
per 12 months
Open surgery for FAI
per 12 months
Frimley Park Hospital NHS
Foundation Trust
2 159 149 1
Guy’s and St Thomas’ 2 333 144 9
Barts and The London
NHS Trust
3 50 140 30
South West London
Elective Orthopaedic
Centre
4 135 129 1
Royal Cornwall Hospitals
NHS Trust
3 157 100 132
Addenbrookes Hospital 2 143 91 0
The Royal Orthopaedic
Hospital Birmingham
2 135 90 15
Robert Jones and Agnes
Hunt Hospital
2 90 80 1
South Tees Hospitals NHS
Foundation Trust
2 73 73 0
Wrightington, Wigan and
Leigh NHS Foundation
Trust
2 76 71 2
Bangor Hospital 3 59 55 9
Buckinghamshire
Healthcare NHS Trust
1 53 53 1
University College
London Hospitals
2 50 50 0
Bolton NHS Foundation
Trust
1 51 50 0
Harrogate and District NHS
Foundation Trust
1 50 50 0
Royal National Orthopaedic
Hospital NHS Trust
1 50 50 30
South London Healthcare
NHS Trust
1 50 50 0
Oxford Radcliffe Hospitals
NHS Trust
2 50 45 0
Great Western Hospitals
NHS Foundation Trust
3 47 43 7
Sheffield Children’s NHS
Foundation Trust
1 102 43 0
Royal Infirmary of
Edinburgh
1 48 42 0
King’s College Hospital
NHS Foundation Trust
2 40 39 6
Plymouth Hospitals NHS
Trust
1 35 35 0
Yeovil District Hospital NHS
Foundation Trust
2 40 33 7
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TABLE 5 Hospitals/trusts performing ≥ 10 hip arthroscopies for FAI per 12 months (continued )
Hospital trust
Number of
surgeons
Hip arthroscopy
per 12 months
Hip arthroscopy for FAI
per 12 months
Open surgery for FAI
per 12 months
Central Manchester
University Hospitals
1 40 30 0
Northumbria Healthcare
NHS Foundation Trust
1 30 25 0
The Princess Alexandra
Hospital NHS Trust
1 25 25 5
Royal Exeter and Devon 1 28 23 0
Weston Area Health
NHS Trust
1 352 23 4
Gateshead Health NHS
Foundation Trust
2 22 22 5
Western Sussex Hospitals
NHS Trust
1 22 22 0
Southern General Hospital –
Glasgow
1 38 20 38
University Hospital of South
Manchester NHS Trust
1 17 17 0
East Kent Hospitals
University NHS Foundation
Trust
1 15 15 0
Maidstone and Tunbridge
Wells NHS Trust
1 40 15 1
UHCW 1 60 15 0
Wirral University
Teaching Hospital
1 30 15 0
Blackpool, Fylde and
Wyre Hospitals
1 31 12 0
Luton and Dunstable
Hospitals NHS Trust
1 15 12 0
North Bristol NHS Trust 1 52 12 20
Royal Surrey County NHS
Foundation Trust
1 12 12 0
South Warwickshire
Hospital
1 18 12 0
Hull and East Yorkshire
Hospitals
1 29 10 4
Poole Hospital 1 20 10 0
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From the initial survey there were 69 hospital trusts in England with at least one FAI surgeon. Of these
69 trusts, 53 had evidence of coded procedural activity from the HES data search. However, the data for
both arthroscopic and open surgery were different by five or more procedures in 68 trusts when the two
sources of data were compared. Local database results at UHCW showed that 12 arthroscopic and zero
open surgeries were undertaken for FAI. The corresponding HES data reported 15 arthroscopic and more
than one but fewer than five open surgeries for FAI.
Discussion
A minimum of 120 practising NHS FAI consultant surgeons collectively undertook at least 2399 FAI surgical
procedures over a 12-month period. Of these, 1908 procedures (80%) were performed arthroscopically.
Although all health boards and trusts and corresponding clinical directors responded to our enquiries, it is
possible that clinical directors are not always aware of all the expertise within their department. New FAI
consultant surgeon appointments made after submission of data from the departmental clinical leads
would not have been included in this data set, but the workload data for these surgeons are likely to be
small given the short tenure and may already be accounted for in work being undertaken by existing surgeons.
The survey data rely heavily on surgeon recall, which is likely to have inaccuracies. However, the alternative
of coded procedural data suffers from two major problems:
l Coding of surgical procedures is known to be inaccurate. One study has reported accuracy of 47%.34
The reason for this is that coding is frequently undertaken retrospectively by staff with no medical
training and there are multiple ways of coding the same procedure.34
l Femoroacetabular impingement surgery has no specific procedural codes and is, therefore, coded using
alternative combinations of the OPCS-4 coding system across NHS trusts.
For this reason, the HES data were used to triangulate/confirm locations of FAI surgery rather than provide
any robust measure of the quantity of surgery.
Based on the ONS population data, the prevalence of surgery for FAI within the UK is 3.9 per 100,000.
This figure represents a conservative estimate for prevalence of surgery for FAI within the UK because
l a total of 20 (17%) surgeons did not provide data
l the survey does not include surgery done outside the NHS.
In the absence of any formal operative coding for FAI, and with FAI surgical registries only recently
commencing, this type of prevalence data has not been available to date through other sources. Although
all health boards and trusts and corresponding clinical directors responded to our enquiries, it is possible
that clinical directors are not always aware of all the expertise within their department. New FAI consultant
surgeon appointments made after submission of data from the departmental clinical leads would not have
been included in this data set; however, the workload of these surgeons is likely to be low given the short
tenure and may all already be accounted for in work being undertaken by existing surgeons.
The results suggest the workload of FAI surgery is not spread evenly by region. There is a suggestion that
more surgery is taking place in the South West, London and West Midlands regions per head of
population, with marked variations in surgical workload across neighbouring regions, for example West
Midlands and East Midlands (5.8 and 0.4 per 100,000, respectively). It is unlikely that these differences are
due to regional variations in the prevalence of FAI; they and are more likely to represent regional variation
in both surgical expertise and funding for FAI surgery. Surgical treatment of FAI is a relatively new and
technically demanding procedure;35,36 therefore, the availability of surgeons with sufficient experience and
expertise to undertake such surgery is likely to be limited. This is supported by the high workload among a
small number of surgeons nationally. The data have highlighted marked regional variances in surgical
workload and it is possible that some patients by the nature of their geography may not have easy access
to the care that they would like.
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The data presented provide epidemiological data on FAI surgery including those sites with a combined
workload of 10 or more arthroscopic FAI procedures over 12 months. These sites may be particularly suited
to become recruitment units for a RCT, provided the staff members involved in a RCT are in a position
of equipoise.
The survey results provide a conservative estimate for both the number of FAI surgeons currently practising
in the NHS and the prevalence of FAI surgery being undertaken. The results also highlight marked regional
variances in surgical workload and it is possible that some patients by the nature of their geography may
not have easy access to the care that they require. Finally, the results presented can be used to help plan a
multicentre RCT based on the FAI surgical workload at each hospital trust.
Clinicians’ attitudes to randomisation of femoroacetabular
impingement patients
Introduction
To participate in RCTs, clinicians need to accept at least collective uncertainty or equipoise between
treatments, including the possibility that surgery does not work.
Objectives
To explore attitudes to randomisation of patients with FAI among a multidisciplinary sample of clinicians
working in the centres performing hip arthroscopy.
Methods
We aimed to recruit a convenience sample of health-care professionals who have a special interest in hip
conditions and were likely to see patients with FAI during their clinical practice. Semistructured interviews
were carried out with a sample of orthopaedic surgeons, sport doctors and physiotherapists. To stimulate
discussion, clinicians were provided with anonymous patient cases that cover the spectrum of patient
presentations, including patient history (with duration of symptoms and previous treatments), examination
findings and imaging (see Appendix 1). The clinicians were asked to ‘think aloud’ while considering the
patient cases and the researcher used prompting questions to facilitate the clinician narrative of these
processes. By introducing patient cases, we sought to deconstruct the cognitive processes involved when a
clinician considers recruiting a patient to a clinical trial. This was done in order to elucidate the state of
individual equipoise that may be influencing a recruitment decision (see Appendix 2).
The interviews were analysed thematically based on the Buckingham–Adams classification model of clinical
decision-making. The analysis allowed to identify (1) relevant cues; (2) psychological representation of
these clues (i.e. importance in diagnosis); (3) knowledge structures used (e.g. past clinical experience);
(4) condition and treatment path inferences; and (5) potential outcomes associated with a particular treatment
including introducing the trial. Key messages about what relevant cues to decision-making, information
sources, clinical uncertainty and risks, and potential outcomes were considered by the clinicians were identified
and discussed within the qualitative team. Recommendations about clinician recruitment and information
provision for clinical teams involved in the trial were agreed and presented to the trial management team.
Results
A total of 28 clinicians were interviewed. Eighteen orthopaedic surgeons were identified from our workload
survey (see Hip arthroscopy for femoroacetabular impingement in the NHS in the UK: a workload survey)
as being high-volume arthroscopic FAI surgeons (> 20 procedures per year). Half of the physiotherapists (n= 6)
were identified through a national survey (see Design of a best conservative care treatment protocol for
femoroacetabular impingement), which requested the opinions of professionals who have a special interest in
hip conditions. The other six physiotherapists and two sports physicians were interviewed when they attended
a during an arthroscopic hip surgery conference. A detailed report of the recruitment processes and analysis of
these interviews is presented in Appendix 3.
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The results showed there was a lack of consensus about how best to treat FAI. The majority of clinicians
accepted uncertainty between operative and non-operative treatments. Twenty-six clinicians (90%)
believed that they were in equipoise and that a RCT was required to generate superior scientific evidence
and guidelines for the care of patients with FAI. These were urgently needed, as they have witnessed
increasing numbers of FAI patients in their routine practice. There were various statements supporting the
trial; for example, a surgeon said:
The study is a very important one, it has not been done before and we need to do it to justify the role
of surgery for this condition.
Surgeon 10
Despite this, five surgeons (36%) and two physiotherapists (10%) showed a lack of active clinical equipoise
when faced with real-life case scenarios or discussing involvement with a pilot RCT. One surgeon has a
fundamental disbelief in FAI, so that a trial of its treatment lacks relevance for them:
I’m not a massive believer that hip impingement exists, I think it’s over diagnosed.
Surgeon 3
Other clinicians are not in equipoise because they approach surgery for FAI with caution (n= 2); for
example, a surgeon, referring to his practice, said:
I’m very careful that I counsel patients about the length of rehabilitation required after surgery, and
that it’s definitely only for failure of conservative management.
Surgeon 6
Finally, some surgeons favoured surgery as the optimal treatment for FAI (n= 2), which is the case for the
two physiotherapists who were not in equipoise; for example, one surgeon said:
I don’t believe there is any more a question of whether good surgery can relieve [FAI] symptoms.
Surgeon 9
There were seven surgeons who displayed both ‘theoretical’ and ‘active’ equipoise when assessing the
case vignettes and these surgeons were invited to act as principal investigators (PIs) in the pilot RCT. Of
these seven, there were three who were clearly of the strong belief that a RCT was the optimum solution
to improving evidence and the remaining four were permissive.
A major concern for the surgeons (n= 10) was the duration of the trial, needing to balance sufficient
length of follow-up to see changes with the potential for deterioration of a patient’s hip during
conservative care; for example, one surgeon said:
The main concern with all of this is that if you’re delaying surgical treatment, are they going to
progress essentially their arthritic symptoms or cartilage damage by introducing that delay.
Surgeon 13
They felt that the proposed duration of 12 months for the trial was pragmatic and, therefore, acceptable
in this respect and would also be long enough to allow the patient to stabilise after either intervention.
One surgeon indicated this agreement by saying ‘12 months may be a little long, but I can understand
with what we are trying to come up’ (surgeon 11). The surgeons were anxious to know the mechanism by
which the outcome of the trial would be assessed and were more comfortable with a patient-reported
quality-of-life instrument rather than any other types of measure. All were familiar with and supported the
use of either the Non-Arthritic Hip Score (NAHS) or the International Hip Outcome Tool (iHOT-33) as
the primary outcome measure for a full trial.
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The physiotherapists and sports physicians frequently mentioned two issues: (1) the need for more clarity
of the eligibility criteria (i.e. patients who do not need surgery do not take part) and (2) the need for the
new conservative care protocol to be more distinctive. For example, a physiotherapist said:
As long as conservative care is standardised and you’ve got a level of expertise by the people giving
the conservative care, I think it is very valid.
Physiotherapist 5
The majority of clinicians that assumed patients would prefer surgery and were concerned about patient
reactions to an invitation to participate in the study, which meant that patient expectations were not
fulfilled. They also thought patient would respond negatively to being randomised. The following quotes
illustrated these assumptions:
Patients get to the point where they’ve tried everything and sometimes they are looking for a surgical
route, she had failed physiotherapy.
Physiotherapist 4
She’s going to be very unwilling not to have an operation, I would imagine.
Surgeon 3
Finally, clinicians reported potential regional sources of bias in the recruitment. For example, surgeons’
preferences for conservative or operative care could be at play. One surgeon said:
I think if it had been done 3–4 years ago, I think it would have been easier, it was less conviction and
most surgeons that were doing it that it was the right thing to do.
Surgeon 14
Although another surgeon explained his own view as:
Of the majority of surgeons offering HA [hip arthroscopy] in the country, I see myself as being a little
less invasive and more conservative [. . .] there are surgeons around the country who will operate in
patients that I wouldn’t touch with a barge pole.
Surgeon 6
There are also perceived differences in physiotherapy provision. Clinicians reported their concern that local
physiotherapy may not be of equal quality across the centres:
Are you suggesting a remote access physio who gives them a programme and liaises with the local
physios? Because we don’t have specialist enthusiastic physios in our area which would be quite as
knowledgeable as the ones you have in Coventry.
Surgeon 7
Discussion
Significant interest was evident in the clinical community for a RCT comparing hip arthroscopy and
conservative care. Even though not all clinicians were in equipoise, almost all recognised uncertainty and felt
that a RCT would help to guide their practice in future. Most surgeons were prepared to randomise patients.
The qualitative methods we described provided a novel approach to determining a more complete
assessment of clinical uncertainty and equipoise. The results suggest that, while many clinicians might think
they were in equipoise (theoretical equipoise) their actions and management decisions did not always
support this position (active equipoise). It was likely that where there was a large discrepancy, recruitment of
patients to a RCT was going to be challenging. Therefore, decisions about participating sites and PIs were
informed by the results of this study. It also helped to provide guidance of study design features including
follow-up duration, outcome measures and the need for distinctiveness of the best conventional care arm.
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Develop eligibility criteria for a randomised controlled trial
and design an operative protocol
Introduction
To date, no RCTs have been undertaken for FAI surgery and no previous eligibility criteria exist to guide a
pilot. In addition, as a relatively new procedure, there are a variety of surgical techniques for arthroscopic
FAI surgery and, therefore, it is necessary to develop and define a protocol of operative care in order to
ensure that patients receive the same standard intervention and that the fidelity of this intervention can
then be measured.
Objectives
l Establish appropriate eligibility criteria for a RCT.
l Establish a protocol of operative treatment for arthroscopic FAI surgery.
Methods
Researchers PW and DG developed draft eligibility criteria and an operative protocol based on their own
experience of arthroscopic FAI surgery and available published literature. Sixteen hip arthroscopy surgeons,
recognised as international experts in the field, were then individually invited to comment on these
provisional documents. These surgeons were from the Multicenter Arthroscopy of the Hip Outcomes
Research Network (MAHORN) (n= 12) and from a group who attended the American Academy of
Orthopaedic Surgeons Research Symposium on Femoroacetabular Impingement in Chicago, IL, USA
(n= 4). All surgeons approached agreed to participate. The feedback they provided was then used to
modify the two documents. The eligibility criteria and protocol were recirculated to the 16 experts for
further comment. The criteria and protocol were then discussed with a further sample of 14 UK specialist
hip surgeons with experience of treating patients with FAI and likely collaborators for a full RCT. A final
version of both documents was agreed and then used in the pilot RCT. The two documents continued to
be evaluated in the light of feedback from the recruiting sites during the pilot RCT.
Results
The draft eligibility proposed that patients be included if:
l they are aged 18–50 years
l they have symptoms of hip pain: they may also have symptoms of clicking, catching or giving way
l they show radiographic evidence of pincer- or cam-type FAI on plain radiographs and
cross-sectional imaging37
l the treating surgeon believes that they would benefit from arthroscopic FAI surgery
l they are able to give written informed consent
l they are able to participate fully in the interventions.
Patients would be excluded from participation in this study if:
l they have previous significant hip pathology such as Perthes’ disease, slipped upper femoral epiphysis
or avascular necrosis
l they have had a previous hip injury such as acetabular fracture, hip dislocation or femoral neck fracture
l they already have osteoarthritis, defined as Tönnis grade of > 1,38 or more than 2-mm loss of superior
joint space width on anteroposterior pelvic radiograph8
l there is evidence that the patient would be unable to participate fully in the interventions, adhere to
trial procedures or complete questionnaires, such as cognitive impairment or intravenous drug abuse.
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Initially, 11 out of the 16 surgeons agreed with these eligibility criteria. Others suggested the following
modifications, which were agreed by the whole group:
l Age range changed to include all patients ≥ 16 years. Some surgeons felt that patients between
16 and 18 years of age were an important part of their practice and that for these patients treatment
effects would be similar to older adults. There was not thought to be any rationale for a maximum age
limit; older patients may be, but need not necessarily be, excluded by the criterion ‘the treating
surgeon believes that they would benefit from arthroscopic FAI surgery’.
l Radiographic evidence of FAI was further defined to include an alpha angle of > 55 degrees or a lateral
centre–edge (Wiberg) angle of > 40 degrees.
The draft operative protocol was:
l general anaesthetic with muscle relaxation
l supine or lateral patient positioning
l operating table with facility for traction and allowing range of movement testing
l arthroscopy of central compartment
l arthroscopy of peripheral compartment working with one of the following: intact capsule, capsulotomy
or capsulectomy
l ability to undertake bony surgery to correct abnormalities on both the femoral head neck junction and
acetabular side of the hip joint
l ability to undertake soft tissue repair and/or debridement to the labrum and/or articular cartilage
l ability to record with photos the intraoperative findings and solutions.
A total of 13 out of the 16 surgeons agreed with the draft operative protocol. Three surgeons proposed
changes, which were agreed by the whole group:
l the entire acetabular labrum should be examined
l the entire articular surface should be examined
l confirm that FAI has been relieved using either range of movement testing or an image intensifier
l need to document intraoperative complication and their solutions.
Discussion
There was ready agreement on eligibility criteria for a trial, suggesting that surgeons have a clear idea who
may benefit from hip arthroscopy for FAI. There was recognition that there are many subtleties of FAI
morphology, but surgeons were happy to be pragmatic and ‘lump’ all of these into a single diagnosis.
There may be differences in treatment effect according to type of FAI (some surgeons mentioned their
sense that patients with cam-type FAI do better after surgery than those with pincer-type) and this raised
the possibility of stratification or an a priori subgroup analysis in a full trial. These criteria define a
generalisable sample representative of the patients currently receiving hip arthroscopy for FAI.
The operative protocol was broad enough to accommodate the variations of arthroscopic FAI surgical
technique being used throughout the UK. However, the protocol retains the key steps regarded by the
expert surgeons as essential to a successful hip arthroscopy for FAI.
We considered whether or not to protocolise the postoperative rehabilitation programme for the group
randomised to surgery prior to the pilot trial. This is a pragmatic trial and we believe that the best option is
for postoperative rehabilitation to reflect usual care as closely as possible. Postoperative rehabilitation varies,
often from surgeon to surgeon and even within the same orthopaedic service. If we were to develop a
postoperative rehabilitation programme that is similar to the personalised hip therapy (PHT) programme, this
would change the question for the trial (and, therefore, it would no longer address the original commissioned
call from the HTA programme). The question would then become ‘Does surgery provide additional benefit to
a package of physiotherapy-led care?’ Our preference was to allow postoperative care to be offered as per
usual practice for those randomised to surgery in the pilot trial and to measure that to allow for assessment
of potential confounding.
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Design of a best conservative care treatment protocol for
femoroacetabular impingement
Introduction
Although conservative care is being used to treat patients with FAI,11 we had previously performed a
systematic review that showed that detailed guidance and evidence on how this care should be delivered
are not available.13 This review suggested that non-operative care for FAI would typically be led by
physiotherapists. Of 53 published articles, only four were empirical investigations of non-operative care for
FAI and only one study39 provided both an experimental evaluation of treatment and an explicit description
of the treatment protocol delivered by physiotherapists.
When there is a lack of evidence to guide care, it is appropriate to use a consensus-gathering approach in
order to develop and rationalise best practice.40 Murphy et al.40 summarised three formal consensus-gathering
techniques which have been used to guide health care in other subject areas:
l Delphi method – involves participants receiving two, three or more sequential rounds of questionnaires
and responding to ‘cues’, that is, statements that provoke decision-making based on responses from
previous rounds. Results are aggregated and reviewed for agreement.41
l Nominal group technique (NGT) – involves a process of generating ideas which are then either
accepted or rejected by group members.42,43
l Consensus Development Conference (CDC) – requires a group of individuals to attend a conference in
which evidence is presented to them by experts.44
Objectives
l To develop a consensus on a best conservative care treatment protocol for patients with FAI that was
both deliverable within the NHS and could be used within a RCT of best conservative care compared
with hip arthroscopy surgery for FAI.
l To agree, through patient involvement, the most appropriate name for the best conservative care
treatment protocol.
Methods
The protocol proposed by Emara et al.39 (Table 6) was used as the starting point for a best conservative
care treatment protocol for FAI. This was developed using Delphi and NGT consensus-building methods,
guided by available evidence and guidance from the MRC for developing a complex intervention.45
TABLE 6 Conservative care protocol proposed by Emara et al.39 and used as starting point for consensus building
Initial assessment and treatment Further assessment and treatment
Stage 1 Stage 2 Stage 3 Stage 4
Avoidance of excessive
physical activity and
anti-inflammatory drugs
for 2 to 4 weeks
Physiotherapy for 2 to 3 weeks
in the form of stretching
exercises to improve hip external
rotation and abduction in
extension and flexion
Assessment of the normal
range of hip internal
rotation and flexion after
the acute pain has
subsided
Modification of activities of
daily living predisposing to
FAI (e.g. hip internal rotation
associated with flexion and
adduction)
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A core study group was formed to oversee the development, evaluate information gathered and provide a
layer of NGT consensus to support the Delphi process. The core study group comprised two senior
musculoskeletal physiotherapists with an interest in managing patients with FAI (David Robinson and Ivor
Hughes), a senior academic research physiotherapist (NF) and an orthopaedic surgeon (PW).
When we began this study, we did not know which physiotherapists were directly involved in
the management of patients with FAI, nor did we think it likely to be efficient to simply sample the
physiotherapy profession in the UK at random. We therefore took a targeted approach to sampling, using
networks of physiotherapists most likely to be involved in the management of this patient group. National
advertisements were placed in the orthopaedic, rheumatology, pain and manual therapy electronic
networks through the interactive, electronic Chartered Society of Physiotherapy (CSP) communication
system in the UK (iCSP) and in the CSP’s Frontline magazine (twice-monthly magazine posted to
approximately 52,000 CSP members in the UK). The adverts invited UK physiotherapists to help develop a
consensus for a best conservative care treatment protocol for FAI. Electronic invitations were also sent to
physiotherapists in the USA and Australia known to members of the core study group through previous
collaborative work on FAI. To encourage a process of ‘snowball sampling’ within the international
community, these therapists were encouraged to invite colleagues with experience and interest in
managing FAI to join in the consensus development process.
Each physiotherapist was given the first protocol39 with a questionnaire. The physiotherapists were asked
whether they agreed or disagreed with the proposed programme for the conservative treatment of FAI
patients and, when appropriate, to provide comments and suggestions for improvement.
Results from the each round of Delphi consensus were tabulated by the core study group, and additional
comments and treatment strategies suggested by the respondents were grouped into themes. An
agreement level of ≥ 50% for this Delphi consensus technique was used. If no consensus was evident from
the survey the core study group refined the protocol in light of the available feedback using a NGT-type
approach. The refined protocol was then recirculated to the physiotherapists taking part in the Delphi
consensus process and the cycle repeated until a consensus of ≥ 50% was achieved.
This protocol was then discussed with our panel of expert patients (described in section Patients’ attitudes
towards randomisation and design of patient information material for a randomised controlled trial) in
individual interviews. They expressed the view that the name ‘best conservative care’ did not fully express
(to patients) the intent and content of the protocol. Previous qualitative research has highlighted the
importance of naming treatments in order to improve uptake and compliance, in particular when being
used in RCTs.46 The expert panel was asked to suggest a suitable name for this best conservative care
treatment protocol.
All physiotherapists identified as likely to be best conservative care providers in the pilot RCT were asked to
detail exercises that would allow them to deliver the protocol. The exercises were then ranked and the
most popular were included as a database resource (exercise template) to be used alongside the best
conservative care protocol. In the early phases of recruitment to the RCT, a workshop (CDC methodology)
was held among the physiotherapists delivering care, to refine the protocol. The physiotherapists attending
the workshop were asked to share their experiences of delivering the protocol and make any suggestions
for further amendments.
In the pilot RCT, all physiotherapists delivering the protocol were asked to complete case report forms for
each patient. This included details about the number, nature and duration of the patient contact, and
details of the exercises prescribed to each patient were recorded.
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Results
Consensus development for the best conservative care protocol
In total, 36 physiotherapists responded and agreed to take part in the consensus process; 24 from the UK,
10 from USA and two from Australia. All were senior musculoskeletal physiotherapists who had previously
managed patients with FAI. Details of the initial round of consensus development received from
36 physiotherapists are summarised in Tables 7 and 8.
TABLE 7 Level of agreement with the Emara et al.39 protocol (initial protocol)
Agreement
Stages 1 and 2 of the Emara et al.39
protocol (initial assessment and treatment);
level of agreement, n (%)
Stages 3 and 4 of the Emara et al.39
protocol (further assessment and treatment);
level of agreement, n (%)
Yes 16 (47) 9 (25)
No 7 6
Unsure 13 21
Total 36 36
TABLE 8 Summary of additional comments made with respect to the Emara et al.39 protocol (initial protocol)
Stages Additional themed comments made
Number of
comments Origin of comments
Initial assessment and
treatment (stages 1 and 2)
Core stability exercise and movement control 21 UK× 17,
Australia × 2, USA× 2
Muscle strengthening important 7 UK× 6, USA× 1
See patients more frequently/over a
longer period
5 UK× 4, Australia × 1
Stretching exercise depending on what
is limited
4 UK× 2, USA× 2
Soft tissue mobilisation to facilitate range
of movement
3 UK× 2, USA× 1
Address flexion contractures 2 UK× 2
Massage to relieve tightness in hip muscles 2 UK× 1, Australia × 1
Avoid flexion stretching exercises during
initial stages
1 UK× 1
Internal rotation stretching when pain free 1 USA× 1
Gentle exercise to mobilise the joint in
all directions
1 UK× 1
Reduce overactive hamstring muscles 1 UK× 1
Work on active abduction and
external rotation
1 UK× 1
Avoid excessive hip flexion 1 UK× 1
See patients less frequently 1 UK × 1
Prolonged follow-up often needed 1 UK× 1
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The level of agreement with the Emara et al.39 protocol (initial protocol) among the 36 physiotherapists
was below the 50% threshold that had been set for the Delphi consensus method. However, using the
additional comments made by the physiotherapists, available evidence and established theory, two further
protocols were developed independently by NF and PW and presented at a core study group meeting.
Using the two independent protocols presented, the core study group derived a second protocol based on
a majority within the group (NGT methodology).
The second protocol that the core study group formulated had four core components and four optional
components, which are described below with a justification for including each component.
l Core component 1: patient assessment. Both independently developed protocols featured this
component.39,47 Although not formally a treatment and as such not specifically mentioned in the
questionnaire feedback received, the core study felt that this component should be explicitly included
in the protocol, as it would underpin the remainder of the best conservative care treatment protocol.
l Core component 2: patient education and advice. Both independently developed protocols featured
this component. Thirteen comments from questionnaire respondents had suggested that
physiotherapists should provide patient specific education about FAI including advice on lifestyle
modification, how to do different forms of exercise and how to undertake common activities. Advice
on activity modification was a feature of the published literature, including the Emara et al. protocol39
and Hunt et al. protocol,47 and the core study group felt that education and advice would be regarded
TABLE 8 Summary of additional comments made with respect to the Emara et al.39 protocol
(initial protocol) (continued )
Stages Additional themed comments made
Number of
comments Origin of comments
Further assessment and
treatment (stages 3 and 4)
Advice that cycling is acceptable with
activity modification
7 UK× 6, Australia × 1
Continue strengthening 6 UK× 6
Zigzag running no better than straight
running
4 UK× 3, Australia × 1
Reassessment important 2 UK× 2
Using orthotics may help 2 UK× 2
Encourage hip capsule stretches 2 UK× 2
Stretches can be harmful 2 UK × 1, Australia × 1
Identify dysfunctional movement patterns to
achieve long-term change
2 UK× 1, Australia × 1
More than twice-monthly supervision required 2 UK× 1, Australia × 1
Advice about lifestyle modification 2 UK× 1, USA× 1
Advice about alternative forms of exercise 2 UK× 1, Australia × 1
Advise to avoid deep squatting 1 UK× 1
Advice on return to sport specific training 1 Australia × 1
Strengthening of internal and external
rotators of hip
1 UK× 1
Activity restriction on an individual basis 1 UK × 1
Modification of running on an individual basis 1 UK × 1
Ensure activities can be undertaken with
minimal adduction/Internal rotation
1 UK× 1
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as a core component of best practice among physiotherapists managing any painful musculoskeletal
condition. Both lifestyle and activity modification draw on relevant theory in that behavioural
modifications that might lead to reduced functional impingement should result in reduced symptoms.3
l Core component 3: help with pain relief. Both independently developed protocols featured this
component. It is a feature of the published literature, including the Emara et al.39 protocol, with which
44% of the physiotherapists agreed.39,47 Analgesia is an established treatment for musculoskeletal
pain.48,49 Controlling musculoskeletal pain associated with FAI with analgesia therefore follows MRC
guidance that treatment draw on relevant theory.
l Core component 4: exercise-based hip programme. Both independently developed protocols featured
this component. Thirty-seven additional comments from questionnaire respondents endorsed both
hip-specific and more general exercises for managing patients with FAI. Of these, core or stability
exercises were the most common (21 additional comments). The feedback suggested that the exercise
programme should be individualised to the patient and progressed over time from core stability
exercise and stretching to strengthening exercises. Exercise was a predominant feature of the Emara et al.39
protocol and the other published literature for managing FAI non-operatively.39,47,50 Exercise is an effective
treatment for many other musculoskeletal pain problems51,52 and exercise-based programmes can produce
similar improvements in symptoms to surgery.53 Therefore, including an exercise-based hip regime to help
manage the symptoms of FAI follows MRC guidance that treatment draw on relevant theory.
The core study group proposed the inclusion of optional components which could be undertaken in
addition to the core components in order to individualise treatment, at the discretion of the
physiotherapist delivering care.
l Option 1: additional symptoms that patients with FAI may present with can also be treated.
l Option 2: orthotics can be used to aid the treatment of biomechanical abnormalities.
l Option 3: corticosteroid hip joint injection may be used for patients who cannot engage with ‘core’
treatment owing to acute pain symptoms.
l Option 4: manual therapy – hip joint mobilisations may be added if appropriate, for example distraction
and trigger point work.
The Emara et al.39 protocol suggested that physiotherapy should be offered over a period of between
2 and 3 weeks. The initial round of physiotherapist responses suggested patients should be seen over a
longer period and more frequently in order to provide best care. Currently within the NHS the average
number of treatment sessions given by physiotherapist to musculoskeletal pain patients is between three
and four face-to-face contacts. There is evidence to suggest that better outcomes are achieved from
exercise-based regimes when they are supervised and the contact between the supervisor and patient is
increased.54,55 In order to allow more contact between therapists and their patients without increasing the
burden of having to travel to clinic appointments, non-face-to-face contacts (e.g. telephone and e-mail)
were also allowed in order to progress the exercise programme and to support patients in their adherence
to the recommended exercises. The core study group suggested that the agreed protocol should be
delivered over at least a 12-week period and a minimum of six treatment sessions (of which at least three
should be face to face). The duration of care was both in keeping with established theory that suggests
physiological changes in muscle occur after a 12-week programme of exercise.56
The core study group agreed on the following protocol exclusions:
l Painful hard end stretches were excluded. Although mentioned by only two physiotherapists in the
initial questionnaire responses, there is some evidence in the literature to suggest that painful hard end
stretches and forceful manual techniques in a restricted range of movement may be harmful.
Therefore, although stretching was permitted, hard end of range stretches were excluded.30
l Group-based treatment was excluded in order to ensure care was individualised.
l Care delivered by a technical or student instructor was excluded in order to ensure that care was
delivered by qualified musculoskeletal physiotherapists.
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The second protocol was distributed to the original group of 36 physiotherapists. Thirty-five (97%)
responded, 30 (86%) agreed with the second protocol and provided no additional suggestions for change,
and five disagreed with elements of the second protocol and made suggestions for change. These points
were discussed among the core study group and the following changes were made:
l Two optional booster sessions that could be delivered between 12 weeks and 6 months were added to
a revised protocol. This was in response to concerns that the initial 12-week programme could prove
to be insufficient to correct what is likely to be a significant chronic biomechanical dysfunction. Booster
sessions would also help with adherence to the programme.
l Taping techniques to help with postural modification/reminding were added to the protocol. Although
mentioned by only one physiotherapist, it was noted that taping was a feature of the published literature.13
Given the level of agreement (83%) achieved with the second protocol, the core study group decided to
use the second protocol with the modifications discussed above for implementation in the RCT. This final
protocol is shown in Box 1.
Naming the best conservative care protocol
Eighteen expert patients participated in consideration of the best name for this protocol. They were
asked to choose between four potential names which had been suggested by the core study group,
with the option to suggest a different name if they wished to do so. Eight patients opted for the name
‘personalised hip therapy’, four patients voted for ‘personalised hip programme’, one patient preferred
the name ‘focused hip therapy’ and three offered their own suggestions (including ‘conservative hip
rehabilitation programme’ and the inclusion of the word ‘non-invasive’). ‘Conservative’ and ‘non-invasive’
were disregarded because they appeared to have a value attached to them; for example, the term
‘conservative’ could be confused with terms used in politics. The word ‘personalised’ was preferred for
most people, as exemplified by this quote from a patient: ‘I said the last two [personalised hip treatment
BOX 1 Final best conservative care protocol: PHT
Four core components. Each patient should receive all four core components over at least a 12-week
programme with at least six patient contacts (of which at least three are face-to-face contacts). Up to a further
four ‘booster’ follow-ups can be arranged between 12 weeks and 6 months.
Patient education and advice
1. Education about FAI and available treatments.
2. Advice about posture, gait and lifestyle behaviour modifications to try to avoid FAI. These may include
measures to encourage posterior pelvic tilt (reduce pelvic inclination); positioning when sitting, standing, sit
to stand; positioning when sleeping; positioning when running/cycling when relevant.
3. Advice about activities of daily living to try to avoid FAI (reducing/avoiding deep flexion, adduction and
internal rotation of hip).
4. Advice about relative rest (for acute pain where patients cannot engage with their exercise-based personal
hip programme) given that soft tissues take at least 8–10 weeks to heal. In particular, relative rest in a
specific ROM when pain in that particular ROM is likely to represent ongoing inflammation and damage.
5. Specific activity/sport technique advice and modification. Examples include running with a broader base to
encourage abduction, cycling with less internal rotation on pedals, skiing with skis further apart and using
knee flexion more than hip flexion to lower centre of gravity.
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
23
Patient assessment
1. History, which should include (although not exclusively) history of presenting complaint; relieving and
aggravating factors; past medical history; medications; previous treatments tried; social history including
occupation; and patients’ concerns/fears/beliefs, individual requirements and expectations.
2. Examination, which should include (although not exclusively) the pain-free and passive range of movement
of the hip; strength of the hip; and the anterior impingement test.
Help with pain relief
1. Advice about anti-inflammatory medication for 2–4 weeks if not already tried and simple analgesics if the
patient does not respond well to anti-inflammatory medication.
Exercise-based hip programme
1. Engagement in, and adherence to, an exercise programme that has the key features of individualisation,
progression and supervision.
2. A phased exercise programme that begins with muscle control work and progresses to stretching and
strengthening with increasing ROM and resistance.
3. Muscle control/stability exercise (targeting pelvic and hip stabilisation, gluteal and abdominal muscles).
4. Strengthening/resistance exercise firstly in available range (pain-free ROM).
5. Stretching exercise to improve hip external rotation and abduction in extension and flexion (but not
vigorous stretching – no painful hard end stretches). Other muscles to be targeted if relevant.
6. Exercise progression in terms of intensity and difficulty, gradually progressing to activity or sport-specific
exercise when relevant.
7. A personalised and written exercise prescription that is progressed and revised over treatment sessions.
8. Encourage motivation and adherence through the use of a patient exercise diary to review progress.
9. Patients to have to access to simple exercise equipment (e.g. resistance bands, exercise balls and
exercise mats).
Additional optional components
1. Additional symptoms that patients with FAI may present with can also be treated as per the treating
physiotherapists’ preferred methods.
2. Manual therapy: hip joint mobilisations (e.g. distraction and rigger point work).
3. Hip joint injection: for patients who cannot engage with ‘core’ treatment owing to acute symptoms.
Maximum of one steroid hip injection.
4. Orthotics: patients can be assessed for biomechanical abnormalities and have these corrected (e.g. referral
to a podiatrist for custom-made insoles).
5. Taping: taping techniques are permissible, for example taping the thigh into external rotation and abduction
to help with postural modification/reminding.
Protocol exclusions
1. Forceful manual techniques in restricted range of movement. No painful hard end of range stretches.
2. Group-based treatment.
3. Care delivered by a student or technical instructor.
ROM, range of motion.
BOX 1 Final best conservative care protocol: PHT (continued)
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and PHT] because it makes it a personal issue for that person . . . going down a non-operative route would
require different treatment for every different patient’ (patient 3). Patients preferred the word ‘therapy’ to
indicate that there was an effort to ‘solve’ or ‘cure’ the condition as opposed to ‘programme’: ‘Therapy
from a psychological point of view, people understand therapy [. . .] with regards to clinical treatment
rather than a programme which can relate to anything in life’ (patient 13).
The name ‘personalised hip therapy’ appealed to and conveyed a positive message to patients. This name
emphasises that the protocol is an active intervention that differs from other regimes patients may have
previously tried. Patients said that these two elements were very important to patients who are
experiencing FAI and considering treatment options.
Developing an exercise template and testing the protocol
Twelve physiotherapists were initially identified as likely to be providers of the best conservative care
protocol during the pilot RCT in their hospitals. They suggested suitable exercises for core component
4 and the most popular 21 exercises are shown in Appendix 4.
A workshop (CDC-type methodology) was held after 42 patients were recruited to the RCT and 21 patients
were allocated to and receiving the PHT protocol. Eight physiotherapists (out of 12 physiotherapists
participating in the RCT) from seven recruiting centres attended the workshop to review the content and
delivery of the protocol. Collectively, the physiotherapists were treating 18 patients within the RCT.
The physiotherapists agreed that the protocol worked well but felt that they wanted to change the number
of treatment sessions and the overall duration of the protocol, in order to ensure that they were able to
deliver best care. As a result, one change was made to the protocol, which allowed a minimum of six and a
maximum of 10 contacts over a 6-month period. In addition, the physiotherapists recommended that three
further exercises should be added to the selection of 21 within the exercise template (see Appendix 4).
The physiotherapists agreed that no further amendments would be needed to the protocol.
Discussion
Despite the increase in attention and recognition of FAI as a source of hip pain in young adults, there has
been very little published information about appropriate conservative treatment approaches. Our aim was
to develop an agreed high-quality best conservative care and physiotherapy-led treatment protocol for
patients with FAI that could be used within a RCT. We combined results from a systematic review, Delphi
consensus surveys with FAI physiotherapists, NGT consensus methodology, relevant literature on effective
conservative care for other musculoskeletal pain conditions and the experiences of physiotherapists
treating FAI patients within a RCT (CDC methodology), in order to develop the agreed treatment protocol,
referred to as PHT.
In summary, PHT comprises four ‘core’ elements designed to be offered over a maximum of 6 months:
(1) patient assessment; (2) patient education and advice; (3) help with pain relief; and (4) engagement with
a supervised individualised exercise-based hip programme. A minimum of six and a maximum of
10 treatment contacts should be provided by the supervising physiotherapist over the 6-month period.
The protocol followed MRC guidance for the development of complex interventions and is based on
theory when possible.45 Research has already shown that exercise is an effective treatment for many types
of musculoskeletal pain51,52 and has identified that exercise-based programmes can produce similar
improvements in symptoms to surgery.53 The PHT protocol provides guidance to other clinicians and
researchers in an area where evidence and guidance are very limited.
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Possible outcome measures and sample size for a full
randomised controlled trial
A variety of outcome measures have been used to study patients with FAI, especially patient-reported
hip-specific pain and function scales. Some, such as the Western Ontario and McMaster Universities
Osteoarthritis Index57 and the Harris Hip Score,58 were intended for older patients with symptoms of severe
arthritis and are most suitable to measure the effect of hip replacement surgery. These measures tend to
exhibit ceiling effects and are not sensitive to change after treatment in patients with FAI.58,59 A review
of hip-specific patient-reported instruments for FAI18 recommended that newer instruments specifically
designed for young adults might be used to measure primary outcome in studies for the effectiveness of
treatment of FAI.
Non-Arthritic Hip Score is a self-administered instrument to measure hip-related pain and function in
younger patients without arthritis. The score is valid compared with other measures of hip performance,
internally consistent and reproducible.60 However, it is not patient-derived, raising concern that it may not
measure what is most important to patients.
The iHOT is a patient-derived, hip-specific, patient-reported instrument that measures health-related
quality of life in young, active patients with hip disorders.59 It was developed in a 5-year study by a large
international collaboration of patients and clinicians led by MAHORN: an academic group of highly
experienced hip arthroscopists closely associated with the International Society for Hip Arthroscopy
(www.isha.net). It comprises 33 items, each measured on a visual analogue scale, to assess functional
limitations, sports activities, job-related and emotional concerns. Importantly, these items were generated
and refined by patients, reflecting their most important concerns. The instrument generates a single score
in the range 0–100. People with no hip complaints usually score ≥ 95; a diverse international population of
younger adults with a variety of hip pathologies had a mean score of 66 with a standard deviation (SD)
of 19.3. iHOT-33 has been validated for use in patients with FAI and is sensitive to change after treatment
for FAI. The minimum clinically important difference (MCID) has been determined using an anchor and
distribution-based approach in a group of 27 young active patients who were independent of the
development population. Clinical change was determined using a global rating scale that asked patients
whether their hip condition had improved, had deteriorated or had not changed since the previous
assessment, using a single visual analogue scale. The MCID was 6.1 points.61–63
The iHOT and European Quality of Life-5 Dimensions (EQ-5D) have been adopted as the principal outcome
measures by the UK Non-Arthritic Hip Registry. This registry is led by the British Hip Society (BHS);
its use in all patients having arthroscopic FAI surgery is required by the National Institute for Health and
Care Excellence.35
In our pilot RCT (see Chapter 3), we tested both NAHS and iHOT-33 as potential primary outcome
measures and found both to be easy to use and acceptable to patients. We asked surgeons for their
preference during our interviews with PIs, and all felt that either would be satisfactory; three suggested
that the use of iHOT in the national Non-Arthritic Hip Registry made this preferable. The extensive patient
involvement in item generation, the availability of an independently determined MCID and the use of iHOT
as the principal outcome measure for the UK Non-Arthritic Hip Registry lead us to suggest iHOT-33 as the
most appropriate primary outcome measure for a full trial.
Observational studies have measured clinical improvement after hip arthroscopy in FAI patients and a
recent systematic review suggests that the effect size in these uncontrolled studies is between 0.67 and
2.95.64 An effect size of 2.0 for hip arthroscopy in general has also been reported, but not specifically for
patients with FAI.59 However, these are descriptions of the mean change in a group of patients before and
after one treatment rather than the difference between two groups of patients having two different
treatments, and we expect that conventional care is likely to provide some benefit. Cochrane reviews have
shown that good exercise-based regimes for patients with musculoskeletal conditions typically have a
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standardised effect in the order of 0.3.53,55,65 We also expect these uncontrolled studies of hip arthroscopy
to overestimate the real effect. We suggest that a realistic estimate of the effect size of arthroscopy
compared with best conventional care in FAI might be 0.5.
The mean iHOT-33 score has been reported as 66 with a SD of 19.3 in a population of patients
undergoing hip arthroscopy for a variety of conditions.59 The baseline iHOT-33 data from our pilot RCT
(see Chapter 3) suggest that the target population of patients being considered for hip arthroscopy for FAI
in the UK have lower scores with less variability, with a mean of 33 points and SD of 16. This is consistent
with an observational study over several years by one of our team (DG), which showed an SD of 14
iHOT-33 points among FAI patients who had no radiographic signs of arthritis.
Our sample size calculation is therefore based on a SD of 16 and MCID of 6.1 – a standardised effect
difference between groups at 12 months of 0.38. Table 9 shows the expected sample size for scenarios
with 80% and 90% power to detect an effect of this size, at a 5% significance level, assuming an
approximately normal distribution of the iHOT-33 score. The table also shows sample sizes for small to
moderate (0.32) and moderate (0.47) effects, which are typical of other pragmatic RCTs measuring
clinical effectiveness.
For a full trial, we suggest a conservative approach, seeking to demonstrate only an effect difference
between groups equal to the MCID. We propose to recruit sufficient patients to be able to analyse
292 participants at 12-month follow-up. Allowing for 15% loss to follow-up (a conservative estimate), we
suggest that a full trial should recruit a sample of 344 participants (172 in each group). This will provide
90% power to detect a difference of 6.1 iHOT-33 units at 12-month follow-up, if that is the
true difference.
Patients’ attitudes towards randomisation and design of
patient information material for a randomised controlled trial
Introduction
Producing high-quality patient information sheets (PISs) and consent forms that are clear, address the
relevant patient concerns and are presented in an easy to assimilate format is essential for successful
recruitment to trials. In order to increase the numbers of patients randomised for the proposed trial,
a qualitative study was set up to investigate concerns that patients may have and how best to inform
patients of this trial.
TABLE 9 Total sample sizes (n of participants) for MCID= 6.1
SD
Power
Standardised effect difference80% 90%
13.3 144 192 0.47
16.0 218 292 0.38
19.3 316 422 0.32
Bold represents suggested sample size for a full trial.
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Objectives
l Explore patients’ views about operative and conservative treatments for FAI and the acceptability of
randomisation between them.
l Develop PISs for the RCT.
Methods
A panel of expert patients was established from among patients who had been treated for FAI at the
UHCW NHS Trust. The panel was chosen by purposive sampling in order to include a range of age, sex,
disease severity, activity and socioeconomic status as well as those who had received operative and
conservative care. An invitation to be part of an expert patient panel was sent to patients and anyone who
replied to the invitation and signed the consent form was asked if they were willing to participate in
one-to-one interviews. Once the expert panel member declared their willingness to be interviewed, the
researcher (AR) contacted them and explained the qualitative study. The PIS and consent form was sent by
post and, when the consent form was returned signed by the participant, an appointment for the
interview was set up, whether face to face at the hospital or by telephone.
A draft version of a PIS for a RCT comparing hip arthroscopy with best conservative care for FAI was
prepared. Panel members were given this draft version and a questionnaire to complete about its
readability. Panel members then had a semistructured interview (with AR), either face to face or over the
telephone, about their experiences with FAI, the treatment they had received and the answers they gave to
the PIS questionnaire (see Appendix 5).
Initially, we had planned to give questionnaires to 50 patients and to interview 15 of these. However,
it emerged that the one-to-one interviews provided much richer in-depth information than administering
surveys alone and that this allowed data saturation to be achieved.
Transcripts of interviews were prepared and thematic analysis was used to extract key messages about
patient experiences of hip impingement and treatments, acceptability of the treatment options, the
understanding of randomisation, and advice on how to improve the trial participant information sheet.
AR coded the transcripts using NVivo (QSR International, Warrington, UK). Agreeing and contrasting views
were identified for each area of interest (e.g. randomisation). After discussing the structure and content of
the results, the qualitative recruitment intervention (QRI) team agreed on some recommendations which
were presented to the trial management team. Further discussions took place in trial management meetings
and, once agreement was reached regarding the recommendations, changes to the trial PIS and recruitment
strategies to be tested in the pilot were implemented.
Results
A total of 18 FAI patients were part of the expert patient panel; 14 of them received operative treatment
and four had managed the condition with physiotherapy and other non-operative interventions
(e.g. steroid injections). A detailed report of the results of these interviews is presented in Appendix 2.
Patients’ experiences of hip impingement and treatments
The majority of these patients were young and physically active. Symptoms of FAI impacted on their
recreational activities, working life and day-to-day activities, which led them to seek treatment. Patients
were often misdiagnosed and sent to physiotherapy in an attempt to address the symptoms before they
met the orthopaedic surgeon. Patients reported feeling relief once a diagnosis was made.
Members of the panel found the operative and conservative treatments for FAI acceptable. Some
commented they were never offered a non-operative option and saw this as a positive addition to available
FAI treatments. The majority of patients regarded surgery as a definite solution for a severe condition that
they thought was mainly about abnormally shaped bones. On the other hand, conservative care was
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perceived as being attractive because it was less invasive. Intensity and history of pain were important
reasons to consider a specific treatment; for example, if the pain was acute and the person had had the
condition for a long time, members suggested operative treatments would be more suitable.
Patients’ views about participating in the research and randomisation
The benefit to the whole community and helping clinicians improve their knowledge and advice for future
patients seemed to be important motivators for patients to participate in research.
However, when the design of the RCT was explained, patients felt that ‘randomisation’ or ’50 : 50
allocation’ was not acceptable. There was a perception that clinicians would be not looking after the best
interest of the patients but distributing people according to the needs of the trial. Patients presumed that
clinicians would know which was the best treatment for them. Therefore, random allocation was perceived
as unnecessary or odd and they were left asking how and by whom the decisions would be carried out.
They also perceived that there was an imbalance between the two treatments in which surgery was
perceived as curative while the comparator, physiotherapy, was not. Two patients expressed concerns
about waiting for 12 months, as it could have an impact on the options available after the study finished.
Another patient asked about how the progress of the treatment would be assessed during the trial and
what would happen if the care plan was not working.
Patients reported that randomisation would be more acceptable if patients were assured that the
alternative treatment to what a patient was allocated would be available to them at the end of the study.
It was also important for patients to feel their treatment plan responded to their individual needs and that
the team would continue to provide health care during and after the study.
Patient information sheet assessment
The expert patient members stated that the PIS presented a balanced view of the two treatments that
were being compared. The language and illustrations used in the document were appropriate and
accessible. Furthermore, patients found and understood easily the information about why it is important to
treat hip impingement, the purpose of the study and what operative care involves and its risks. One
patient mentioned there was not much information on the risks of not treating hip impingement. Patients
did not find satisfactory the information related to conservative care risks, what happens after the study
finishes and 50 : 50 treatment allocations. These items were related to the explanations about the
trial procedure.
Patients suggested that the PIS would benefit from adding a rationale for offering physiotherapy for a
morphological condition such as FAI. They also commented that patients needed to be reassured they
would continue with the same consultant and health-care team, and that they needed to be given more
details about what happened after the end of the trial. Additionally, some members of the panel said
patients tended to look up FAI and available treatments on the internet, so links to trusted websites were
suggested. Information about follow-up, details about possible benefits of the best conservative treatment
and trusted website links were added to the PIS. The words ‘trial’ and ’50 : 50’ were removed and replaced
by ‘study’ and ‘allocated to one treatment’, respectively.
Finally, the expert patient panel emphasised the importance of making patients feel they are receiving
personalised care for their hip. They said that being given enough time to ask questions should be a
priority during the recruitment consultations and patients should be reassured they would receive adequate
treatment independently of how it is chosen. They thought the name ‘personalised hip therapy’
corresponded to these patient needs.
A new version of the PIS was developed that addressed these comments. It was reviewed and approved by
the patient and public involvement (PPI) member of our research team and is shown in Appendix 6.
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Discussion
Patients were prepared to take part in research to identify the best treatment for FAI and were even
enthusiastic about a trial. They expressed concerns about the language of random allocation and wanted
to be assured that treatment would be personalised for them. Patients felt that these concerns could be
addressed by modifications in the PIS, which we subsequently tested in the pilot RCT.
We recognise that this study was of expert patients who had already been treated for FAI. Their assertions
that they would have been prepared to be randomised, when considering the question retrospectively,
may not be representative of the behaviour of patients presented with a new diagnosis and making a
decision that would actually affect their treatment. A prospective study of patients in this situation is
presented in the pilot RCT. However, this was sufficiently reassuring to support performing that RCT, and
comments from these patients substantially influenced the design of that pilot.
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Chapter 3 Pilot study
Objectives
l To estimate recruitment to a RCT of arthroscopic surgery compared with PHT for FAI.
l To test trial procedures and to ensure acceptability of the trial to ethics and research and development
(R&D) committees.
l To test measures of treatment fidelity for both arthroscopy and PHT.
Methods
Design
A pragmatic multicentre, parallel group, pilot RCT of hip arthroscopy compared with best conservative care
for FAI with a QRI was undertaken at 10 NHS centres within the UK.
Participants
Patients were eligible to participate in the study if:
l they were aged ≥ 16 years
l they had symptoms of hip pain – they may also have had symptoms of clicking, catching or giving way
l they showed radiographic evidence of pincer- or cam-type FAI on plain radiographs and
cross-sectional imaging37
l the treating surgeon believed that they would benefit from arthroscopic FAI surgery
l they were able to give written informed consent and to participate fully in the interventions.
Patients were excluded if:
l they had previous significant hip pathology such as Perthes’ disease, slipped upper femoral epiphysis or
avascular necrosis
l they had a previous hip injury such as acetabular fracture, hip dislocation or femoral neck fracture
l they had osteoarthritis, defined as Tönnis grade of > 1,38 or more than 2-mm loss of superior joint
space width on anteroposterior pelvic radiograph8
l there was evidence that the patient would be unable to participate fully in the interventions, adhere to
trial procedures or complete questionnaires, such as cognitive impairment or intravenous drug abuse.
Participants were recruited from among patients presenting to young adult hip clinics in each of the
following 10 NHS centres:
l UHCW, Coventry, UK
l Yeovil District Hospital, Yeovil, UK
l Royal Devon and Exeter Hospital, Exeter, UK
l Royal Orthopaedic Hospital, Birmingham, UK
l Frimley Park Hospital, Frimley, UK
l Royal Cornwall Hospitals, Truro, UK
l Epsom and St Helier University Hospitals, Epsom, UK
l Guy’s and St Thomas’ Hospitals, London, UK
l St Bartholomew’s and Royal London Hospitals, London, UK
l University College Hospitals, London, UK.
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This was an increase in the number of sites originally planned and included some changes of sites. During
the pre-pilot phase the surgeons from all of the eight potential sites listed in the protocol v 12.0 12/02/2012
were interviewed to determine their equipoise and willingness to take part in the pilot trial. The interviews
suggested that some surgeons would not be suitable recruiters/PIs. However, interviews with surgeons from
other potential sites were more promising and as a result they replaced some of the original sites.
One potential site declined participation as it wanted to take part in another study involving patients
diagnosed with FAI and felt it could not offer both studies to patients.
Recruitment
Possible patients with FAI (adults with hip pain and without a prior diagnosis of osteoarthritis) were
identified by collaborating surgeons from referral letters. These patients were then invited to a diagnostic
consultation with one of the collaborating surgeons. Prior to their appointment, patients were approached
to seek consent for audio recording of their clinic consultations.
Surgeons assessed patients as usual, taking a history, examining the patient and performing appropriate
imaging investigations. Patients in whom a diagnosis of FAI was made, and who met the eligibility criteria,
received a ‘diagnostic consultation’ including a description of the condition from their surgeon and an
explanation that there are two possible treatments. This diagnostic consultation was recorded where
consent had been given. Patients were provided with a PIS about FAI and the pilot RCT.
Patients were then invited to attend a ‘recruitment consultation’ by a trained research associate.
Typically this occurred on the same day and during the same clinic. During the recruitment consultation,
information was provided about FAI and its possible treatments and about the pilot RCT. Patients were
given an opportunity to ask questions. This recruitment consultation was recorded where consent had
been given. Patients were then invited to give their consent to become participants in the RCT. Patients
who wished to take more time to consider were given an opportunity to do so. Those who agreed to take
part completed baseline questionnaires and were then randomised to one of the two treatments.
Treatment allocation
Participants were randomly allocated to arthroscopic surgery or best conservative care using 1 : 1 secure
centralised telephone randomisation provided by Warwick Clinical Trials Unit. Patients were usually
informed of their allocation at the recruitment consultation and plans for delivery of the intervention made
at this point. Participants were allowed to withdraw from the trial at any time without prejudice.
Participants who decided to have the treatment to which they were not randomised were followed up
wherever possible and data collected as per the protocol.
Interventions
Participants were treated according to protocols summarised below.
Hip arthroscopy
Participants received the following protocol of care from a NHS orthopaedic consultant specialising in
hip surgery:
l Pre-operatively, patients underwent a routine pre-operative assessment of their general health and
suitability for a general anaesthetic.
l Perioperatively, patients underwent arthroscopic hip surgery under general anaesthesia in a lateral or
supine position. Arthroscopic portals were established in the central and peripheral compartment under
radiographic guidance in accordance with the surgeon’s usual practice. Shape abnormalities and
consequent labral and cartilage pathology were addressed. Bony resection at the acetabular rim and at
the head neck junction was ensured by intraoperative image intensifier radiographs and/or satisfactory
impingement-free range of movement of the hip.
l Post-operatively, patients were allowed home when they were ambulatory and safe with or without the
aid of crutches. On discharge all patients were referred to outpatient-led physiotherapy services for a
course of rehabilitation.
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Best conservative care: ‘personalised hip therapy’
Participants received the following protocol of care from a substantive NHS physiotherapist specialising in
musculoskeletal care who had attended a FASHIoN study PHT training workshop:
l Pre-treatment – after allocation to PHT, patients received an information pack that provided details
about PHT and what to expect during the course of their treatment.
l Treatment – PHT was provided according to the protocol developed in the pre-pilot study and
described above. In summary, participants had a detailed assessment of their condition, including an
assessment of their pain, function and range of hip motion. Participants then received a further three
core components of treatment: education about FAI and how to manage it; help with pain relief; and
an exercise programme that had the key features of individualisation, progression and supervision.
The protocol was delivered over at least 12 weeks with a minimum of six contacts. Some of the
contacts were permissible using either telephone or e-mail in situations for which geographical distance
prevented all contacts being carried out face to face.
l Post-treatment booster sessions: after the 12-week treatment period, participants were offered
additional support or guidance in up to four booster sessions with the physiotherapist up to 6 months
after PHT began. A maximum of 10 treatment sessions in total was allowed.
Outcome assessment
Although the primary objective was to determine recruitment to a pilot RCT, patients were followed up as
though they were part of a full RCT and the study conducted as though it was an internal pilot RCT.
The following outcome measures were used:
l hip pain and function – NAHS and the iHOT-33 (see Chapter 1)
l activity level – University of California, Los Angeles (UCLA), activity score (a reliable and validated
patient-reported activity grading system)66
l health-related quality of life – Short Form questionnaire-12 items (SF-12)67 and EQ-5D68
l a resource-use questionnaire.
These measures were taken at 3, 6 and 12 months after randomisation using a postal questionnaire
(see Appendix 7). Questionnaires were posted and recipients were then followed up twice by telephone.
Concealment of treatment allocation
Patients, surgeons and physiotherapists were not blinded to the treatment allocation. The patient-reported
functional outcome data were collected by post and entered onto the trial central database by a research
assistant who was blinded to the treatment allocation. The statistical analysis was also performed blind.
Consent
Written informed consent for both consultation recording and involvement in the pilot RCT was
undertaken by a clinical researcher or treating surgeon delegated and trained by the central research team.
Sample size
The pilot RCT was not powered to estimate a treatment effect, but rather to achieve a reasonable CI
around the estimate of the recruitment rate, measured as the proportion of eligible patients who consent
to participate and be randomised. Previous studies in orthopaedic surgery of operative compared with
non-operative treatments have achieved recruitment rates of around 30%, so we modelled around this.
Table 10 shows 95% CIs around various recruitment rates for a range of scenarios. Approaching
60 patients to invite them to take part in the trial would allow a 95% CI of 18% to 41% if the true
recruitment rate was 30%. We judged this to be a good balance between cost and duration of the pilot
RCT and the required precision of the estimate.
Therefore, we approached 60 eligible patients across 10 centres in order to estimate recruitment with
sufficient precision to plan a full RCT.
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Adverse events and serious adverse events
Adverse events (AEs) and serious adverse events (SAEs) not already identified locally and reported from the
recruiting site were determined by a patient questionnaire at 6 weeks and 3, 6 and 12 months. Each
recruitment site that discovered a SAE was obliged to report details by fax to the Clinical Trials Unit within
24 hours of the investigator becoming aware of them. Once received, causality and expectedness were
confirmed by the chief investigator. All participants experiencing SAEs were followed up as per protocol
until the end of the trial.
Fidelity of treatments
The quality of the evidence produced by a full RCT depends on the fidelity with which the two treatments
being compared are implemented. Therefore, the following measures to determine treatment fidelity were
tested in the pilot RCT.
Hip arthroscopy
For each participant, a vignette comprising an operative note describing the operation that had been
performed, at least two intraoperative photos and a postoperative three-dimensional (3D) shape analysis
from a single sequence magnetic resonance proton density volume acquisition were prepared. The 3D
shape imaging was radially reformatted perpendicular to both the long axis of the femoral neck and the
face of the acetabulum. Image slices for both the femoral head neck junction and acetabulum at 0 degrees
(towards the patient’s head), 45 degrees and 90 degrees (directly anterior) were then included in the
vignettes (six images in total) (see Appendix 8 for an example). Each vignette was then analysed by an
international expert group comprising Mark Philippon (chairperson of the Research Committee of the
International Society for Hip Arthroscopy; USA), Martin Beck (one of the investigators credited with
developing the early understanding of FAI; Switzerland), John O’Donnell (a highly respected high-volume
arthroscopic hip surgeon; Australia) and Professor Charles Hutchinson (an expert in musculoskeletal
radiology; UK). Any disagreements were resolved by discussion and group consensus. When protocol
deviations were noted, these were discussed with the surgeons involved in order to enhance compliance
with the agreed intervention protocol.
Best conservative care: personalised hip therapy
For each participant, physiotherapists recorded full details of the advice and treatments, number and mode
of treatment sessions, any non-attendance and any AEs for each patient on specifically designed case
report forms. These case report forms were audited against the physiotherapist’s clinical notes to ensure
accuracy and to determine protocol compliance by participating physiotherapists before collation by the
research team and assessment by members of the core study group (see Chapter 2) in order to fully
describe the interventions delivered. Any disagreements were resolved by discussion and group consensus.
When protocol deviations were noted, these were discussed with the physiotherapists involved in order to
enhance compliance with the agreed intervention protocol.
TABLE 10 The 95% CIs for recruitment based on sample sizes of 15, 30, 60, 90 and 120
Expected recruitment rate (%)
Sample size
n= 15 n= 30 n= 60 n= 90 n= 120
10 0.0 to 25.2 0.0 to 20.7 2.4 to 17.6 3.8 to 16.2 4.6 to 15.4
20 0.0 to 40.2 5.7 to 34.3 9.9 to 30.1 11.7 to 28.3 12.8 to 27.2
30 6.8 to 53.2 13.6 to 46.4 18.4 to 41.6 20.5 to 39.5 21.8 to 38.2
40 15.2 to 64.8 22.5 to 57.5 27.6 to 52.4 29.9 to 50.1 31.2 to 48.8
50 24.7 to 75.3 32.1 to 67.9 37.3 to 62.7 39.7 to 60.3 41.1 to 58.9
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Economic analysis
One purpose of the feasibility study was to test measurement approaches and data collection systems that
would facilitate an economic evaluation to be conducted as part of a full RCT. A patient-completed
economic questionnaire was designed to capture health and social service resource use and any costs
borne by the patient, including time and travel costs incurred in the receipt of care, out-of-pocket
expenditures and time off work and usual activities. The economic questionnaire also included the EQ-5D
and SF-12 health-related quality-of-life measures that can generate health utilities for economic evaluation
purposes. The economic questionnaire was completed by study participants at baseline and, subsequently,
at 3, 6 and 12 months. Information extracted from the resource-use component of the questionnaire was
validated by cross-checking data provided by the first 10 patients concerning contacts with hospital
services (inpatient and day case admissions and outpatient visits) at baseline in the lead site against
electronic patient records available in the lead site. The validation process did not extend beyond local
hospital services and, therefore, did not include contacts with primary care, other community services or
contacts with other hospital services.
Statistical methods
Baseline characteristics (e.g. age and sex) are presented for both treatment groups (hip arthroscopy and
PHT) to assess balance after randomisation; continuous data (e.g. age) were summarised by means and
SDs and categorical (binary) data by counts and percentages. The distributional properties of the baseline
scores were assessed visually using box plots. For the 42 patients recruited into the study, all data were
complete (i.e. there were no missing data). Only 31 participants had completed 12 months of follow-up at
the time of writing (February 2014), so only baseline scores are presented; outcome data will be described
in future publications.
Summary of changes to the project protocol
Research Ethics Committee (REC) approval was received on 15 February 2012 for version 12.2 of the
protocol. Following the original submission, a further three amendments have been made to the protocol
and REC approval has been received for all three (listed below).
Amendment Protocol version, date Summary of changes
1 12.3, 19 June 2012 The eligible age range was amended from 18–50 years to ≥ 16 years
The title ‘best conservative care’ was amended to ‘personalised hip therapy’
SF-36 was replaced with SF-12 measure of quality of life
Addition of three new sites:
Yeovil District Hospital NHS Trust
Royal Devon & Exeter NHS Trust
Royal Cornwall Hospitals NHS Trust
Deletion of the following sites:
Cambridge University Hospitals NHS Foundation Trust
BMI The Meriden Hospital
2 12.4, 30 October 2012 Addition of UCLA activity score
Inclusion of operative photographs for the surgery quality review
Inclusion of a new section on international collaboration detailing four
potential international sites
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Amendment Protocol version, date Summary of changes
Addition of two new sites:
Frimley Park Hospital NHS Foundation Trust
Barts Health NHS Trust
Deletion of one site:
Royal Berkshire NHS Foundation Trust
3 13.0, 30 January 2013 The number of approaches was amended to ‘a minimum of 60 approaches’
SF-36, Short Form questionnaire-36 items.
Results
Trial approval and procedures
The trial was approved by National Research Ethics Committee (ref: 11/WM/0389) and by national and
local R&D committees without changes and registered with the current controlled trials database under
reference number ISRCTN 09754699. We identified several problems in obtaining local R&D approval and
in setting up the trial across the 10 sites. These problems were different at each location, but were almost
all solved. Further details are given in Appendix 9. Local R&D approval at one of the 10 sites was so
delayed by local procedures that the centre opened only after target recruitment for the pilot RCT was
completed. Once approval had been granted, we did not identify any major problems in the application of
trial procedures at any of the sites.
Recruitment
A total of 60 eligible patients were approached for recruitment to the pilot RCT across nine centres during
almost 10 months. One centre (site 10) was delayed in being set up and did not attempt recruitment
before 60 approaches had already been made. Of these 60 patients, 42 consented to take part in the pilot
RCT; therefore, recruitment was 70% (95% CI 58% to 81%). During this period a total of 151 patients
were screened for the study. Overall recruitment activity is shown in Figure 5 and recruitment at individual
centres is shown in Table 11. Note that centres opened for recruitment at different times and recruited for
different periods. Reasons for these differences in uptake were explored in the QRI and they mainly related
to logistical issues such as difficulties in setting up funding sources and assigning recruiters to attend clinics
attended by potential participants (see Chapter 4).
Participant demographics were as expected, participants typically being young (mean age 35 years) and
active (50% had a UCLA score of 1, 2 or 3, indicating regular participation in sport). Table 12 and Figure 6
show patient characteristics and baseline outcome scores by treatment group; there were no significant
differences between those allocated to hip arthroscopy and those to PHT.
Follow-up
This pilot study focused on estimating the recruitment rate and was not designed for estimation of a
treatment effect. The majority of the participants had not reached final follow-up by the time this report
was prepared. However, only 2 out of 42 participants did not receive their allocated treatment
(one decided not to proceed with surgery and one asked to have surgery after beginning PHT), and
follow-up rates were 98%, 94% and 100% at 3, 6 and 12 months, respectively. A Consolidated
Standards of Reporting Trials (CONSORT) diagram for the pilot RCT is shown in Figure 7.
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TABLE 11 Site recruitment data
Site
Recruitment
duration (months)
Eligible
patients
Recruited
patients
Eligible
patients/month
Recruited
patients/month Recruitment (%)
1 9.3 24 19 2.6 2.1 79.2
2 7.1 7 3 1.0 0.4 42.9
3 4.4 3 2 0.7 0.5 66.7
4 5.0 6 3 1.2 0.6 50.0
5 4.1 4 4 1.0 1.0 100.0
6 3.1 4 4 1.3 1.3 100.0
7 3.0 1 1 0.3 0.3 100.0
8 2.8 10 5 3.6 1.8 50.0
9 2.2 1 1 0.5 0.5 100.0
10 N/A N/A N/A N/A N/A N/A
Mean 4.6 6.7 4.7 1.5 1.0 70.0
(95% CI 58 to 81)
N/A, not applicable.
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FIGURE 5 Recruitment during the pilot RCT.
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TABLE 12 Patient characteristics by treatment group at recruitment
Characteristics PHT (n= 21) Hip arthroscopy (n= 21) All (n= 42)
Patient characteristics
Age (years)a 33.4 (6.4) 36.2 (9.8) 34.8 (8.3)
Sex (female :male) 6 : 15 (29%) 10 : 11 (48%) 16 : 26 (38%)
Side (left : right) 11 : 10 (52%) 5 : 16 (24%) 16 : 26 (38%)
Smoker (no : yes) 15 : 6 (71%) 17 : 4 (81%) 32 : 10 (76%)
Diabetic (no : yes) 21 : 0 (100%) 21 : 0 (100%) 42 : 0 (100%)
CRF (no : yes) 21 : 0 (100%) 21 : 0 (100%) 42 : 0 (100%)
Duration of symptoms (months)a 30.9 (24.4) 30.9 (28.5) 30.9 (26.2)
Alcohol unitsa 8.4 (9.4) 8.9 (14.8) 8.7 (12.2)
Scores
EQ-5Da 0.58 (0.23) 0.57 (0.30) 0.57 (0.27)
NAHSa 57.9 (18.9) 52.9 (18.5) 55.4 (18.6)
iHOT-33a 31.4 (15.2) 31.0 (17.3) 31.2 (16.0)
SF-12 PCSa 31.1 (14.8) 28.6 (11.6) 29.7 (13.3)
SF-12 MCSa 46.4 (15.0) 46.3 (11.8) 46.3 (13.4)
CRF, clinical reporting form; MCS, mental component score; PCS, physical component score.
a Mean and SD.
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FIGURE 6 Box plots of functional hip scores. (a) iHOT-33; and (b) NAHS, with means and 95% CIs.
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Assessed for eligibility
(n = 151)
Excluded
(n = 91)
Reason for ineligibility
• No radiographic evidence, n = 53
• Would not benefit from  surgery, n = 21
• No symptoms of hip pain, n = 2
• Previous hip pathology, n = 1
• Unable to give written consent or 
   adhere to trial procedures, n = 4
• Patient has osteoarthritis, n = 1
• Did not want to take part in
   research, n = 1
• DNA’d appointment, n = 7
• Unknown, n = 1
Numbers approached
for randomisation
(n = 60)
Randomised
(n = 42)
Follow-upa
Allocation
• Wanted surgery, n = 11
• Wanted physiotherapy, n = 3
• Did not want treatment, n = 1
• Did not want to take part in
   research, n = 1
• Patient wants to choose own
   treatment, n = 1
• Not known, n = 1
Arthroscopic surgery
(n = 21)
Received allocated intervention, n = 19
Currently receiving allocated intervention, n = 0
Did not receive allocated intervention, n = 2
• 1 declined surgery
• 1 lost to follow-up
3 months (n = 21)
n = 19 (90%)
3 months (n = 21)
n = 20 (90%)
6 months (n = 21)
n = 19 (90%)
6 months (n = 21)
n = 19 (90%)
12 months (n = 16)
n = 15 (94%)
12 months (n = 16)
n = 16 (100%)
Personalised hip therapy
(n = 21)
Received allocated intervention, n = 19
Currently receiving allocated intervention, n = 0
Did not receive allocated intervention, n = 2
• 1 declined intervention
• 1 crossed over to surgery
Declined to take part
(n = 18)
 
FIGURE 7 The CONSORT diagram for pilot RCT. a, Follow-up rates reflect progress of patients as of
1 February 2014.
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Procedures to ensure fidelity of interventions
Hip arthroscopy
Vignettes for the first seven participants to have hip arthroscopy were reviewed once the necessary
post-operative MRI had been completed. Vignettes were provided by e-mail and the review was performed
by teleconference. The panel felt that the balance, quantity and quality of the information presented was
adequate to make a decisions about the fidelity of the surgery delivered. The panel resolved to classify
each vignette as either demonstrating per-protocol care or not demonstrating per-protocol care. They
discussed a category of borderline per-protocol care in circumstances for which they felt uncomfortable
about one aspect of the surgery, but decided in the interests of a pragmatic trial to collapse this into
per protocol care. Of the seven cases considered, the panel classified six as per protocol and one as
not per protocol. This last patient had extensive cartilage damage at arthroscopy, which had not been
identified during pre-operative assessment and was not sufficiently apparent on radiographs to warrant
exclusion. The surgeon had decided not to proceed with reshaping and the panel considered this clinically
appropriate, even though it deviated substantially from protocol, and suggested that such events be noted
and considered in the analysis of a full trial.
Personalised hip therapy
Personalised hip therapy treatment logs and corresponding hospital notes were reviewed by the core study
group for the first eight patients to complete PHT. After independent assessment, all members of the
group agreed that the treatment logs accurately reflected and corroborated the corresponding patient’s
notes and that these could be used to judge adherence to the protocol. Five of the eight participants were
judged to have had per-protocol treatment. Deviations from protocol were for the first three patients in
the trial and provided lessons on aspects of the protocol to be emphasised both in subsequent patient in
the pilot trial and in the PHT training workshops for a full trial.
Economic analysis
We found a minimum of 98% completeness for all aspects of the economic questionnaires (encompassing
resource use and health-related quality-of-life measures) at all follow-up points (Table 13). During the
validation process, no discrepancies were found between use of hospital services reported by the patient
and the corresponding electronic records.
Qualitative research found the economic questionnaire to be acceptable among patients at the lead site
and that it could be completed by patients without any extra support from a research assistant.
We were able to establish estimates of unit costs for the majority of relevant resource inputs from a range
of secondary sources, including national cost compendia such as the Patient Social Services Research Unit
Costs of Health and Social Care and the British National Formulary. If unit costs were missing, these could
be estimated using primary research methods in consultation with the lead site’s finance department.
TABLE 13 Completeness of economic questionnaires
Resource-use questionnaire EQ-5D SF-12
Time point
Number of
forms Overall Time point
Number of
forms Overall Time point
Number of
forms Overall
Baseline 42 99% Baseline 42 99% Baseline 42 99%
3 months 39 98% 3 months 39 100% 3 months 39 100%
6 months 38 99% 6 months 38 100% 6 months 38 100%
12 months 31 99% 12 months 31 100% 12 months 31 100%
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Discussion
In this pilot RCT, we demonstrated that it was feasible to obtain ethics approval for this research question
and to obtain R&D support in a variety of hospitals. Clinicians were prepared to take part, with surgeons
agreeing to follow a defined operative protocol, and physiotherapists attending a training workshop and
agreeing to deliver the PHT protocol.
We also demonstrated that that recruitment of study participants is possible across multiple sites. The
recruitment rate (70%, 95% CI 58% to 81%) was encouraging when compared with similarly challenging
RCTs that compare surgical and non-surgical interventions. The lead site (UHCW) was recruiting for the
longest period (9.3 months) and achieved the highest recruitment rate among eligible patients, which is in
keeping with published research suggesting that lead sites achieve the highest recruitment in RCTs.44 Higher
recruitment rates at the lead than other sites are probably a reflection of local enthusiasm for the RCT
among investigators and the relative ease with which recruitment problems can be identified and resolved.
When using the pilot data to plan a full RCT, it may be reasonable to exclude the lead site or make
appropriate adjustments in order to more accurately predict recruitment rates across a multicentre study.
Even excluding the lead site, eight other sites had a mean recruitment rate of 64%.
The number of potentially eligible patients identified in initial screening of clinic letters (n= 151) in the
pilot trial was more than double the number of patients found to be eligible (n= 60), creating a substantial
amount of work for research associates. Within hospitals, constraints on funding provided by the
comprehensive local research network (CLRN) and the availability of research associates to recruit meant
that not all clinics where potentially eligible patients could have been identified were able to be included.
These two findings have implications for a full RCT, suggesting that considerable resources should be
allocated for research associates to ensure identification of eligible patients at the fastest rate.
The two procedures to assess treatment fidelity that we tested within the pilot RCT worked well and could
feasibly be implemented within a full RCT. This is important because, for the surgical protocol at least,
we were not sure that clinicians would be comfortable with an independent panel assessing their surgical
performance. Although the pilot RCT was pragmatic in design, all clinicians involved felt that some
measure of treatment fidelity was important in order to ensure that an estimate of treatment effect
was credible within the wider clinical and research community. Although the numbers were small,
our assessment of fidelity suggests that clinicians and patients were able to follow the treatment protocols.
Participant compliance with treatment allocation was satisfactory: one participant allocated to PHT decided
to have surgery (one crossover) and one participant who was allocated to surgery declined an operation
and decided to be treated by a chiropractor. Follow-up rates were good and consistent with the 90–95%
follow-up rate at 1 year that we have achieved in other orthopaedic surgical trials. Participants completed
the questionnaire packs fully and expressed no concerns, confirming that the burden of the clinical
effectiveness and cost-effectiveness instruments was not excessive.
An economic questionnaire encompassing a broad profile of resource-use questions and health-related
quality-of-life measures that generate health utilities (e.g. EQ-5D, SF-12) was validated locally and shown
to be acceptable to patients with high completion rates. These components, combined with the unit cost
data we have estimated, will facilitate the economic evaluation planned as part of the full RCT.
In summary, the pilot RCT showed that clinicians and their patients with FAI are prepared to participate in
a RCT comparing hip arthroscopy and best conservative care and that such a study is feasible.
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Chapter 4 Qualitative recruitment intervention
Objectives
During the pilot RCT, we performed a QRI to understand how to optimise recruitment in a future full RCT
of this question. The objectives were to:
l understand the recruitment process so that any difficulties related to design or conduct can be
identified and changes put in place
l determine any staff training needs and develop a strategy to address these needs.
Overview of methods
Various methods were used to gather evidence to describe recruitment as it happened, which provided the
basis for a plan of action to improve it. The aspects of the qualitative study of recruitment were not
necessarily employed sequentially. The nature of the QRI meant that the research was moulded to fit the
needs of the project and was completed when theoretical saturation was reached (that is, new data
collection did not materially add to the findings). Qualitative data were collected at eight participating sites
that recruited patients for the pilot RCT. Two sites were excluded from this report, as they had only just
started recruitment at the time of submitting this report and needed more time before the teams could
be interviewed.
Aspects of the qualitative study of recruitment are presented in the following sections, including, when
appropriate, the data sample used, collection and analysis methods employed, and the corresponding
summary of findings. A discussion of the overall results is presented in Discussion.
Patient pathways
Methods
A comprehensive process of logging of potential RCT participants through screening and eligibility phases
was put in place in order to ensure compliance with the CONSORT checklist. These data were made
available to the qualitative researcher (AR) on a regular basis to facilitate monitoring recruitment. These
data and interviews with the different recruitment teams helped to develop a flow chart of the most likely
patient pathways.
Results
Figure 8 presents a flow chart summarising the patient pathway. It was important to assess patient
pathways in relation to their complexity and compliance with the protocol as well as variation between
centres. This information provided indications of particular points where patients could potentially be ‘lost’
from the RCT.
Referral
The participating centres varied in size, from medium-sized hospitals to highly specialised units in
orthopaedic care within large institutions. Therefore, many patients arrived at the appointment after being
referred by other orthopaedic surgeons or local physiotherapy services. On average, patients attended their
first diagnostic consultation with an orthopaedic surgeon after 2 years of presenting symptoms.
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Diagnosis
Usually further tests were requested before a FAI diagnosis could be confirmed. The waiting time between
ordering the tests and confirming the diagnosis varied from a few hours on the same day to 12 weeks.
The patient referral letters were screened prior to the start of the clinic and patients who could potentially
have a FAI diagnosis were identified and approached in the waiting room. The recruiter sought consent
from them to have their consultations audio recorded. The recruiter then facilitated the recording of the
diagnostic consultation with the surgeon. Every so often a patient with suspected FAI needed further
investigations before the diagnosis could be confirmed. According to the protocol, these patients were not
eligible for the trial at this point and therefore should not be approached about the study. These situations
had a tendency to confuse surgeons and recruiters because the patients might not be eligible to take part
in the trial once the results were in, and yet they had been introduced to the audio-recording parts
of the research. Further clarification of the protocol process and guidelines for this particular aspect of
recruitment were developed and given to all the PIs and recruiters.
Successful recruitment experiences were common in larger centres where the PIs were able to run targeted
young people’s hip clinics where the research associate could attend and carry out the trial recruitment
processes immediately after the diagnostic consultation. However, this was not always possible,
commonly because:
l patients with a variety of diagnoses were being seen in the clinics, which had to respond to service
demands and time constraints
l not enough patients with FAI were being referred to the participating site or
l limited research associate time made it difficult to assign a research associate for every appropriate
clinic or a potential participant diagnostic consultation.
GP/
physiotherapist
Surgeon
orders tests
Surgeon discusses
results
Orthopaedic
surgeon
Recruitment
consultation
First
treatment
appointment
Consent to audio
recording of
consultations
t = same day – 4 weeks
t = 18 weeks/hip arthroscopy
t = 4 weeks/PHTt = same day – 12 weeks
t = 2 years
Or
Here He
re
1. Referral 2. Diagnosis 3. Trial information 4. Treatment
FIGURE 8 The FASHIoN pathway through eligibility and recruitment.
QUALITATIVE RECRUITMENT INTERVENTION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
44
Once patients were told about their FAI diagnosis, the surgeon was meant to introduce the trial briefly and
invite the patient to talk to the research associate. The PIs were aware of the division between diagnostic
and recruitment consultations and the requirement of not discussing treatment options with the patients.
Nevertheless, surgeons varied in the amount of information they gave to the patients about the trial in
their introduction; for example, one surgeon opted for stopping at the point of discussing interventions
and sending patients to talk to the recruiters directly, as illustrated by the following extract:
Surgeon: I’m quite happy that the diagnosis is femoral acetabular impingement, you may well have a
bit of back pain going on as well, but there’s certainly enough, I think, symptoms around your hip to
identify that.
Patient: OK.
Surgeon: So move things forward, is it all right if I leave you with [research nurse] to discuss the
options that we’ve got for treatment, because the whole purpose of the research we’re doing is to
obviously get to the bottom of that.
SN008: diagnostic consultation
By contrast, other clinicians discussed the treatment options with the patient at length. This situation was
connected with unsuccessful recruitment consultations as explained later in this report. Some clinicians
actually invited the patient to take part in the trial, which seemed to facilitate the subsequent recruitment
consultation; for example, surgeons used phrases such as ‘I think you would potentially be suitable to enter
the trial, should you wish’ (SN014).
Trial information
Patients were handed the PIS and were left to consider it. The time lapse between the diagnostic and
recruitment consultations varied from a few minutes to weeks, depending on the clinic set-up at the
particular site. Success in recruiting patients seemed independent of when the recruitment consultation
happened; however, more recruitment appointments were carried out directly after the diagnostic
consultation than when the recruiter and patient met on a different day. Patients who decided to become
participants were asked to sign a consent form and recruiters then called the randomisation centre.
Participants were told what intervention they would have and the contact details of the person in charge
of making appointments. Some centres offered written information about the surgery to participants
allocated to this group.
Treatment
The waiting list for the non-operative arm of the trial, PHT, tended to be shorter in most sites than the
operative arm. Waiting times also varied across the centres and clinicians found it difficult to make an
accurate estimate of waiting times during the interviews. Access to treatment centres was difficult in rural
areas, especially for physiotherapy, as it was not readily available in the same sites where the surgery
would have taken place. This was perceived as a disadvantage to those participants allocated to PHT and a
concern for the recruiters at these sites.
Recommendations derived from the patient pathway analysis were incorporated into feedback given to the
Trial Management Group (TMG) and site teams (see Recordings of diagnostic and recruitment consultations).
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In-depth interviews with members of the Trial
Management Group
Methods
In-depth, semistructured face-to-face interviews were conducted with members of the TMG, including
the chief investigator and those most closely involved in the design, management, leadership and
co-ordination of the trial.
Informants were asked about the background, development and purpose of the RCT; their knowledge of
the evidence and their own opinion or equipoise; their role in the trial; and their expectation of the
pathway through eligibility and recruitment. They were also asked to provide a short verbal summary of
the RCT for the interviewer, as if AR was a patient.
Interview topic guides were used to ensure similar areas were covered in each interview, based on those
used in previous studies,27 but also encouraging the informants to express their own views about the RCT
and any recruitment challenges expected or experienced (see Appendix 10).
Transcripts of the interviews were analysed thematically by AR, using techniques of constant comparison
and case study approaches. This involved detailed coding and then comparing emerging themes looking
for shared or disparate views among TMG members. The coding was carried out using the qualitative data
analysis software NVivo. The initial coding (AR) was checked by two other QRI researchers (AA and JD)
and inconsistencies resolved by discussion. Detailed descriptive accounts of the themes and cases
were produced.
Results
Ten interviews were conducted with members of the TMG. Analysis of these and observation of the TMG
meetings showed the group was formed of four subteams with specific functions:
1. orthopaedic surgeons and senior physiotherapists in charge of designing the interventions, recruiting
participants and offering a critical view of the research procedures
2. the trial administration and finance control group dedicated to data management, liaison with other
agencies, and finance planning and expenditure
3. expert statisticians in charge of designing and planning statistical analysis
4. qualitative researchers in charge of the QRI.
Members of each subgroup had at least three different levels of involvement with the research. The first
one was with the day-to-day running of the trial; at a second level, senior members supervised tasks and
made major decisions (e.g. TMG meetings); and, finally, some members of the team remained distant from
the trial procedures and provided a critical assessment of the trial and/or consultancy in particular aspects
of the research (e.g. statistical analysis).
The team members showed an adequate knowledge of the trial protocol according to their level of
involvement. Clinicians were the most knowledgeable as well as those involved with everyday activities,
which was as expected. Task delegation within this multidisciplinary team prevented recurrent role conflicts
and helped the team to develop ‘collective equipoise’. This term refers to the tendency of the team
members to challenge each other’s expectations about the results of the RCT without favouring either of
the two treatments tested. For example, although it was likely the orthopaedic surgeons running this trial
tended to advocate for the operative treatment of FAI, they had a strong background in research and,
therefore, were able to suspend clinical judgement and achieved a balanced view of the treatments that
were compared, as illustrated by the following quote:
I distinguish there between my sort of gut feeling and my instinct. My instinct is that it works, surgery
works [. . .] However, I do recognise that I have also seen it not work and I recognise that the evidence
that supports it working, even the evidence I’ve generated myself, is methodologically weak and
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therefore I think that a scientific and objective perspective of the evidence [. . .] I am therefore an
equipoise so I’m able to hold two views on it. And obviously, I mean the equipoise view is the one
that I use when I’m involved in a trial.
TMG01
As a result, the team sought collaboration with physiotherapists at national and international levels and
developed a credible conservative care protocol. Additionally, the TMG included professionals without
expertise on hip arthroscopy or physiotherapy that facilitated equipoise.
A major concern for the TMG was the multicentre aspect of the pilot. They mentioned challenges such as
difficulties implementing and overseeing procedures in other centres, delays in setting up, low numbers of
eligible patients and lack of equipoise in research teams. The following quotes exemplified these concerns:
I know that the start of some of the sites has been a bit delayed but that is not unusual nor is it
surprising given the complexities of setting up research in different sites.
TMG05
I’ve got major doubts [the study will be successful]. I think it was entirely the right thing to do it as a
feasibility study, I have serious concerns that we won’t be able to recruit outside of this centre [. . .]
Finding that surgeons and patients at the same time have both got equipoise is just going to be
very difficult.
TMG02
Among the suggestions collected from the group to address the concerns were:
l regular visits to the centres by the PI and other TGM members to keep momentum
l delivery of a slick and easy-to-implement recruitment process in order to be the least disruptive to
routine clinical practice
l providing frequent and comprehensive training to recruiters helping them to develop skills and
confidence (e.g. role playing, FAQ, peer support, etc.)
l modifying the support to teams in other centres according to their research experience
l setting recruitment targets and engendering a healthy competition between centres
l sending regular newsletters providing information about recruitment.
In-depth interviews with surgeons, physiotherapists and
research associates at participating sites
Methods
In-depth, semistructured face-to-face interviews were conducted with clinicians and research associates
tasked with recruiting patients in visits to sites soon after they had started to recruit patients for the
pilot RCT.
Informants were asked questions about their knowledge of the evidence for the treatment of FAI and their
personal views about equipoise; the recruitment pathway; how they feel the protocol fits their clinical
setting; and any adjustments they thought were needed to the trial procedures. They were also asked
about the audio recording of their consultations with patients, with a view to discussing any discomfort or
perceived difficulty with this.
Again, interview topic guides were used (see Appendix 10) and informants were encouraged to express
their own views about the RCT and any recruitment challenges expected or experienced.
Analysis was as for the TMG interviews, but themes were also explored to examine differences or
similarities between the TMG members and specialist clinicians and recruiters, and within or between
centres or clinical specialties.
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Results
Twenty-one interviews of clinicians and research associates were performed at eight participating sites.
Common concerns and good practice examples were identified across the transcripts and were organised
in the following themes.
Patient preferences and reactions
Various participating sites (n= 5) were pleasantly surprised by the acceptability of the trial to patients;
for example, one PI reported:
I’ve been surprised at how willing people have been to go into the trial.
PI 3
This encouraged clinicians to continue approaching patients, despite their concerns about patient reactions
and preferences at the start of the trial, which eased after they approached a few patients who consented
to the study enthusiastically. PIs have found patients who were willing to be advised about a course of
treatment (i.e. without set preferences) were generally happy with them suggesting they take part in the
trial. One surgeon mentioned concerns about discussing uncertainty with patients because it could be
detrimental to creating trust in their relationship:
I think the patients wouldn’t trust me. They would wonder what I was up to if I’d had one
conversation and then reversed the conversation the second time around. And if there’s anything you
need it’s for this kind of patients to trust you for this condition.
PI 6
However, this was not a majority view; surgeons and recruiters (n= 18) involved in this trial mentioned
being comfortable explaining uncertainties within the context of the research, because they explained
surgical uncertainties routinely in their clinical practice, e.g. one PI said:
I don’t have a problem with [explaining uncertainty]. Many of the conditions that we treat, there is no
certainty about the results of treatment
PI 4
Contextual aspects of patient care
Principal investigators and recruiters commented on how external circumstances concerning the services
they provided or patient-specific situations may have an impact on who might approach prospective
candidates and how they would do it. For example, various sites expressed concern about patients being
referred for ‘surgery’ instead of ‘treatment’. One site took the initiative of writing to the local referring
professionals to make them aware of the trial and to ask for the referral letter to the patients to be
changed so patients would expect to receive ‘treatment’ and not ‘surgery’. Some centres use a
conservative approach and, therefore, patients tend to go for physiotherapy first before arriving at a
surgeon appointment, as exemplified by the following quotes:
The other problem we’ve got is that patients who are referred from the other centres where they
might have had extensive physiotherapy.
PI 3
Up here, prior to the trial starting, I’d always wanted patients to be seen by physio first to see if they
could be improved by conservative means anyway.
P5
Recruiters said they would find it difficult to approach these patients or to feel confident they would agree
to take part in the trial. The same applied to patients who would have to travel long distances in
rural areas.
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Accord with clinical practice
Clinicians concurred that the trial procedures and paperwork were not disruptive of routine clinical practice
because they were clearly explained during the first visit and the study file was well organised. Research
associates had a key role taking the burden of research procedures from the PIs and consultants during
busy clinics; for example, a recruiting surgeon said:
So it’s a pressurised environment but with the research nurse it seemed to have run without causing
too many time delays or any problems.
PI 6
This proved successful in that clinicians were less likely to disengage from the research procedure in order
to complete their workload for the day. Nevertheless, teams experienced issues such as remembering to
approach patients at each possible opportunity, or the need not to discuss surgery before diagnosis was
confirmed. These issues happened more often when research associates were not available to attend the
clinics. Some teams reported that communication between research associates and consultant surgeons
about upcoming recruitment opportunities could be better in order to arrange the attendance of the
research associates. The person in charge of the clinician’s diary or clinic appointments allocation at the
site was in a privileged position to facilitate the communication between these two groups of professionals.
Some research associates expressed their concern about talking to patients about the audio recording of
the consultation. Patients were asked to give consent for the audio recordings at the beginning of their
clinic but at times they were not eligible for the trial. Research associates did not know how to explain the
recordings without telling patients about FAI and the FASHIoN study and felt uncomfortable to ask for
consent from people not eligible to the trial.
Confidence of research associates about approaching patients
The research associates found the initial training received during the opening site visit was particularly
useful because they had an opportunity to watch an experienced recruiter discuss the trial with a patient;
for example, a recruiter said:
[Research fellow] came down and went through things with both of us on the first day and we’d had
the material to read, you know, in the site file and things. So I’d say that the training on this study was
better than I’ve had for a lot of studies.
R6
Research associates shared their concerns about not being able to answer patient questions and obtain
consent without a surgeon or other senior clinician signing the form for them. For example, a research
associate recalled a particular ‘bad recruitment’ experience when a patient did not understand how a
computer could select their treatment and preferred the surgeon to choose a treatment for them instead,
and another research associate wished a doctor to be present during the recruitment consultation.
Alternative ways of explaining randomisation were collected and shared in the feedback to research
associates. In addition, misconceptions that patients are taking a greater risk by consenting to the trial
than by making a decision about their treatment were examined in training. Long periods between
recruitment clinics represented a challenge for these research associates to maintain confidence and
knowledge about the UK FASHIoN trial. The majority of them worked on different projects and gaps in
recruitment meant it was likely they would forget the knowledge acquired in the previous recruitment
appointments; for example, a recruiter said:
The gaps can be quite big between the patients so I go back to my notes and reread everything again
just before I’m going to see them so it’s fresh in my mind because otherwise you’re likely to forget.
R3
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Concise information about the trial and treatments as well as the six-step recruitment consultation model
were made available to recruiters as quick reminders of the trial procedures prior to each
recruitment opportunity.
Team familiarity with femoroacetabular impingement treatments and
trial procedures
Principal investigators and recruiters recognised the importance of familiarising themselves with the
material and were confident that more recruitment experiences would help them become effective at
giving information. The majority of these clinicians were enthusiastic about their potential contribution to
answering a relevant and valid scientific question through methods they found acceptable. However, some
surgeons did not know or did not want to know about the non-operative arm and some divergent views
were expressed among these professionals; for example, two surgeons thought (1) the conservative care
arm did not seem an appropriate comparator:
I share the concerns and doubts that many of the patients do, i.e. that it won’t work and it’s difficult
to sell a treatment when you yourself don’t really believe it’s going to make any difference.
PI 4
and (2) enough evidence of the benefit of hip arthroscopy for treating FAI was already available:
I spent 20 years learning how to treat patients with certain problems and I’ve gradually learned over
the years which ones I can help and which ones I’m less effective in helping.
PI 7
These views were difficult to reconcile with their commitment to participate in the trial. Surgeons explained
their participation out of a sense of duty to professional collaboration between peers; for example, one of
the surgeons said:
My aim is to help Damian Griffin with his study and one day I may ask him to help me with a study
that he thinks is awful.
PI 7.a
These themes were shared with the TMG and were used to design action plans for supporting recruitment
at the different sites (see Evidence base for the trial).
Recordings of diagnostic and recruitment consultations
Methods
The chief investigator and TMG decided that the meeting in which randomisation was discussed, the
‘recruitment consultation’, as well as the prior appointment when the patient was told their diagnosis of
FAI, ‘diagnostic consultation’, represented pivotal points of the recruitment to this trial and, therefore, sites
were asked to record these two consultations for each potential trial participant.
The importance of audio recording discussions about RCT recruitment was emphasised at site initiation
visit. All participating centres in the pilot RCT were asked to audio record recruitment and diagnostic
consultations when appropriate and feasible. One main point of contact (usually the research associate)
was identified per centre and digital audio recorders were provided. PISs and consent forms for audio
recording and instructions for the operation of the recorder, dictation of patient/recruiter/recording
identifiers, naming and transferring of the recording to the computer and then to the QRI team were
provided to centres. Clinicians were assured the feedback to them was going to be confidential and
positive (not critical). Prior to their consultation with the surgeon, patients were approached and the PIS for
the audio recording of consultations was given to them to read. Once their questions were answered and
if they agreed to the audio recording, patients were then asked to sign a consent form.
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Audio recordings of consultations were analysed following thematic analysis and some of the techniques
of focused conversation analysis pioneered in previous studies (Donovan et al. 2003;26 Donovan et al.
200927). The analytical techniques were used to identify and document aspects of informed consent and
information provision that were unclear or disrupted or which hindered recruitment. The content of the
appointments was evaluated, including what basic content was covered, the order of presentation of RCT
arms and other treatment options, time spent on interventions and time spent describing both the RCT
design and the randomisation process. Furthermore, an assessment was made as to whether or not the
recruiter listened to patients’ concerns and addressed them and also the degree to which there was
evidence that the participant understood the key issues of equipoise, randomisation, participation in the
RCT, the option to choose their treatment and the option to withdraw from the research at any time.
AR documented these details and provided an account for JD and AA. When at least three recordings per
recruiter had been analysed, the QRI researchers decided what confidential feedback would be given in
order to promote research associates’ communication skills development and recruitment effectiveness.
Issues to be fed back to the RCT chief investigator/TMG, or to be used anonymously in training
programmes, were discussed and defined.
Results
Eighty-seven diagnostic and recruitment consultations relating to 60 individual patients were recorded and
analysed. A subset of eight successful and 13 unsuccessful recruitment consultations were studied in
detail in order to understand communication patterns that were linked to improved recruitment rates and
which could be repeated in future patient approaches. The remaining audio recordings were used to
validate the best recruitment practice model (see Figure 9) and create personalised feedback for recruiters
who had submitted the recordings.
Qualitative recruitment intervention support focused on three sites where recruitment was comparatively
low (42–66%).
Common problems identified were:
Unbalanced presentations of treatment options, for which surgery has been presented at greater length and
more favourably than either choosing conservative care or participating in the RCT (surgeons tend to talk most
about what they are most familiar with). The following quote illustrated this information unbalance:
There are other centres and other people have shown physiotherapy to be very useful. It has to be
quite specialist, quite bespoke physiotherapy and the chap here from W [Warwick] University today
has actually come down to recruit patients to a trial. The overall sort of duration of therapy is roughly
around sort of 6 months for both of them to have their benefit, so it’s a similar timescale. Obviously
the operation has small risks attached to it. There’s a very small risk of serious nerve injury, I mean it’s
less than half a per cent, but, you know that’s the main concern with keyhole hip surgery, because we
have to put the leg on traction in order to get in to the hip joint. And sometimes people’s nerves do
not like being pulled upon, but that is very rare. We’ve had 2 cases at this hospital in around about
1000, so you know it’s a rare complication. A little bit of wound infection is a possibility, a little bit of
bleeding, blood clots, things like this. They are all theoretical risks; they all seem to be quite low for
keyhole surgery, so nerve injury is the only sort of serious problem that we’ve experienced. You can
get a bit of numbness of the outside of the thigh because of the skin nerve that can get pranged
because it’s near one of the portals. So these are the kind of downsides of surgery. So you know
those are the two options available and I think you’re a good candidate for either one.
PI8
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Graphic descriptions of surgery that may have put patients off randomisation; for example, one
clinician explained:
There’s always a risk from the traction that it may stretch the nerves down the leg, so that could leave
you with some numbness. If you’re very unlucky it could leave you with a little bit of weakness there.
PI4
Presenting trial information in an order that is confusing for patients, which is illustrated in the
following quote:
OK, and I’ll probably bring [surgeon] in to explain more about the pros and cons of each of the
treatments. Mr [local surgeon] would do the arthroscopy, but for the purpose of the study, we ask
people if they’re happy to do it, and either of the treatments is chosen for you. So a specialised
programme, a computer programme will choose the treatment of your . . . that you will receive.
SN004
Surgeons going beyond their protocol brief, to explain the trial rather than referring patients on to the trial
recruiter for this information; this is illustrated in the following quote in which the surgeon has already
discussed and agreed on a treatment before calling the researcher:
Surgeon: So I’m going to recommend that we (drilling continues) err, at least consider looking inside
your hips.
Patient: Yes.
Surgeon: If you’ve got a moment, I would appreciate if you have a chat with P, who’s the researcher.
Patient: OK.
Surgeon: And just see if the study appeals to you. But you don’t have to, there’s no pressure, you
don’t have to be enrolled in the study.
SN008
Conversely, surgeon endorsement of trial participation to patients appeared to have a positive impact
on recruitment.
Previous research has shown that, in general, one in four people decline to participate in a RCT despite
high-quality recruitment practices because of strong patient preferences or treatment refusal. The
recruitment rate for the FASHIoN study was 70%, which suggested processes of informed consent and
participant self-selection were working well. Therefore, identifying what worked in the recruitment
appointments was relevant in order to replicate recruitment practices in the full trial.
A model of a good FASHIoN recruitment consultation was developed based on communication patterns
identified in the observation of successful recruiters and the comparison and contrast of these patterns
with the ones observed in unsuccessful recruitment consultations. Aspects such as sequence of
presentation, balancing the time and level of detail of the treatment discussions and the sufficiency of
explanations about the trial procedures were addressed. Figure 9 shows the stepwise approach to a good
a recruitment consultation that has been developed based on the analysis of the audio recordings collected
during the FASHIoN trial.
QUALITATIVE RECRUITMENT INTERVENTION
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The main principle underpinning the model is that recruitment consultations are different from clinical
consultations in that they should enable patients to understand uncertainty and lack of clinical research
evidence. In routine clinical consultations, clinicians and patients may be dealing with many uncertainties at
the beginning, but these are soon resolved through the interaction and when a decision about treatment
options is made. The direction of the clinical consultation is from uncertainty towards decision-making,
while in recruitment consultations the sequence of information sharing starts from stating what is currently
known about the treatments and moves towards uncertainty. During the observation of successful
recruitment consultations, a logical sequence emerged which achieved this purpose and is explained next.
Explain FAI  
Reassure about 
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FIGURE 9 The FASHIoN model of a good recruitment consultation: a six-step approach.
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Step 1: explain what femoroacetabular impingement is to the patient
The first step in the recruitment process is the diagnostic consultation. In successful recruitment
consultations, patients received an explanation about FAI that was easy to understand. Clinicians tended to
use lay terms to illustrate what happens to the body because of this condition (e.g. ‘shape abnormality’,
‘egg shape’, ‘extra little piece of bone’, etc.). They also made use of metaphors from common everyday
experiences, for example piston heads in a car, as illustrated by the following quote:
If we imagine a car has a piston that’s not smooth, yours, your hip joint is like a, sort of a joint that’s
not completely smooth and so when you try to move it, it’s causing damage to and pain in your
hip joint.
SN034
These attempts to make sure the patient understands what it is happening to their bodies are important
investments in the relationship and helped patients to feel confident in the care they were receiving. In
addition to the ‘shape abnormality’ explanation of FAI, successful recruiters also introduced the role of
muscle control in the diagnosis of FAI. This information permitted patients to make a logical link between
the condition and the PHT as a plausible treatment, which could be utilised later in the discussion. Many
recruiters expressed their concern about not being able to justify why physiotherapy could be effective.
This explanation addressed this concern; for example, a surgeon summarised it as:
My idea on this is if you’ve got the egg shape, and your muscles are not good at supporting it, then
you run into trouble.
SN053
Surgeons also introduced the common incidence of this condition in the population, which supported the
sense of urgency about answering the research questions and increasing the available knowledge
about FAI.
Step 2: reassure the patient that they will receive treatment
Patients who agreed to participate in the trial were reassured their diagnosis was confirmed. They were
also reassured they would receive the best treatment to meet their individual needs, whether they agreed
to be in the trial or not, as illustrated in the following quote:
You’re getting a bit of extra rubbing. And that rubbing is causing the pain, so there’s not really any
mystery, we know what the problem is [. . .] my suggestion is that we treat this problem; I don’t think
we should just leave it alone, I think we need to try and make you better.
SN034
This was important because many patients waited for a long time to reach the appointment with the
surgeon and may have been previously misdiagnosed. Patients may arrive at the clinic dissatisfied with the
treatment they received so far. Often patients who declined to be part of the trial have experienced these
difficulties. Being told that finally they have the right diagnosis, that someone is confident about it,
generates trust and openness to the invitation to help improving care for other patients like themselves.
This step addressed the previously identified concern that the treatment allocated to them is not taking
into consideration their personal circumstances and their individual needs for care. A direct invitation from
the consultant surgeon to the patient about participating in the trial seems particularly effective in getting
the person to consider the trial and to listen to the recruiter; an example is presented in the
following extract:
And in a minute, one of my colleagues, if you agree, will come and talk to you about how that
particular study is working. And, if you would like to, I would very much like to include you in
that study?
SN053
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Step 3: explain that there is uncertainty about which treatment is the best
Steps 1 and 2 promote certainty, whereas step 3 is about introducing uncertainty. In successful recruitment
consultations, uncertainty was mentioned earlier on and by the consultant, and then it was reinforced
repeatedly by the recruiter during their appointment with the patient. Even in effective recruitment
consultations, recognising uncertainty may be difficult for patients. Effective recruiters enabled the patient
to understand that the two treatments that were being compared are effective in their own right. This
argument helps to compensate for the uneasiness of not knowing which treatment is best. The following
extract of a diagnostic consultation exemplifies this step:
Consultant: I think we can offer you some treatment for it, but the trouble is we’ve only really just
started to understand this disease [. . .] we’ve got two treatments that we know can help, but we just
don’t know which is the better one.
Recruiter: What we’re doing is, as [the consultant] has explained, we don’t know which is best, we’re
not sure. [Consultant], myself and any of the other consultants that specialise in hips here, can’t tell
you. For you, I think the best thing to do is X or Y because we don’t know.
Patient: You don’t know what the best treatment is?
Recruiter: Well, we need people like you to say, ‘OK, I’m happy to take part, and whichever treatment
I get then I should, should get a little bit better’, but one will be better than the other probably.
SN034
Step 4: explain the purpose of the study
Once uncertainty was been explained, the purpose of the study follows logically. Recruiters stated how the
findings of the research would help clinicians to advise patients like them in the future. At this point,
successful recruiters mentioned the need for evidence, implying the real contribution to advancing science
and health care that patients could make. Recruiters were successful at harmonising the message that FAI
is a condition that clinicians are interested in knowing more about how to treat and the message that
patients would be valued, respected and cared for during the trial. An example is presented below:
[The recruiter] can explain the study to you, and explain how we try and find out the answer to the
question and how you might get involved in that. One thing though, is whatever we do, and I’m
going to do everything I can to make you better.
SN006
Step 5: give the patient a balanced view about the pros and cons of each of
the two treatments
In some cases, the recruitment consultation was introduced as a conversation about the options available
to patients. For example, one surgeon said:
[Recruiter] is doing a study looking at the different solutions and he could talk to you about the
options if we got to the point where you said you’d like to do something about it.
SN007
Instead, some successful recruiters and clinicians avoided the word ‘options’ when referring to the
treatment arms of the RCT because it implies there is a decision to be made between the two treatments,
whereas the patient has to decide between being part of the trial or not. Alternative expressions such
as ‘available treatments’ or ‘ways to treat FAI’ were used, providing a clearer message. In effective
recruitment consultations, the treatment arms were presented as two ways of dealing with the same
condition. Recruiters spent similar amounts of time explaining each one of the arms. They tended to start
with the non-operative arm and the balance between the two treatments was maintained when talking in
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
55
detail about the benefits and risks of each arm (e.g. number of visits to hospital for each arm, duration of
the intervention). For example, a recruiter discussed the balance between arms as:
The kind of use of your time is equal, whichever one you go for, whichever one you’re allocated to . . .
The reason I say that is because if you have an operation you have to come for a pre-operative
assessment, you have to have the operation and you have to have some rehab. If you’re allocated to
the personalised hip therapy, you’ll have to come here on three, at least three occasions, and then
they’ll give you specific exercises to practise at home.
SN034
Effective recruiters also emphasised the benefits of the two treatments in order to assure patients they
were not taking any more risks than if they were making the choice themselves. After step 5, patients
usually were not sure what treatment to choose. They may have thought about having one treatment at
the start of the conversation, but at this point, they expressed either the opposite choice or simply
uncertainty about which one to have. Patient equipoise was thus achieved.
Step 6: explain the study procedures
Once uncertainty and equipoise were established, the allocation of treatments by randomisation seemed
more acceptable. Randomisation was mentioned later on in the conversation and recruiters spent a lot less
time explaining it than the time they spent on the other steps. Randomisation was usually presented as an
allocation or being invited to join one of the groups, which should allow a fair comparison. The following
quote exemplified this explanation:
But in order to make it a fair test and in order to make sure that we’re truly, truly testing which one’s
better, we have to go through a process whereby we allocate you with a treatment. So I don’t choose
and [Professor] doesn’t choose and we don’t choose which, which treatment you have . . . it’s
randomly allocated to you
SN003
The questionnaires and the reassessment after a year were constructed as part of a closer follow-up of
participants in the trial than for people going through regular care. This was part of the efforts of the
recruiters to emphasise that patients would be treated with respect and receive personalised care.
Two more tasks were added to the model. They are not a fixed part of the six-step sequence; instead they
happen at different points throughout the most successful consultations. These two tasks appeared to be
essential and determinant in the successful of a recruitment consultation.
Task 1: respond to patients’ concerns and questions
The majority of patient questions occurred after the two treatments were explained. Often patients wanted
to know about the details of each arm and the rationale for the non-operative arm. Successful recruiters
stopped delivering information and answered the questions or listened to patient concerns before moving
onto the next step. The conversations in the most successful recruitment consultations were highly
patient-centred, with evidence the clinicians were responding to the patient’s concerns and doubts about
the trial. Patients asked more questions than in unsuccessful recruitment appointments. Recruiters
confirmed that patient participation was voluntary and that patients would receive treatment regardless of
their involvement with the study, which encouraged trust.
Task 2: show confidence and a relaxed manner
Effective recruiters appeared confident and relaxed when talking about the study. This was based on
having a good working knowledge about the condition and the treatments or taking actions towards
achieving it. In addition, successful recruiters used a set of ready-made answers to common patient
questions prepared by the TMG and worked closely with the clinicians in order to deal with
tricky questions.
QUALITATIVE RECRUITMENT INTERVENTION
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The model structure is identical to the approach used in the PIS. Therefore, giving the patient the opportunity
to read this document at the beginning of recruitment could save time dedicated to information sharing.
Instead, this time can be used to respond to patients’ concerns, showing the balance between risks and
benefits between the two trial arms, reassuring patients about participating in a trial, explaining the condition
in more detail or discussing uncertainty. Feedback to the sites was prepared based on this model and
presented to the recruiters and PIs (see Evidence base for the trial). Further data collection continued to be
used to develop and validate the model.
Study documentation
Patient information sheets were compared with the findings from the interviews and recorded diagnostic
and recruitment consultations, to identify any disparities or improvements that could be made. Careful
preparation of the study documentation was carried out during the pre-pilot phase of the study as
reported in previous sections. The pilot trial showed this documentation fulfilled its purpose well and
would be suitable for a full trial.
Evidence base for the trial
During the interviews and recorded appointments, the QRI team checked for any relevant and emergent
evidence that could support or threaten the RCT. Surgeons in participating sites referred to case studies of
successful FAI treatment with hip arthroscopy as the highest level of evidence. However, the clinician
group in this RCT has been actively involved in the assessment of the scientific literature for operative and
non-operative FAI treatments and recently published a systematic review of best conservative treatment for
FAI. The evidence is still that a RCT is required.
Qualitative recruitment intervention feedback to chief
investigator and trial management group
The TMG met regularly and aspects of the recruitment and eligibility criteria as well as the day-to-day running of
the pilot trial were discussed. The QRI research team attended the TMG meetings providing an update on
recruitment progress, raising issues discovered during the QRI and suggesting training or advice about
recruitment. The QRI team prepared and presented various reports (e.g. Appendices 4 and 7) identifying any
aspects of the study design or conduct that could be hindering recruitment with the supporting evidence. These
findings were the basis for action plans that included issues with patient pathways and logistical challenges in
particular centres. Agreed actions with the chief investigator and TMG to address these issues were:
l Feedback to PIs and recruiters should be given through personalised letters. These were prepared and
sent to the centres (see Appendix 11 for examples).
l Specific centres and PIs needed follow-up with text messages and newsletter reminders about the need
to recruit.
l Contacts between research and clinical departments about recruitment opportunities should
be encouraged.
l Training materials should be prepared and disseminated. These included:
¢ a document explaining the FASHIoN recruitment consultation model
¢ an example of successful recruitment consultation
¢ patients’ frequently asked questions and answers document and
¢ treatment protocols.
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Overall, the recruitment rates have remained stable over the course of the pilot. The qualitative study of
recruitment therefore showed there are no major concerns about the feasibility of patient recruitment
for this trial. The work with the three centres with lower rates continues and their improvement will be
assessed shortly; however, owing to the pilot time scale, these results had not been received by the time
this report was completed.
Discussion
The pilot phase of this RCT has shown the recruitment of patients is feasible and acceptable. The
qualitative analysis of recruitment highlighted good practices that can continue to be promoted in a full
trial. There is evidence the separation between diagnostic and recruitment consultations led by research
associate recruiters can be implemented and have a positive impact on recruitment rates. These research
associates contribute to making the research process less disruptive of clinical practice and promote
equipoise when presenting the available treatments to patients. Clinic attendance and communication
between the research associates and personnel in charge of scheduling appointments has been shown to
be relevant. Therefore, it is important sufficient resources be allocated to these aspects of the research in a
full RCT.
The study documentation was well organised and performed as expected. The initial visits to the sites
included training sessions modelling good recruitment consultations, which were valued by research
associates, as they helped them to develop their understanding and skills about recruitment for this
particular RCT. Creating a video and material that they can access easily before each recruitment
opportunity arises may be an ideal way to disseminate and standardise recruitment practices across
participating sites.
We had been concerned that clinicians and research associates would be unfamiliar with audio recording
and, even if they agreed to it, might resist making successful recordings. However, there was no evidence
that this was the case in this pilot RCT. The audio recordings of consultations were introduced to the sites
at the site initiation visits and adequate information about the recording and transfer of files was
developed. Further clarity about the consent process for the audio recording will be required to avoid
misunderstandings within the research teams at participating sites.
Two qualitative analytical methods described in the protocol were not used in the pilot study. We
proposed to transcribe and analyse the TMG and TSG meetings. Recruitment difficulties were expected at
the early stages of the RCT and the analysis was set up to foster discussions between team members.
However, the QRI team attended these meetings and observed the groups were generally in agreement
about the way forwards and hence functioning sufficiently well. Consequently, it was decided that no
further intervention was necessary.
The second method we did not use was the Roter Interaction Analysis System (RIAS) system. Initially RIAS
was going to be applied to diagnostic and recruitment consultations that failed to recruit patients to the
trial. The RIAS system works based on the frequencies of certain target behaviours, which then can be
analysed statistically. However, there were few unsuccessful recruitment consultations, which were likely
to register low frequencies in RIAS. As a result, this quantitative method was not viable. The QRI team
decided instead to focus on the qualitative analysis of successful consultations using focused conversation
analysis, a method developed and tested by JD in previous research.22 The method is suitable for small
samples and has the advantage of uncovering subtleties in communication that can be modified. The
analyses highlighted and illustrated key messages for successful recruitment practice, providing data that
helped underpin the training materials developed.
QUALITATIVE RECRUITMENT INTERVENTION
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Some challenges to recruitment success emerged from this research connected to logistical issues.
Strategies for reminding research teams, and especially surgeons, about identifying and approaching
potential participants for the trial should be implemented. These could be electronic remainders sent on
the day of clinics, regular visits to the site and newsletters to maintain momentum and engagement at
participating sites. It is also important to consider how the TMG can facilitate awareness of the trial
at referring centres and among orthopaedic surgeons who are not directly involved in the trial. This is a
concern for the PIs and research associates who perceive they may need support in dealing with patient
expectations. Based on the evidence collected in this qualitative study of recruitment, the TMG has shown
a high level of organisation and effectiveness in delivering an acceptable research study for patients with
FAI and clinicians dedicated to its treatment.
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Chapter 5 Discussion and conclusion
We have shown that a RCT of arthroscopic surgery for hip impingement compared with bestconservative care is feasible.
The feasibility study included (1) a pre-pilot phase including patient and clinician surveys and interviews;
(2) a workload survey of hip arthroscopy for FAI; (3) development of best conventional care and
arthroscopic surgery protocols; (4) a pilot RCT to measure recruitment rate; and (5) an integrated
programme of qualitative research (QRI) to understand and optimise recruitment.
The feasibility study specifically addressed the following aspects of the design of a full-scale RCT.
l Define eligibility criteria: we have defined these by international consensus and confirmed that they are
applicable in a pilot RCT.
l Define a protocol for hip arthroscopy for FAI: we have defined this and shown that it can be applied in
several centres and by several surgeons in the context of a RCT. We also developed a method to
measure fidelity by intraoperative photographs and postoperative MRI, assessed by a panel of
independent international experts. We showed that this approach was acceptable to surgeons and
demonstrated complete adherence to protocol in six out of seven operations at the first
panel conference.
l Define a protocol for best conventional care (comparator): we have developed a physiotherapy-led,
four-component protocol through national and international consensus. We used a patient focus group
to choose the most acceptable name for this protocol of best conventional care; they selected
‘personalised hip therapy (PHT)’. In the development of PHT we struck a balance between the need for
a meaningful comparator for hip arthroscopy, the need to ensure PHT is different from previous
physiotherapy that FAI patients may have experienced and the need for PHT to be deliverable in the
NHS outside a trial. We tested the protocol and a logbook approach to assessing fidelity in
21 participants randomised to PHT in the pilot trial. The protocol was acceptable to patients and
physiotherapists and we demonstrated complete adherence in five of the first eight participants.
l Define willingness of centres and patients to be recruited to a RCT: we have demonstrated that around
2000 patients have arthroscopic surgery for FAI each year in the UK and that most of these are treated
in relatively few high-volume centres. Most (17/18) of the surgeons in these centres expressed a
preparedness to randomise patients. All (18/18) of a sample of patients who had been treated for FAI
said that they would have been prepared to take part in a trial if it had been offered to them, but
expressed concerns about how the trial and treatment might be explained adequately.
l Understand and optimise recruitment: we identified structural features associated with successful
recruitment, such as running targeted clinics, having a dedicated research associate in attendance and
ensuring referred patients arrived with expectations of receiving treatment for FAI rather than being
told they had been referred for surgery. We identified clinician and research associate behaviours that
were associated with successful recruitment and developed training packages to correct common
problems. Analysis of 87 consultations with 60 patients led to the development of a six-step model for
presentation of trial information (see Figure 1) to optimise recruitment.
l Estimate recruitment rate: we have demonstrated a recruitment rate of 70% in a pilot RCT, with a
lower limit 95% CI of 54%. This suggests that it would be reasonable to conservatively plan for a 50%
recruitment rate in a full trial.
l Select appropriate outcome measures: we have shown that iHOT-33 and NAHS are both easy to use
and acceptable to patients. The extensive patient involvement in item generation, the availability of an
independently determined MCID and the use of iHOT as the principal outcome measure for the UK
Non-Arthritic Hip Registry lead us to suggest iHOT-33 as the most appropriate primary outcome
measure for a full trial.
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l Estimate the SD and effect size of the primary outcome measure: in our pilot study, the baseline
iHOT-33 data of patients who were suitable for inclusion had a SD of 16.0, which is consistent with
other studies. There is little information with which to estimate the likely effect of hip arthroscopy
compared with best conventional care, but an analysis of observational studies suggests a standardised
effect size of > 0.5. iHOT-33 has a reported MCID of 6.1 points, so a RCT using this instrument should
be able to demonstrate a standardised effect size as low as 0.5.
l Develop and test trial procedures: we designed protocols, eligibility criteria, patient information material
and case report forms and found that they performed well in the pilot RCT. REC and national R&D
approvals were granted for the pilot trial promptly and without any significant concerns.
l Estimate follow-up rates: the pilot RCT was designed to estimate recruitment rate. As of 1 February
2014, 32 patients have reached the full 12 months of follow-up. We have achieved 93% (39/42)
follow-up at 3 months, 90% (38/42) follow-up at 6 months and 97% (31/32) follow-up at 12 months.
l Calculate sample size for a definitive study: we estimate that 292 participants would be required for
a full trial to have 90% power to detect an effect difference equal to or more than the MCID at
12-month follow-up, between treatment arms, in iHOT-33 (6.1 points) at 5% significance. Assuming
85% follow-up at 1 year, this suggests a total sample size of 344 participants. With a 50% recruitment
rate, we estimate that this could be achieved in 25 of the higher-volume centres in the UK over
20 months.
l Public and patient involvement: patients made a very large contribution to this study. A patient was
part of the research team from the outset and is one of the authors of this report. A panel of expert
patients made key contributions to the pre-pilot work, particularly in expressing enthusiasm for a trial,
explaining how patients would feel about being approached to be randomised and designing the
patient information for the pilot RCT. Patients told us that we had to be careful to design a credible
best conventional care comparator for hip arthroscopy and chose the name for it. Our patient
collaborator helped us to develop our ethics submission and then participated in the Trial Steering
Committee. In subsequent work to plan a full RCT, a second patient has joined our collaboration and
we have created a panel of patients and members of the public drawn from the University of Warwick
University/User Teaching and Research Action Partnership (UNTRAP) PPI programme. They are guiding
us in marketing the trial and ensuring dissemination methods such as Twitter (San Francisco, CA, USA)
and Facebook (Cambridge, MA, USA) that are suitable for our target patient population.
In conclusion, it is clear that a full RCT of hip arthroscopy compared with best conventional care for FAI is
feasible. The technology of hip arthroscopy is sufficiently mature and in sufficiently widespread use for a
pragmatic trial to be done. Our findings were that equipoise is not universal, but that there are still enough
patients and surgeons with enough uncertainty for a trial to be completed now. The design and structure
of a RCT was developed and tested in a pilot RCT, which can be used as an internal pilot for a full RCT.
Recruitment was challenging, largely because the two interventions under scrutiny are so very different.
Despite this, a QRI helped us to achieve a recruitment rate of 70% recruitment across the sites. A full RCT
involving more sites will need to continue to use a QRI to ensure successful recruitment.
The window of opportunity for a trial of this technology is open now and we have developed a study
design that we have demonstrated to be feasible. We propose that a full trial be performed.
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Appendix 1 Anonymous patient cases and
clinician interview schedule
“Aileen”
· 49 year old Business Woman.
· Enjoys cycling and horse riding and wants to continue.
· Left sided groin pain after for over 2 years.
· Examination suggests anterior femoroacetabular impingement.
· Imaging radiographs, CT and MRA imaging show evidence of 
pincer type FAI.
· Aileen is prepared to have treatment for this.
· Aileen has already had a course of physiotherapy by her GP 
which did not help her symptoms.
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“George”
· 40 year old Schoolteacher.
· Enjoys playing hockey, windsurfing and swimming and wants 
to be able to continue these pursuits.
· 12 month history of right sided groin pain.
· Examination suggests anterior femoroacetabular impingement.
· Imaging radiographs, CT and MRA show evidence of right 
sided CAM type FAI with a labral tear.
· George is prepared to have treatment for this.
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Protocol Pre-pilot Clinicians Interviews
UK FASHIoN
Chief Investigator: Professor Damian Griffin
1. Greeting 
“Thank you for agreeing to take part in this study. As you know, we are seeking the advice of expert 
clinicians like yourself, about randomising patients to clinical trials. We would like to talk to you 
about this”
2. Verbal consent
“Will it be okay with you if we audio record this conversation?”
3. Explaining the trial
“The context for this request is a new research project - the UK feasibility study of a trial of 
arthroscopic surgery for hip impingement compared with non-operative care (the UK FASHIoN 
project).”
“We would like you to imagine that there is a randomised controlled trial currently taking place 
comparing hip arthroscopy versus best conservative care (physiotherapy) for femoroacetabular 
impingement.”
“The trial design is outlined in this information sheet.”
“As a recruiting clinician, it is up to you whether to send a patient to the randomised trial or continue 
with usual care. If the patient is referred to be part of the trial, a researcher will discuss the trial with 
the patient and obtain informed consent to the randomisation.”
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“These are the notes of a patient who may have hip impingement. I would like you to think aloud and 
tell me what is going through your mind as you read this case. I am particularly interested in thoughts 
you may have when considering an intervention including referring the patient to the randomised 
control trial. So, can you tell me what it is in your mind about this patient?”
Prompts: 
What other interventions are you considering in this case?
What concerns do you have about sending the patient to randomisation?
What would make you decide one way or another?
What would you do if the trial was not running? 
Will you opt for operative or non-operative care? 
Which treatment do you think will help this patient more? 
What do you think about the control condition, conservative care? 
Are there any patients you would prefer not to randomise?
5. Next case
“Please have a look to the next case and just as before I would like you to think aloud and tell me 
what is going through your mind as you read this case. I am particularly interested in thoughts you 
may have when considering an intervention including referring the patient to the randomised control 
trial. So, can you tell me what it is in your mind about this patient?”
(Prompts)
4. Case study Introduction 
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Your contribution is much appreciated and extremely valuable to us. It will help us to improve the 
information available to clinicians deciding whether or not to participate in the UK FASHIoN study in 
the future.
6. Closing
Thank you very much! 
Any other comments or thoughts?
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Appendix 2 Detailed results of patient interviews
Integrative qualitative study of recruitment pre-pilot report:
patients’ views
Method
Semistructured interviews were conducted with a sample of patients who have received treatment for FAI.
The interviews explored patients’ perspectives on their hip problems, previous experiences with treatments,
views about arthroscopy surgery and conservative care and the acceptability of randomisation between the
interventions. Fourteen patients interviewed were also asked to complete the expert patient survey while
talking to the researcher.
Procedure
An invitation to be part of an expert patient panel was sent to patients who have been diagnosed and
treated for FAI at the UHCW NHS Trust. Patients who replied to the invitation and signed the consent form
were asked if they were willing to participate in one-to-one interviews. Initially, we had planned to give
questionnaires to 50 patients and to interview 15 of these. However, it emerged that the one-to-one
interviews provided much richer in-depth information than administering surveys alone and that this
allowed data saturation to be achieved. Participants were purposively chosen to include a range of age,
sex, disease severity, activity and socioeconomic status as well as those who had received operative and
conservative care in the patient sample.
Once the expert panel member declared their willingness to be interviewed, the researcher (AR) contacted
them and explained the qualitative study. The participant information sheet and consent form was sent by
post and, when the consent form was returned signed by the participant, an appointment for the
interview was set up, whether face to face at the hospital or by telephone. The participant was also asked
to read and assess the draft trial PIS prior to the interview. The expert patient questionnaire was given to
the participant in order to facilitate the assessment of the trial PIS. During the interview, open-ended
questions were used to guide the conversation and the participant’s answers to the questionnaire were
discussed. The participants did not receive any monetary or other reward for their participation. The study
was approved by the ethics committee at University of Warwick and NHS.
Data analysis
Transcripts of the interviews were prepared and thematic analysis was used to extract key messages about
patient experiences of hip impingement and treatments, acceptability of the treatment options, the
understanding of randomisation and advice on how to improve the trial participant information sheet. AR
coded the transcripts using NVivo. Agreeing and contrasting views were identified for each area of interest
(e.g. randomisation). After discussing the structure and content of the results, the QRI team agreed on some
recommendations which were presented to the trial management team. Further discussions took place in trial
management meetings and, once agreement was reached regarding the recommendations, changes to the
trial PIS and recruitment strategies to be tested in the pilot were implemented.
Findings
Sample
Eight female and 10 male patients who were members of the expert patient panel answered the invitation
to a one-to-one interview. The conversation was focused on their experience with hip impingement and
the RCT proposed in UK FASHIoN. Five patients were currently undergoing treatment for FAI, one was
scheduled to have the surgery in the next few months and the other four were about to start a course of
non-operative treatment. The remaining 13 patients have had hip arthroscopy. The surgery had taken
place from a few months earlier to over the past 8 years.
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Patients’ experiences of hip impingement and treatments
The patients in this sample tended to be generally fit and healthy. They were involved in various sporting
activities at different levels of competence or they have physically demanding jobs (e.g. military, farming):
I’m member of my local football team, I play for the first, I’m captain, and it’s important to me that I’m
involved, I’d love playing over the weekend, I play once a week, it’s been great that I can continue to
do that.
EP 4
I’ve always been, through my school life, been very active, doing lots of sports, sky, horse riding when
I was younger, and for quite a long time now I’ve gone to my local gym and all kinds of running, cross
training, row machine.
EP 5
However, the condition was not exclusively developed by people who did sports:
I’ve never been terribly active . . . I don’t take regular exercise apart from being the mother of three
and two grandchildren, so I’m on the go all the time.
EP 10
About half of the patients in this sample reported at first feeling acute pain after physical activity, which
did not have a great impact in other activities of everyday life. Other common symptoms reported were
discomfort and lack of sleep owing to pain. Some have had pain over a few years before they
sought treatment:
During the course of playing golf, it wasn’t that bad, it was afterwards [. . .] it was very painful, it was
bad enough to stop me sleeping and things like that because I couldn’t feel comfortable in bed.
EP 7
I had pain for 2–3 years not knowing what it was, thinking it was some kind of strain.
EP 5
The pain increased with time and started to interfere in patients’ lives, which led to seeking a solution to
their discomfort. A patient, who is in the military, explained that he had been involved in many different
treatments wasting time and opportunities for career advancement (EP 2). For other patients, seeking
treatment was related to their lifestyle and coping mechanisms, as demonstrated by the following quote:
It started like a general discomfort and then it became more of impact in our day-to-day lives, me and
my husband like long distance walking and that became a problem . . . when you are in pain it gets
you down after a while.
EP11
Patients were often misdiagnosed and sent to physiotherapy in an attempt to address the symptoms
before they met the orthopaedic surgeon:
I did get sent to a lot of physiotherapy, it was only when I pushed it ‘look this isn’t right, this is not
how it should be’ the hip specialist in a private hospital, put me through to [orthopaedic surgeon].
EP 4
Because I originally went to the doctor with groin pain, they thought it was perhaps a strain, they
thought my back wasn’t aligned or something.
EP 5
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As a consequence, they experienced different types of physiotherapy with little results. This was reported
often by those who underwent hip arthroscopy:
The symptoms came and went, I did a lot of climbing, a lot of twisting, stuff like that [. . .] I’ve got
to the point where I was referred to a physio, that didn’t do any good and then it was suggested
I went private.
EP 9
As the majority of patients have private health insurance, it appeared that their waiting time between their
first complaint and the consultation with the surgeon was shorter than those on the public health service:
I do have private health care which allowed me to go down this route and used
[orthopaedic surgeon].
EP 4
The patients who had hip arthroscopy reported the recovery time was acceptable and, although some still
experience occasional pain, they were in general very satisfied with the outcome:
It was great, the first one I’ve done, the recovery was really fast, I was in the clinic that day I had the
surgery, I went through heavy intensive physiotherapy for 2 months after, but within 3 months I was
back running again.
EP 4
The two patients who were managing the condition conservatively reported being pleased with not
having to go through surgery, one because of an unsuccessful operation that led to more complications
and the other because it would involve more time off work following a previous health complaint.
However, the non-operative care plan is perceived as a temporary measure:
I like the approach, we know what it is now, let’s try the cortisones, I’m surprised about having a
second cortisone, but on the basis it worked quite well last time, who knows if it may work this time,
I think we are all sort of expecting seeing me back here again in a few months’ time.
EP 1
Acceptability of treatment options
This section summarises the different ideas that patients shared regarding the two treatment options that
have been compared.
Hip arthroscopy surgery
The majority of patients regarded surgery as a ‘point of last resort’ (EP 1) and a definite solution for a
severe condition that is mainly morphological:
I was a bit shocked to realise that I would need surgery to remove part of the bone, it was probably
more serious than I thought it was going to be.
EP 5
With the exception of doing nothing, some patients did not know of, or were not offered, any other
treatment option at the time than surgery:
I didn’t know there was a decision to be made . . . I had a problem and that’s how you corrected it,
so it wasn’t like there was a choice and needed an explanation.
EP 4
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Patients perceived hip arthroscopy as an acceptable option and those who had this treatment decided to
go ahead because they trusted the surgeon and had the expectation of a shorter recovery time than other
surgical options such as open surgery:
Because of my partner had the hip surfacing I thought that was going to be the course of action . . .
then when there was a lesser intrusive operation available I was completely happy to attend that and I
realise if and when that no longer works for me then I have a surfacing after that so it was weighting
up the logical course of treatment.
EP 10
Another advantage of the surgery was the possibility of preventing the progression of arthritis and the
need for a total hip replacement later in life:
This is just feeling, not proven, I can see if I didn’t do anything now in 20 years’ time I’d probably need
a hip replacement surgery.
EP 1
One patient who was having conservative care at the time expressed concerns about nerve damage,
surgery complications or ending with a limp and visible scars. Furthermore, this patient worried about the
postoperative care:
Because you have to be out work and in crutches, and it would have implications for me for childcare
if I have it, I don’t know how immobile you’d be.
EP 3
However, it appeared that for those patients who have undergone surgery the benefits outweighed the
risks and they tended to recommend this option even though they may not have experienced
total recovery:
Being through the arthroscopy myself and the successful nature of it, or nearly successful nature, let’s
remember I still feel a little bit of pain in my right hip [. . .] it’s not 100% resolved or solved, I do feel it
has a big impact there.
EP 4
The explanations giving by the consultant were particularly useful for patients to decide to go ahead with
the surgical treatment:
[surgeon] actually went through everything in a precise way, he showed me the scans in the laptop
and he showed me what he needed to do in order to alleviate my problem that certainly thinking in a
mechanical way in a laptop was very good.
EP 11
Conservative care
Conservative care was perceived as a less invasive procedure acceptable for people who experience less
serious FAI symptoms or were at risk of complications with surgery:
Try to resolve it in a more considerate more gently fashion, as opposed to going to surgery.
EP 1
Therapy in some situations would be a better way of treating this problem, because there is no surgery
involved and the risks that come with that.
EP 4
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One patient mentioned the funding may have been a consideration in the treatment that was offered:
I just think if you don’t get many symptoms, they are not going to use the funding to operate.
EP 3
A patient in conservative treatment made sense of the physiotherapy as an opportunity to retrain
the muscles:
The idea is that the physiotherapy will teach me to my muscles to work in a way that doesn‘t impinge
in my hip. If that can happen, great.
EP 1
However, for the majority of patients, non-operative care was perceived as a provisional solution or as a
first step treatment plan because it was not clear how physiotherapy alone can repair the damage.
Understanding how conservative treatment could cure the condition was a major concern for patients in
this sample.
Various patients expressed fears of further damage of the tissue or eventually developing arthritis if the
intervention was conservative:
Physio may improve a bit but I can’t see how physio can resolve the problem if it is hip impingement.
I, it can tear again if I get active, and if I’ve got arthritis, I don’t see how it can get better.
EP 3
Additionally, attending physiotherapy appointments may be troublesome for some, especially for those
with previous experience of conservative care who did not obtain good results. A patient ‘was not keen on
physiotherapy’ as he was involved in a 7- to 8-hour workout to relieve pain, which in his view was
completely impractical. Therefore, it seemed to be a less optimal treatment option:
I think I would have been a bit cynical and assumed that the operative choice would work for me so if
the pain was not improving significantly, I would have probably lost patience quite quickly.
EP 10
The idea of personalised care that includes different treatments may be more appealing:
Different treatment for every different patient that was involved, someone would react better to
steroid injections, some would react better to acupuncture, some wouldn’t, so I think a personalised
programme, or therapy, would be good because people would realise the treatment would be specific
to them and their particular situation.
EP 4
However, as previous experiences with treatment seemed important in deciding future care paths, the
non-operative treatment should be presented as a different alternative to just physiotherapy. For example,
a regime that addresses the particular issue of FAI could be perceived more positively:
In terms of physio[therapy] on my hip, the only physio[therapy] I’ve done is the post-operation
physio[therapy], so certainly I would be interested in [physiotherapy], something that focus and look
the area and work with [the hip muscles].
EP 8
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Alternatively, more explanation about what can be achieved with this treatment may help to convince
patients to join the trial:
I’d say because I had physio and have not have had much success with it I would be less willing to go
into the clinical trial where I’d end with more physio, that would need to be what else is other
than physiotherapy, which in this trial is because you are talking about injections, massages and
acupuncture . . . that there are alternatives, what the steroid injections do, why is that done and what
they are hoping to achieve with that.
EP 11
[physiotherapy] didn’t help me, but it wasn’t in combination [. . .] perhaps therapy rather than the
surgery would include steroid injections and things like that, so I don’t know, maybe in combination it
may help with this.
EP 9
Acceptability of randomisation
Various patients shared their thoughts about the importance of being involved in research. The benefit
to the whole community and helping clinicians improve their knowledge and advice for future
patients seemed important motivators; hence, they responded to the invitation to participate in the
one-to-one interviews:
I understand why it’s been done, and it sounds like it probably needs to be done, so medical teams
and authorities know the best course of action for hip impingement, so that’s where we are in reality,
and I could see in terms of the benefit of the whole, taking a holistic approach to it for future patients
having that sample undertaking.
EP 1
However, when confronted with the design of the RCT, patients felt the 50 : 50 allocation was not
acceptable. They gave various reasons summarised below.
The first issue with the allocation was the perception that clinicians would be not looking after the best
interest of the patients but distributing people according to the needs of the trial:
It is not ethical if it’s random [. . .] It makes you wonder 50 : 50 if you’re just going to be put in one or
the other without looking at how your symptoms are or how you are, it sounds worrying.
EP 3
You’re going to take part on our study and we will tell you which treatment you are having, whether
it’s the right necessary for you, that’s how it come across.
EP 5
Connected to this issue, patients presumed that the health-care providers would know what is the best
line of treatment for them. Therefore, allocation was perceived as unnecessary or odd and they were left
asking who would make the decisions and how. Patients described randomisation or 50 : 50 allocations as
‘a toss of a coin’, ‘bingo’, ‘being a guinea pig’, ‘everybody is put into a hat’, ‘a lottery’:
I think it ought to be dependent on your particular situation rather than on a 50 : 50 toss of a coin
which way you went. I’m sure some issues, and some hip injuries, are probably more suited to one
route rather than other.
EP 4
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The word ‘allocated’, I think it is the wrong word to use, your consultant would decide which
treatment is best for you, but allocated makes me feel that actually they are not really taking my
medical complaint seriously or the best to what it would make it better.
EP 5
The third issue mentioned was the imbalance between the two treatments when one is perceived as
curative and the other is not:
I don’t know to be honest, I don’t know if that feels the right way to do it, and having pain that I had
for so long, would I like to have go and have an injection and wait for another few months, and then
have to have an operation, that’s probably a hard decision.
EP 5
If they have the symptoms the same as somebody else and the other person’s having surgery to
correct it, the person who’s having physio would think ‘how can it be corrected without the surgery?’
EP 3
Two patients expressed concerns about waiting for 12 months, as it could have an impact on the options
available after the study finishes:
It’s about if the problem was left and treated by physiotherapy there was the possibility of something
else being affected during the physiotherapy that then the surgery couldn’t cure, which could have
been cured straight away.
EP 6
Similarly, another patient asked about how the progress of the treatment would be assessed during the
trial and what would happen if the care plan was not working:
Do you see the consultant at any point during the year? I presume you see him at the beginning, but
how is it assessed during the trial as whether it is not actually getting worse? Because that’s not in the
information, is there? . . . it may be worth thinking about putting at the end because it doesn’t say . . .
how the year progresses, how am I improving? So it may be nice for the patients to actually think
3 months, 6 months actually it is getting worse.
EP 11
Finally, patients felt that comparing surgery with injections and medication treatments would be more
acceptable, leaving physiotherapy for the postoperative care. Alternatively, by making sure that the
operative option is available at the end of the trial:
Surgery for most people has got to be the last option, now if they can sort it out with physio, and
after 12 months of physio doesn’t work, OK let’s do the surgery, I think that’s acceptable to me,
I won’t have a problem with that, it is information that I’d like to have.
EP 13
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Patient recommendations to improve the participant information sheet and
study in general
Time to ask questions with a specialist
Patients valued the opportunity to talk to a specialist without being rushed and the ability to ask questions
about their particular situation:
It’s always about explaining the options, being opened, honest with the patient, [surgeon] had time to
talk about the options and explained the option, so great!
EP 4
I have complete faith in the [surgeon] because he was incredibly good at explaining everything, and
very reassuring, he showed the diagrams, the pictures and explain everything and how the picture
relates to my hip, but he provide an environment where you feel very comfortable to ask questions, he
also explains things in lay terms, he doesn’t baffle you with medical terminology.
EP 12
Continuity of care
People trusted their surgeon and wished to continue under his care, in contrast to the experience of a
patient who previously had consulted with up to 15 different doctors, which caused delays in
the treatment:
If you are comfortable with your consultant, the manner of the consultation and the consultant would
go a long way to give you confidence that that’s the best treatment.
EP 10
Trusted information sources
The majority of people were satisfied with the explanations received during the consultation with the
surgeon and did not wish to have a second professional opinion. However, they looked up FAI and
available treatments in the internet and found the information confusing, wrong and worrisome.
When I went to the internet I found things that people had had done but also the internet could be
quite a scary thing and you may get worried.
EP 5
In particular, one patient suggested that links to trusted websites could be added to the PIS for those who
wanted more details about the condition and its treatments.
Others commented that having read the PIS for the RCT has clarified and enriched their understanding of
the condition. One patient said:
Perhaps if someone’s been diagnosed with this problem, then given the [PIS] document and then ask
to have a discussion with a consultant. That would work for me!
EP 4
Patients suggested that more information could be added specifically about the long-term risks of hip
impingement (i.e. arthritis), the risks of non-operative care and details of the postoperative care (i.e. what
happens soon after the surgery):
I’d probably I would have liked more information on after I had it done, what happens and how
would I feel? And what I can/can’t do, and I’m talking immediately after, the day you wake up after
the operation, what can you do? What pains are you going to feel? I remember the first time I had it
done, I had terrible pins and needles, and my leg was going numb.
EP 5
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Detailed follow-up/physiotherapy protocol
A few patients appreciated the level of detail of the rehabilitation guide after the surgery. It seems that,
despite it being a demanding programme, people were able to follow it and remain motivated:
That’s something I would highlight, it was amazing, how detailed and supportive that follow-up
programme was. I was giving a 12-week programme, basically week 1, these are the exercises you
should be doing, then week 2 progress to this, so that was very informative and helpful, because you
have that guidance it made me very diligent.
EP 12
I suppose I’m the sort of person that asks a lot of questions at the start. I, it was useful to know how
much the rehab programme was going to be, there was a lot in it, and it was useful to have
that beforehand.
EP 13
Trial patient information sheet review by patient panel
The purpose of the expert patient panel was to involve patients in the revision and redesign of the PIS that
would be used in the pilot work and eventually in a full RCT. Initially we provided an online and on-paper
questionnaire and targeted 50 patients who have been diagnosed with FAI and received treatment at
UHCW. However, in order to obtain a richer source of information about how patients perceived and
interpreted the PIS, the majority of the expert patients who agreed to be interviewed also answered the
questionnaire with the researcher (AR). This method has been used in another RCT by a member of the
team (JD).69 It allowed us to access the thinking process behind the answers given by the participants. The
QRI team decided that the questionnaire in combination with the interview was a more effective way of
obtaining the key messages required to change the PIS. Therefore, the collection of questionnaires was
stopped before we could complete the target sample size.
Findings
Sample
Fourteen questionnaires were filled in by participants during the interview, one questionnaire was returned
by post and one was filled in online.
Feedback
The patients received the PIS positively because the wording was easy to understand and the
information clear:
I think the patient information sheet was very readable . . . I gave it to my husband and he was quite
happy, even my children read it, my boys are 11 and said ‘Mum, what are you reading?’, and I gave it
to them and they understood it and they asked me ‘Mummy, why are you having another operation?’,
but they understood what a clinical trial was at the end of it.
EP 11
Patients also appreciated the hip diagram at the front and the flow chart at the end of the PIS. They
tended to refer often to those graphs when discussing their experiences. Two patients suggested one
diagram of an abnormal hip with FAI.
Perhaps some more detail in terms of photos/images of damage and typical damage, because there is
a big [picture] about the socket area and a normal hip joint and it would be interesting to see what it
isn’t [. . .] to suggest what the problems look like and why they don’t know what the best fixers are.
EP 10
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Concretely, patients found and understood easily the information for (1) why it is important to treat hip
impingement, (2) the purpose of the study and (3) what operative care involves and its risks. One patient
mentioned there was not much information of the risks of not treating hip impingement.
Patients did not find satisfactory the information related to (1) non-operative care risks, (2) what happens
after the study finishes and (3) 50 : 50 treatment allocations. These items are related to the explanations
about the trial procedure.
Other patients wanted to know if the same clinician would look after them and if they would have access
to an alternative treatment after the study:
There is nothing in the information sheet that says actually if it doesn’t work you can then go on to
discuss further options which may involve surgery.
EP 11
[About the flow chart] the last box doesn’t make it entirely clear that your treatment plan may alter
after the trial, maybe that bit can be elaborated to clarify that.
EP 9
Some patients requested more information about the postoperative care and others wanted further
information about what risks are involved with the non-operative care (i.e. further tears to the labrum).
Finally, people were unclear about how the decisions to allocate patients were made and if the patient’s
clinical needs were considered in this procedure.
The patients in this sample were reluctant to make a decision to enter a RCT and the reasons were
explained in the section above. They reported that the PIS presented the options in a balanced way; a
couple of patients said it was a useful document and wished it had been available when they were first
diagnosed. Some patients made suggestions about the level of information it contained, also discussed in
the previous section.
The preferred name for the conservative care was discussed and in general people opted for the
word ‘personalised’:
I said the last two [personalised hip treatment and personalised hip therapy] because it makes it a
personal issue for that person . . . going down a non-operative route would require different treatment
for every different patient.
EP 3
I liked the word ‘personalised’ rather than ‘focused’ because if you are going to have something done,
it is nice to feel that it is personal to you.
EP 11
One patient expressed a preference for the word ‘therapy’ as it indicates an effort to ‘solve’ or ‘cure’ the
condition, as opposed to ‘programme’, which does not have that connotation.
Therapy from a psychological point of view, people understand therapy [. . .] with regards to clinical
treatment rather than a programme which can relate to anything in life.
EP 13
The name of the conservative arm was decided on the basis of these patients’ responses; eight patients
voted for the name ‘personalised hip therapy’, four preferred ‘personalised hip programme’, one voted for
‘focused hip therapy’ and three offered other suggestions, such as conservative hip rehabilitation
programme or the inclusion of the word ‘non-invasive’.
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Recommendations
Recruitment
1. Be aware of patients’ previous treatment history, as past experiences with either of the treatments
seemed to have great value in the decisions made afterwards.
2. Allow time for patients to consider the PIS and then ask questions.
3. Use open communication and clear explanations of the condition, as these are linked to patient
satisfaction and compliance. In contrast, if the patient feels rushed and overwhelmed by the
information provided, this creates anxiety and mistrust, and the patient is probably less willing to
participate or stay in the trial.
4. The non-operative arm of the trial should be called ‘personalised hip therapy’ in accordance with
patient preferences.
Patient information sheet
The following points need to be given greater emphasis:
1. The patient should have the opportunity to talk to a researcher for longer and should be able to ask
questions and raise concerns.
2. Success rates of both treatments should be included. Patients need to feel that treatment will solve the
problem. It may be useful to include some patient testimonies describing positive experiences of
both treatments.
3. The differences between any past physiotherapy regime and this new programme should be
highlighted. ‘Personalised’ seemed to be a preferred term.
4. Continuity of care with the surgeon and team should be assured. Patients care about the reputation of
their clinicians and do not like to be referred to another doctor. In addition, the PSI should point out
that participation in the study may result in extra care and attention and this can be a selling point for
some patients.
5. Altruistic motivations, such as the need for research and the personal contribution to the whole
community, should be emphasised.
6. It should be made clear that participants are guaranteed access to treatment at the end of the trial, that
is that the non-operative treatment offered is a precursor to surgery.
The following additional information is required:
1. a logical explanation or reasons for considering physiotherapy/conservative care as an acceptable
treatment option within the context of FAI
2. details about the postoperative recovery
3. details about the non-operative arm: purpose, expectations, time commitment (i.e. required on a
regular basis) and risks associated with allocation to this arm in terms of aggravation of symptoms
4. details of the 50 : 50 allocation procedure, including how patients’ clinical needs will be met, and by
whom, as well as how the decisions will be made and whether the patient’s condition will be
assessed regularly
5. details of trusted websites that the patient can consult or else create a new site in which the balance
between operative and non-operative care can be explored further.
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Appendix 3 Detailed results of clinician
interviews
Integrative qualitative study of recruitment pre-pilot report:
clinicians’ views
Clinicians’ interviews
The purpose of this activity was to explore attitudes to randomisation of FAI patients of a multidisciplinary
sample of clinicians working in the centres performing hip arthroscopy. Semistructured interviews were
carried out and, to stimulate discussion, clinicians were provided with anonymous patient cases that cover
the spectrum of patient presentations, including patient history (with duration of symptoms and previous
treatments), examination findings and imaging (for examples and interview schedule please see Appendix 1).
By introducing patient cases we sought to deconstruct the cognitive processes involved when a clinician
considers recruiting a patient to a clinical trial. This was done in order to elucidate the state of individual
equipoise that may be influencing a recruitment decision.
Procedure
We aimed to recruit a convenience sample of health-care professionals who have a special interest in hip
conditions and were likely to see patients with FAI during their clinical practice (i.e. orthopaedic surgeons,
physiotherapist and sports doctors). We invited clinicians attending to two national events, the BHS annual
meeting and the 2012 Hip Surgery Conference. We also contacted physiotherapists who participated in a
national survey that contributed to the development of the PHT protocol. The clinicians were contacted by
the researcher (AR) during the conferences or by e-mail. Those contacted during the event were invited to
have an interview in a private room. The rest of the clinicians were interviewed at their offices or over the
phone. After consenting to take part, the clinicians were presented with the two anonymous patient cases.
The researcher used the interview schedule and materials presented in Appendix 5. The clinicians were
asked to ‘think aloud’ while considering the patient cases and the researcher used prompting questions to
facilitate the clinician narrative of these processes. The interviews were audio recorded. The study received
the relevant ethics approval from the West Midlands Ethics Committee.
Data analysis
Transcripts of the interviews were prepared and coded using NVivo by AR. The coding was based on the
Buckingham–Adams classification model of clinical decision-making, which allowed identification of
(1) relevant cues; (2) psychological representation of these clues (i.e. importance in diagnosis); (3) knowledge
structures used (e.g. past clinical experience); (4) condition inferences generated as a result of these
processes; and (5) consideration of the potential outcomes associated with a particular treatment including
introducing the trial. Key messages about what relevant cues to decision-making, information sources,
clinical uncertainty and risks and potential outcomes considered by the clinicians were discussed with AA
and JD. Recommendations about clinician recruitment and information provision for clinical teams involved
in the trial were agreed and presented to the trial management team.
Findings
Sample
The majority of the surgeons (n= 12) interviewed were recruited during the BHS annual meeting and are
currently treating patients with FAI. Of the total sample of surgeons, two do not operate on the hip and
one carries out open surgery; these surgeons tend to refer patients to another colleague who does hip
arthroscopy. Surgeons who specialise in arthroscopy have more expertise than those who are still
in training.
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Six physiotherapists were identified through a national survey that requested the opinions of professionals
who have a special interest in hip conditions. The other six physiotherapists and two sports doctors were
interviewed during the Hip Surgery Conference 2012, an event dedicated to health professionals who also
have interest in hip issues and rehabilitation and a high level of expertise.
Patient’s’ characteristics and their psychological representation in clinical
decision-making
Patients’ age was mentioned by the majority of surgeons and physiotherapists. In general, they reported
that patients with FAI are young and active. When the patients were relatively older, clinicians were
mindful of distinguishing FAI from early arthritis onset.
Between mid to late 40s even early 50s, that are borderline [. . .] they don’t have full on arthritis but
they have mechanical symptoms with relatively early onset.
Surgeon 3
A surgeon and a physiotherapist also mentioned certain patient personality traits that may influence their
decisions. One surgeon described the ideal patient as ‘a highly motivated and intelligent patient’
(surgeon 3) with a good prognosis. According to one physiotherapist ‘again it depends on the state of
mind, some patients are very driven, they are going to get better’ (physiotherapist 1).
Clinicians were also interested in the type and level of patients’ physical activity and the impact the
symptoms had on patients’ lives. This seemed to be important when assessing the level of severity of the
condition and the need for treatment:
I would like to know if he’s able to do his job or not because that’d be important, or whether it is just
wicket keeping that precipitates his symptoms.
Sports doctor 1
Will surgery enable him to continue the sporting activity that he wishes to undertake? Are there
other activities that he can’t undertake at the moment? So it’s not interfering with his work, it’s
purely recreation.
Surgeon 9
In terms of patients’ medical history, various surgeons and physiotherapists mentioned that patients with
FAI have typically experienced pain for a few years. They also remarked on the type of impingement
suggested by the tests.
He has pain, positive clinical examinations and positive radiographic findings a triad you showed me in
each one that is consistent with a diagnosis of FAI, this guy has labrum tear as well I see.
Surgeon 14
The gap between first experiencing the symptoms and seeking treatment was reported to be shorter when
the patients are private:
Obviously being the private sector, we tend to see them [patients] sooner rather than later.
Physiotherapist 2
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Finally, the treatment history of the patient seemed to be particularly concerning for a group of clinicians,
especially when deciding what treatment they should recommend. The general perception is that the
majority of patients may have already had a course of conservative care and are seeking advice from the
consultants to obtain a more definite solution, which in most cases involves a surgical procedure:
Patients come when [they have] already had a course of physiotherapy, that is patients have often
come [after] non-operative treatments, and they look at you as if you are mad if you say ‘I want to
send you back to physiotherapy for more treatment’.
Surgeon 7
Recommended treatment in case studies
The section above showed the aspects that clinicians tend to focus on when suggesting a course of
treatment for patients with FAI. In general, no one disputed the diagnosis in any of the fictional cases
we presented, although some surgeons and some physiotherapists remarked on the need for
further examinations.
Other thing would just want to know about any other issues that she’s had, whether it’s lower back
pain, chronic pain problems, yellow flags that [she] may have an issue.
Physiotherapist 3
The physiotherapists suggested that activity modification in most cases would help to alleviate the
symptoms, along with exercises to stabilise the hip joint. Three physiotherapists were of the opinion that
the fictional patients were ‘suitable for operable or non-operable treatment’ (physiotherapist 3). Others
mentioned that, in their experience, patients with this pathology started with a course of physiotherapy:
If he didn’t have any labrum or chondral changes then we would automatically send him to
physiotherapy first, purely to see if we can upload symptoms with conservative measures [. . .] if they
can’t do the physio because of the pain, we would inject them surgical local anaesthetic, partly to
confirm that what we’re seeing on the scan is to sort out their symptoms.
Physiotherapist 7
The group of surgeons generally agreed the fictional cases portrayed patients to whom they offered hip
arthroscopic surgery. In the case of a young farmer who had experienced pain for 5 years, seven surgeons
were happy to offer operative or non-operative care. However, one of them was cautious
about intervening:
He is someone I would not rush into surgery with him. I would ask him to see my physio. I would ask
her possibly in the course of being on a waiting list to see this patient.
Surgeon 6
When the fictional case of female patient was presented, the majority of surgeons would advise this
patient to undergo arthroscopy on the hip; however, one surgeon and one physiotherapist disagreed:
This particular patient in my practice and also speaking to a lot of the colleagues, they all know about
this condition, they don’t do well by the surgical intervention.
Surgeon 11
If she was my patient I’d be keen to go down the conservative route, just because reading it, it doesn’t
sound that the symptoms are bothering her that much.
Physiotherapist 2
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Another surgeon raised the question about the effect of sex in the natural history of FAI: ‘maybe the
literature has moved on, the last time I looked the difference between men and women having hip
impingement was not that clear’ (surgeon 8).
The clinicians’ hypothetical decisions are linked to their level of certainty about the usefulness of operative
and non-operative routes for treating FAI. They are explored in the following sections.
Certainty of conservative care
A subgroup of clinicians agreed that conservative care can have a positive impact in relieving FAI
symptoms. Seven physiotherapists cited examples from their own practice in which they have seen
satisfactory recovery after a course of treatment. One of them explained it like this:
Some people have and we’ve never heard from them again because with activity moderation and
changes in their lifestyle that’s been enough.
Physiotherapist 2
Physiotherapists explained how the non-conservative care could improve outcomes:
[Physiotherapy will be an advantage] in individuals who are poorly conditioned, the muscles around
the hip are in poor condition and they are weak, more improvements can be made there and their
control on the hip and the lumbar area(?) [. . .] Other sources of pain which are related to the hip, as it
is not always the hip pathology that is causing the pain, there are other things that can trigger it.
Physiotherapist 5
However, they were aware that this line of treatment did not address morphological issues, and
physiotherapists tended to agree that success may be related to the severity of the symptoms: ‘but I’d
guess with those that the impingement and the damage was not as bad as it can be in some’
(physiotherapist 9) and ‘the ones with the most middle signs maybe if they just have a pincer or a cam
rather than mixed on the radiographic findings’ (physiotherapist 11).
Eight surgeons in this sample expressed the opinion that there may be a group of patients who could gain
relief from conservative care:
There is a small cohort of patients [. . .] whom maybe benefit from physiotherapy. These patients are
those who have small cam lesions and who are not going to strain their hip to the extent that is going
to cause that impingement, so modification of activity for them may be the treatment they required.
Surgeon 2
However, it is not clear what type of patients would benefit the most, as two other surgeons suggested
that patients with pincer impingement may respond better to this treatment. This is because they usually
see mixed results after surgery with patients with pincer impingement. Additionally, some surgeons have
noted that patients may get better when there is nothing done to them.
You won’t surprise me if it turns out this is a condition where the pain resolves with time, because we
know a lot of people with meniscus tear, for instance, the pain would get better despite the tear
being there and also a lot of musculoskeletal pain is episodic.
Surgeon 8
Because we didn’t have access to [a surgeon] for 3 years, we just got on with it, and did realise that
people settle down. We only had one last year that needed referral out of six [patients].
Sports doctor 2
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There is also a general concern about the quality of the physiotherapy offered, which seemed to affect the
outcomes, as expressed in the following quotes:
Depending on the type of physio and the quality, the physiotherapist understanding of the pathology
[. . .] I think if the right people are involved with the right level of skill, the outcomes will be a
lot better.
Physiotherapist 5
But has he had proper physiotherapy? Do you think? Has he had proper activity modification? No, the
answer generally will be no, he needs to give it a good shot, it’s my feeling.
Surgeon 11
Physiotherapy has to be carefully considered as how it is going to be delivered in the local hospitals . . .
huge variations in the quality.
Surgeon 3
Several clinicians suggested that non-operative treatment would not work. The physiotherapists who
shared this opinion mentioned that some patients do get better when not participating in the usual
activities that cause them pain but that symptoms return once they resume those activities. Some surgeons
also reported this experience:
We’ve seen in elite sports people who have access to very good therapy despite all that still they don’t
get any better.
Physiotherapist 2
I don’t think conservative care works very well. I, it does in some people, but my experience is that
conservative care means they go away for 6 months and come back.
Surgeon 14
Another argument to doubt the success of conservative care is that the non-operative treatment ‘would
not help the morphological abnormality’ (surgeon 12). This surgeon continued to explain that sending
someone to physiotherapy may be a breach of ethics, as they know the condition could worsen.
How can you possibly subject that patient to physiotherapy with higher deflection exercises, whatever
they may be, with the possibility of the morphological abnormality increasing that tear?
Surgeon 12
This is also a concern for other surgeons, who believe that their patients are seeking a solution to
their problem:
People come to me because their life is no longer working satisfactory, they tried the conservative
treatments and they haven’t worked.
Surgeon 9
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
93
Certainty of hip arthroscopy
Various clinicians, including physiotherapists, expressed the opinion that surgery is a curative treatment for
FAI. The main reason given is the morphological description of the condition:
Young men like [patient] have very specific symptoms and have often cam impingements and big
bumps on the front femur and have slightly restricted movements but otherwise they are fit and well.
And have good muscle control and that a group who do well with surgery.
Physiotherapist 3
Some surgeons were satisfied with the amount of case evidence series collected in the scientific
community which, according to them, has shown surgery is successful in relieving FAI symptoms:
I don’t believe there is any more a question of whether good surgery can relieve symptoms.
Surgeon 9
The literature by and large shows 80% of the people get good results, as far as symptoms go with
surgical treatment. There is no evidence anywhere that conservative treatment will work.
Surgeon 8
However, the expressed views showed an inherent debate between surgeons who believe that surgery
stops the advance of hip arthritis and those who think that operative care has limited benefits, which is
demonstrated in the quotes below:
[FAI] is probably the result of a morphological problem, therefore, simplistically by dealing with the
morphological problem, hopefully you should limit or slow the disease progression [. . .] I’ve done a lot
of research with regards to impingement and firmly believe that it does cause arthritis.
Surgeon 8
I am reasonably convinced of that FAI surgery in carefully selected patients has a short-term functional
benefits but I’m not convinced at all that we have the evidence that it is the cure for progression
to arthritis.
Surgeon 2
Furthermore, a number of clinicians have spoken of the risks and side effects of surgery, which may
outweigh the clinical benefits of undergoing hip arthroscopy:
There are some patients who would be worse after this operation, they need to be told that so it’s not
all benefit if you have surgery because there are some real downsides.
Surgeon 5
It’s only now in the last five-ten years that a lot of operations are useless . . . for knees, that’s been
shown not just being useless but also counterproductive for knee pain . . . I suspect some of those
cases will get better conservatively.
Sports doctor 2
A surgeon also mentioned that hip abnormality is found in the normal population, which would suggest
that some of these operations may be unnecessary:
Because the uncertainties about the long-term outcome, about the problems about the same imaging
findings within the normal population and the uncertainties whether treating these imaging findings is
going to result in improvement.
Surgeon 7
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Equipoise
Up to 10 surgeons, the physiotherapists and the sports doctors seemed to agree with the need to gather
scientific evidence that could answer the question about what FAI treatment performs better and in
which circumstances:
I think it’ll be excellent if there was one and it’d put the whole issue to bed.
Surgeon 3
We don’t have enough details of the natural history of FAI that we could say that doing nothing is
not reasonable.
Surgeon 2
Some clinicians feel it is a matter of finding which cohort of patients benefits more from operative and
non-operative treatment, as they have witnessed different outcomes in their practice:
My feeling would be there may be subgroups of patients who do well with one or the other.
Physiotherapist 3
I don’t have strong opinions about the outcome of the surgery. M, my feeling is that it works in
certain people and doesn’t in some of them.
Surgeon 14
Other clinicians think that finding out the evidence for or against surgical intervention could prove to have
further consequences in their practice:
You look at the parallel hip situation, one side they have pain, the other side they don’t have pain.
I, if you are the school of thought that you need to prevent arthritis, you should do both sides.
Surgeon 11
If we had the study then it should provide us with the justification that we need [to commissioners]
or it’ll educate us into thinking we shouldn’t be doing the surgery.
Surgeon 10
However, some opinions that challenged the equipoise of the treatments on the base of previous
experience and case evidence:
As far I am concerned, there isn’t a position of equipoise for consent on this, because there is enough
data in the literature, which admittedly, isn’t high-quality data, particularly with cam impingement, we
get good results with surgery in terms of symptom relief.
Surgeon 8
Another surgeon was particularly vocal in relation to this point, arguing that the most pressing issue is to
answer the questions of whether [surgery] can significantly change the natural history of what it would
happen to the hip over time (surgeon 9) rather than which treatment works better.
Potential outcomes of a randomised controlled trial
This section is dedicated to exploring a number of concerns the clinicians expressed in relation to the RCT
that has been proposed. The differences between the treatments, the length of time of the trial,
patient preferences, surgeon attitudes and the importance of clear eligibility criteria were the most
recurrent themes.
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Differences between the treatments that are being compared
Clinicians seemed concerned about sending patients to the trial who may need surgery, as they may be in
the non-operative arm of the trial. This is understood as wasting another year, as conservative care is not
perceived as curative:
I feel a bit guilty, ‘Have I given them the best advice’, you know?
Physiotherapist 1
Similarly, other clinicians are worried that people who may not need to go through the operative route
can be rushed into it owing to their participation in the trial and they are also worried about the risks
associated with surgery:
I suppose if the trial is there, you still want to make sure they didn’t have surgery earlier than you
normally want to.
Sports doctor 2
I think the trial only kicks in if he is eligible for surgery not otherwise, if he’s not eligible for surgery,
the trial doesn’t kick in.
Surgeon 11
There are significant risks in people who undertake surgery compared to those that don’t, that’s
where it is awkward because these two treatments are so very different.
Surgeon 2
Those surgeons who believe that operative treatment does cure the condition and stops the deterioration
of the hip joint would find difficult to send a patient to the trial:
So you’ve got the data so in that setting randomising patients to physiotherapy, i.e. not surgery, I
don’t think it’s ethically correct.
Surgeon 13
If the findings are really clear of specific impingement, then it is a bit hard to convince them to
undergo conservative treatment.
Surgeon 7
Other potential sources of bias in the recruitment were that the patient may have had
physiotherapy before:
If you get referrals from me, and I think all the sport docs will be the same, we would have done to
death the therapy.
Sports doctor 1
that the selected patients would have only milder symptoms:
He’s only symptomatic in his recreational activity so therefore it is not impinging in his activities of daily
living and he is possibly the candidate on who the study might be safe for but it is not the candidate
that needs my help badly.
Surgeon 9
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and that the local physiotherapy may not be of equal quality across the centres:
Are you suggesting a remote access physio who gives them a programme and liaises with the local
physios, because we don’t have specialist enthusiastic physios in our area who would be quite as
knowledgeable as the ones you have in Coventry.
Surgeon 7
Duration of the trial
The duration of the trial is a major concern for the clinicians that were interviewed. They felt that delaying
the recommended treatment could compromise the outcome of future surgical interventions:
The main concern with all of this is that if you’re delaying surgical treatment, are they going to
progress essentially their arthritic symptoms or cartilage damage by introducing that delay.
Surgeon 13
I feel as it is, by the time they are referred to me it’s too late, if I actually send them for another year
of physiotherapy, it’ll be a failing.
Surgeon 12
This concern was expressed in the context of finding damage to the joint and signs of deterioration. This is
because, according to some surgeons, the opportunity to successfully treat FAI with hip arthroscopy
depends on the level of cartilage damage. In addition, they wondered if there was going to be enough
time to recover from surgery:
One of the thing [that] is potentially an issue is how advanced the degenerative change may be that
you can pick up on your MRI.
Surgeon 10
Whether you’re going to follow up for only 12 months, I wonder if that gives enough time for
recovery from surgery.
Surgeon 13
The same clinician suggested that it would be important to feed back this information to the patient:
If I was a patient and I wasn’t aware that there is a possibility that things can progress during that
interval, I’d feel I’m not being fully informed about going into the trial.
Surgeon 13
On the other hand, other clinicians thought it was not long enough to answer the question about the
natural history of the condition:
Follow-up of 12 months is interesting, I am also interested in the long-term outcome, because the
question we really want to know is ‘are we influencing the natural history of the condition?’, which is
going to take a lot longer to know.
Surgeon 7
However, they were aware of the restrictions of a RCT:
Generally I do wait for 6 months, 12 months maybe a little long, but I can understand what we are
trying to [do].
Surgeon 11
DOI: 10.3310/hta20320 HEALTH TECHNOLOGY ASSESSMENT 2016 VOL. 20 NO. 32
© Queen’s Printer and Controller of HMSO 2016. This work was produced by Griffin et al. under the terms of a commissioning contract issued by the Secretary of State for
Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals
provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be
addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
97
Importance of the eligibility criteria
Seven clinicians reported that they wanted to have clear inclusion and exclusion criteria before they would
consider sending patients to the RCT.
A physiotherapist explained that an age range would be useful, as well as criteria that are specific to
their specialty:
I would want some more information or an assessment [of] the neuromuscular problems and the
pain problems.
Physiotherapist 3
Surgeons suggested that eligibility requirements should include accurate classification of morphology and
degenerative changes. They also mention the difficulties in determining the levels of activity and
discomfort, which are subjective. The criteria would also assist the distinction between similar diagnoses:
I suppose dysplastic patients we need to be careful about, making sure those patients who have
acetabula dyspraxia are not confused as having FAI.
Surgeon 13
Two surgeons asked about the outcome measures that would be used to assess the performance of the
two treatments. They suggested that patient outcomes such as ‘time off work, period of mobility,
complications [. . .] very important if you go into the operative group’ (surgeon 7) would provide useful
information for the comparison of treatments.
Patient preferences
Up to 13 clinicians expressed concerns about how the trial would be perceived by their patients. Once the
patient is willing to have some treatment, clinicians seem to worry how to present the non-operative arm
of the trial, especially to those patients who have already had physiotherapy in the past. Some clinicians
expected that patients would not agree to participate because it would be perceived as the same as they
had already tried or because it would require much more effort:
I think that’s the problem with randomisation in that there may be not many patients who will be
willing to be randomised because if they perceived they’ve already been through a trial of physio and
other non-operative treatments they would not want to go into that arm of the trial.
Surgeon 10
I think we probably have to get her to buy in to it because it’d probably be hard work.
Physiotherapist 12
Another concern is that patients may be already set on having a particular intervention; specifically, those
who are more seriously affected by the condition may want to have surgery:
[Surgeons] who have a special interest in [hip arthroscopy] may [have] a bias against randomization
because some patients come through saying ‘I want surgery’- and this is the sort of patients who
would do that - because they are keen sportsmen and have had pain for 12 months.
Surgeon 10
Other clinicians were concerned that patients might drop out of the trial if they were allocated to the
non-operative arm and failed to see results within a few months.
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Some surgeons mentioned that the way in which the non-operative treatment is presented would have a
huge influence on whether or not patients agreed to enter the trial:
The problem is recruiting the patients, I think if you couldn’t come up with a logical alternative
method of treatment, I think it is more likely to be accepted.
Surgeon 8
It can’t be seen as just physiotherapy, it needs to be a complete management plan, not just a group of
exercises to strengthen [. . .] so it is a whole life style change, medication, physiotherapy intervention,
the whole package, maybe even psychological interventions. Who knows?
Surgeon 1
Surgeon attitudes
A few surgeons in this sample spoke about how the attitudes towards surgery and being involved in a RCT
vary across the scientific community, which may have an impact on the levels of recruitment to this
specific trial.
The first obstacles could be described as the lack of equipoise in the community and the preference for
surgical intervention:
I think if it had been done 3–4 years ago, I think it would have been easier. There was less conviction
and most surgeons that were doing it [thought] that it was the right thing to do.
Surgeon 14
Of the majority of surgeons offering HA [hip arthroscopy] in the country, I see myself as being a little
less invasive and more conservative [. . .] there are surgeons around the country who will operate in
patients that I wouldn’t touch with a barge pole.
Surgeon 6
The second obstacle is the lack of awareness or willingness to be involved in research despite the
institutional requirement in health services to do so:
I am an atypical hip surgeon who sees these types of patients. I am heavily involved in clinical trials.
Surgeon 10
I mean I have a quite strong research background. I, if you’re recruiting people potentially to this trial
they need to be adequately informed.
Surgeon 2
Finally, there may be a bias introduced by vested interests of practising surgeons:
Trial is very important because FAI is expensive [. . .] however, I think it is going to be a very difficult
trial [. . .] it is practised predominantly by a group of specialist surgeons that have vested interests in
the success of the FAI over conservative care.
Surgeon 1
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Recommendations
1. Clinicians asked for clear inclusion and exclusion criteria. These should include requirements that can be
interpreted by a multidisciplinary team. Surgeons, physiotherapists and sport doctors tend to
work together.
2. Surgeons are concerned about accurate classification of morphology and degenerative changes in order
to exclude similar conditions. Physiotherapists would like more information about neuromuscular
problems and other examination parameters.
3. Reaching agreements about the age range, level of activity, severity of symptoms and even
psychological assessment of patients will be useful, as they are important cues in deciding what
treatment to suggest.
4. Concerns about NHS patients who usually have tried non-operative care plans and may ask for the
surgical treatment need to be addressed. The non-operative arm has to be presented as a different
option from past care plans, to the clinicians as well as to the patients.
5. Information about outcome measures and how the results will be disseminated can be a
motivational tool.
6. Clarification about how the fact that patients have had past therapy will affect the results of the trial
may be necessary.
7. In the process of choosing the centres where the trial will be run, and the surgeons who will take part,
there has to be awareness about possible vested interests in showing that the surgery works better,
willingness to participate in research and quality of the local physiotherapy.
8. Addressing the concern of deterioration during the 12-month period would be helpful, for instance by
explaining the procedure of regular and continuous assessment of patients’ condition and also showing
that patients will be informed about the risks of delaying treatment.
9. It may be advisable to provide more information about how the non-operative arm will be presented to
patients and how patients’ expectations will be managed to minimise drop-out rates owing to lack
of results.
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Appendix 4 Database of exercises to accompany
personalised hip therapy protocol
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Appendix 5 Pre-pilot patient interview schedule
and patient information sheet questionnaire
UK FASHIoN 
Expert patient interview schedule
These open-ended questions will be used to prompt the discussion of relevant topics. 
1. What has it been like for you to have hip impingement? 
2. How did you reach the decision about your hip treatment?
3. What options did you explore?
4. What are the advantages and disadvantages of each treatment?
5. What sort of information did you have and from where or whom?
6. What impact has the treatment had on your life? 
7. What/ who helped you the most to reach a decision? 
8. What did you find less useful?
9. What could we do to best support patients making a decision? 
Was there anything we did or said which made it more difficult for you to reach your 
decision?
10. What do you think could most help other patients make a decision? 
11. What do you think would be less useful?
12. How do you feel about operative and non-operative care?
13. What do you understand for randomisation? 
14. How would you feel about being involved in randomization? 
What do you think randomisation is?
15. How would you like the information to be presented?
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UK FASHIoN
Expert patient panel questionnaire
Thank you for agreeing to take part in the expert patient panel. We appreciate your views and any 
advice you can give us about how best to present information about a trial to future patients, who, like 
you, have been diagnosed with hip impingement. 
This questionnaire is designed to test the following:
· Whether the information offered to patients is easy to understand
· Whether sufficient information is given to allow a patient to make a decision about taking part 
in a study comparing two treatments for hip impingement.
Please bear in mind that it is the patient information sheet for the UK FASHIoN Study that is being 
tested and not your knowledge about the condition. 
Instructions 
1. Please read the attached patient information sheet for the UK FASHIoN study.
2. Please read the list of 6 statements about the text you have just read. 
For each one, please answer according to your agreement with the following: 
· The information related to the statement is on the information sheet 
· The information is easy to understand
The options are: 
· Disagree
· Partially agree as the information is difficult to find / understand (i.e. I spent more than 
3 minutes looking for it)
· Agree  
3. Please complete the general questions on the last page 
4. Finally, please print study ID number and today’s date in the space provided.
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Imagine you have just been diagnosed with hip impingement.  Your consultant tells you about a study 
that is comparing two different treatments for your condition and which you are eligible to take part in 
if you decide to do so. 
In order to help you decide, your consultant gives you the UK FASHIoN patient information sheet to 
read. 
What does the information say about the following? 
Why it is important to treat hip impingement Disagree Partially agree Agree
The information is in the patient information sheet O O O
The information is easy to understand O O O
The purpose of this study Disagree Partially agree Agree
The information is in the patient information sheet O O O
The information is easy to understand O O O
What operative care involves and its risks Disagree Partially agree Agree
The information is in the patient information sheet O O O
The information is easy to understand O O O
What  happens after the study finishes Disagree Partially agree Agree
The information is in the patient information sheet O O O
The information is easy to understand O O O
What non-operative care involves and its risks Disagree Partially agree Agree
The information is in the patient information sheet O O O
The information is easy to understand O O O
Why 50:50 treatment allocation is important Disagree Partially agree Agree
The information is in the patient information sheet O O O
The information is easy to understand O O O
Comments:
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Imagine you have to make the decision to enter this study, would you agree to take part? Please tell 
us about the reasons for your decision.
Do you think the treatment options discussed in the patient information sheet are presented in a 
balance way (operative vs. non-operative treatment)? Is one option better than the other according to 
the information sheet?
Is the wording in the patient information sheet easy to understand?
What do you think about the level of detail included in the information sheet? (For example, is it too 
little? Did it address all your concerns? Or is it too much? What would you leave out?)
What do you think of the layout and design of the information? Do you have any suggestions about 
how to improve it?
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Any other comments
Please print ID study no: .
Today’s date: ................................................................
Please return the questionnaire using the pre-paid envelope supplied
What name would you prefer for the non-operative treatment? 
Please help us to choose a name, your suggestions are welcome.
Focused Hip Therapy (FHT) O
Focused Hip Programme (FHP) O
Personalised Hip Therapy (PHT) O
Personalised Hip Programme (PHP) O
Other ___________________________________
Please tell us why
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Thank You!
Thank you for your time and valuable contribution. Your feedback will be used to improve the patient 
information sheet that will be used in a trial comparing the operative vs. non-operative care of future 
patients. This trial will help us to obtain important evidence about the best treatment for this condition. 
If you have indicated on your consent form that you are willing to take part in an interview, we will 
contact you again. Interviews will explore further aspects of the treatment you have already received 
and how you would feel if you were asked to take part in a trial such as this. If you do not wish to be 
interviewed, you can opt out without any consequences for your care. 
If you have further comments or questions regarding this study please contact the study co-ordinator, 
Rachel Hobson by either telephoning 02476 968629 or emailing at fashion@warwick.ac.uk
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Appendix 6 Final patient information sheet
Patient Information Sheet
UK FASHIoN Study
Principal Investigator: XXXXXX
You are invited to take part in our research study.  Before you decide whether to take 
part we would like you to understand why the research is being done and what it 
would involve for you. Once you have had a chance to read and absorb this 
information sheet a member of our team will personally go through the information 
with you and answer any questions you may have.
Background Information
Your hip joint has two bones that fit together like a ball in a socket, see figure 1.
Figure 1 – Normal Hip Joint
In some people like you these bones have abnormal shapes. Therefore as your hip 
moves these abnormally shaped bones press against each other and damage the 
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local soft tissues such as the labrum (a soft cushioning around the hip joint- see 
figure 1) which can cause pain. 
This is called Hip Impingement and the medical term for this is femoroacetabular
impingement (FAI for short). Hip impingement has only been discovered in the last 
10 years and we do not understand everything about the condition. Most importantly 
it is not clear what the best treatment for hip impingement is. Good results have been 
shown for both physiotherapy and hip arthroscopy (explained below) as treatments 
for hip impingement, but we do not yet know if one is better than the other. There is 
thought to be a long-term risk of osteoarthritis in patients with hip impingement. It is 
not known if either of these two treatments (physiotherapy or hip arthroscopy) has 
any effect on this risk. In order to decide which treatment is best for you and future 
patients we need a study to compare these two treatments.
What is the purpose of this study? 
This study aims to compare two different treatments for your condition - hip
impingement:
· Personalised Hip Therapy – this is a new individualised and structured
programme of exercise therapy designed for you by a physiotherapist. A more 
detailed description is provided later.
· Hip Arthroscopy – this is keyhole surgery and is designed to reshape the bone 
around your hip joint. A more detailed description is provided later
Why have I been chosen to take part in the study?
We need 60 volunteer patients like you with hip impingement to take part in the 
study.
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Do I have to do to take part?
It is up to you to decide whether or not to take part. If you do take part you can 
withdraw at any time and this will not affect the care you receive.
What will happen to me if I take part?
If you decide to take part you will be asked to sign a consent form. You will then be 
invited to one of the two treatments. In order to make our study work it is crucial that 
we have equal numbers of volunteers in each treatment group and that the one you
(are invited to) join is determined by a sophisticated machine designed for this 
purpose, and not influenced by us. More information about the two possible 
treatments is given below. Whichever treatment you have, please be assured that 
your care will be based on meeting your individual needs, and you will continue with 
the same team of physiotherapists and surgeons throughout. Both these teams work 
closely together and they will be able to monitor your progress and share information 
with one another about your individual case continually. During the study we will ask 
you to complete 4 short questionnaires by post /email (whichever is easier for you). 
You will do one questionnaire before you begin treatment and then one at 3, 6 and 
12 months after your treatment. If you need help completing a questionnaire, a 
researcher can contact you by phone soon after you receive it to help you complete 
it.   In addition, if you have hip arthroscopy as part of the study, we will arrange for 
you to have a further MRI scan of your hip after the surgery. The scan will happen at 
least 6 weeks after your surgery and will help us to analyse the surgery that has 
been undertaken.
Which treatments are you comparing?
The two treatments that are being compared are: 
· Personalised Hip Therapy - this is a personalised programme of hip 
therapy that is supervised by a senior physiotherapist and designed to meet your 
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individual needs. You may already have had a course of physiotherapy for your 
hip, however this programme of care is different and has been designed 
specifically to relieve pain in your hip and improve how it works. You will meet a 
senior physiotherapist with a specialist interest in hip impingement who will 
undertake a thorough assessment of your condition including the effect it has on 
your life. They will then customise a specific programme of hip exercises 
designed to help your hip. They will teach you these exercises in clinic and you 
will then be able to practise these exercises at home. This programme of 
exercises will gradually increase in intensity and difficulty so that by the end of 
the programme (12 weeks) we hope you will have developed improved control 
and strength around your hip with less pain. In addition to the hip exercise 
programme, a range of additional treatments will be offered to you. These 
include:
o Techniques to improve the control and strength of your posture and 
walking
o Personalised advice on techniques to modify the way you undertake daily 
activities
o Specific advice about pain medications to help control your pain in the 
initial stages of the therapy.
The programme lasts 12 weeks and you will need to be able to attend the 
physiotherapy clinic at least 3 times to be assessed, and to have your treatment 
progressed by your physiotherapist. In addition to this, your physiotherapist will 
keep a close eye on your progress over the telephone and will contact you at 
least 3 times in order to ensure you progress well with the programme. The
exercises you will be taught will focus on muscle control and balance in the first 
few weeks. You will then progress to resistance and stretching exercises, and 
activity/sport-specific exercises in later stages of the programme. You and your 
physiotherapist will be able to arrange an additional 2 “booster” sessions of 
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assessment / treatment if either of you feel that more time is required to undergo 
the therapy after the 12 week plan is over.
· Hip arthroscopy – The procedure is done under a general anaesthetic (you 
will be put to sleep). The surgeon opens up a small passage through to your hip 
joint using special instruments introduced through incisions on the surface of your 
skin. A telescope is passed through these small passages, to look inside the hip, 
and further instruments are inserted that allow the surgeon to reshape the hip 
joint and repair locally damaged tissues, such as the labrum. You will normally 
need to stay in hospital for between 1-3 days after the procedure. Depending on 
the extent of surgery, some patients have to use crutches to walk for between 6-8
weeks after the procedure. There is a period of rehabilitation after the procedure,
which will be supervised by a physiotherapist in clinic, and practised at home. It 
will take between 2-3 months to complete the rehabilitation programme.  In 
addition, we will arrange for you to have a further MRI scan of your hip after the 
surgery. The scan will happen at least 6 weeks after your operation and will help 
us to analyse the surgery that has been undertaken.
What are the possible risks of taking part?
The treatments are designed to help you, however, this cannot be guaranteed. The
individual risks of each treatment are outlined below:
· Personalised Hip Therapy - There are some small risks with pain 
medications and joint injections. However, the main risk is muscle soreness and 
short-term increases in pain from the exercises that you will undertake. Generally 
the risks of this treatment are much lower than hip arthroscopy (surgery)
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· Hip Arthroscopy – about 1 in 50 people have specific complications from hip 
arthroscopy. One very rare but serious risk is a break (fracture) of the hip during 
the surgery. If this happened you would need an additional operation to fix the 
break. Other risks of hip arthroscopy include:
- Infection within the joint or around the wounds. This can sometimes be treated 
with antibiotics alone. In more serious cases it requires a further procedure to 
washout the hip.
- Bleeding from the wounds, but this is usually a very small amount and quickly 
settles. 
- Numbness in groin, leg or foot. To undertake hip arthroscopy we need to
apply a pulling force on your leg in order to access the hip joint. This can 
cause some numbness in your groin, leg or foot as a result. This usually 
resolves within a few hours or days after the procedure.
How do these treatments work?
Personalised Hip Therapy – this therapy works by allowing soft tissues which are 
damaged and painful as a result of hip impingement, such as the labrum, a period of
relative rest, so that they can heal naturally. This can take up to several weeks or 
months. During this period you will have learnt and practised many exercises that 
improve the movement and control of the hip and local joints (such as your lower
back and pelvis), which should ensure that your hip impingement can no longer 
occur, and that damaged soft tissues, such as the labrum, can continue to heal.
Hip Arthroscopy – this procedure relies on surgically removing bits of bone from 
around the hip so that they no longer rub together and damage the soft tissues such 
as the labrum. Once the bits of bone have been removed, a period of rehabilitation is 
required so that the soft tissues can continue to heal. 
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One of the long-term concerns with hip impingement is that you have an increased 
risk of developing arthritis of the hip. It is really important that you know that at the 
moment we have no evidence that any treatment (including personalised hip therapy 
or hip arthroscopy) will have any effect on whether you subsequently develop 
arthritis of your hip. However by taking part in this study it will help us in the long 
term to determine if either of these two treatments can help prevent arthritis. 
What if new information becomes available?
Sometimes during the course of a study, new information becomes available about 
the treatments that are being studied.  If this happens, someone from our research 
team will tell you about it and discuss with you whether you want to continue in the 
study. If you decide to withdraw, you can discuss your continued care with your 
doctor. If you decide to continue in the study you might be asked to sign an updated 
consent form. Also, on receiving new information, we might consider it to be in your 
best interests to withdraw you from the study.  If this happens we will explain the 
reasons to you and arrange for your care to continue.
What happens when the research study stops?
You will be in the study for one year.  If you are still having problems after this time, 
we will arrange for you to see your hip specialist to continue your care.
What if something goes wrong?
In the event that something goes wrong and you are harmed during the research due 
to someone’s negligence, then you may have grounds for legal action for 
compensation against the University of Warwick (contact Miss Nicola Owen, Deputy 
Registrar, 02476 522713) and /or UHCW NHS Trust (contact Mrs Ceri Jones, 
Research & Development Services Manager, 02476966196), but you may have to 
pay your legal costs. The normal National Health Service complaints mechanisms 
will still be available to you. 
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Will my taking part in this study be kept confidential?
All information which is collected about you during the course of the research will be 
kept strictly confidential.  Research data including your name and address will be 
sent to the University of Warwick so that research staff can stay in touch with you 
over the course of the year, and send you follow-up questionnaires at 3, 6 and 12 
months by post or email.  These details will be sent from the hospital by secure 
means, and kept in locked filing cabinets or in password-protected computer 
databases accessible only to essential research personnel at the University of 
Warwick. All other information about you which leaves the hospital will have your 
name and address removed so that you cannot be recognised from it. If you agree, 
your GP and other doctors who may treat you, but are not part of this study, will be 
notified that you are taking part in this study.
What will happen to the results of the research study?
At the end of the study we will publish the findings in medical journals and at medical 
conferences.  You will not be identified in any reports or publications resulting from 
the study.  If you would like to obtain a copy of the published results, please contact 
the study coordinator Rachel Hobson on 02476-968629 or email: 
fashion@warwick.ac.uk
Who has reviewed this project?
This study has been reviewed and approved by West Midlands Edgbaston Research 
Ethics Committee. Approval was granted on 15th February 2012. 
Contacts for further information
If at any time, you would like further information about the study, you may contact the 
study coordinator, Rachel Hobson, by either telephoning 02476 968629 or emailing
fashion@warwick.ac.uk or telephoning Professor Damian Griffin, who is the Chief
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Investigator and overall lead of this study on 02476 869618. For independent advice 
contact the PALS service (Patient Advice Liaison Service) at Freephone 0800 
0284203.
Where can I get additional information?
As well as the researcher and your surgeon who can provide advice and guidance, 
we have developed a website 
http://www2.warwick.ac.uk/fac/med/research/csri/orthopaedics/research/fulllist/fashion/
This website provides additional useful information about hip impingement and its 
treatments, including a series of answers to frequently asked questions. In addition, 
it provides internet links to other trusted sources of information.
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STEP by STEP guide to the study
Step 4: Enter the treatment study
Treatment you receive will be from experienced 
specialists.
Step 2: Talk to a study researcher
A specialist researcher will talk to you about the study 
and answer any questions.
Step 3: Consent to enter treatment study
Consent to take part in the treatment study. 
Step 1: Attend the hip clinic at hospital
A consultant hip specialist will discuss with you your diagnosis. 
You will be invited to talk to a researcher about entering a study.
Treatment outside the study
If you choose not to take part in the study 
or you have been in the study for one 
year you will continue to receive 
treatment from experienced specialists in 
the NHS.
Step 4: Treatment study finishes
After 12months the study will finish and you will 
continue to receive care from specialists in the NHS
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Appendix 7 Outcome questionnaire
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Appendix 8 Hip arthroscopy surgery vignettes
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Appendix 9 Site research and development
approval
The diversity of sites, from a small district hospital to a large London teaching hospital, provided valuableinformation on the processes required in order to gain site R&D approval. For all sites, significant
improvement in the time taken to approval was achieved following the site visit (Figure 10). Ensuring that
a member of the R&D department was able to attend the site visit was key in order to clarify queries about
the study.
Problems encountered in time taken to achieve R&D approval
Good clinical practice (GCP) training: for two sites (8 and 10) delays occurred in submission to R&D as at the
time it was thought that the PI required GCP training. Identification of GCP training within each of the site
Trusts was proving difficult. Combining this with the PI’s schedule made finding a suitable time virtually
impossible. Both Trust R&D departments then confirmed that in fact no GCP training was required as this was
not a trial involving an investigational product.
Ionising Radiation (Medical Exposure) Regulations (IRMER) review: two sites (5 and 9) experienced delays in
obtaining IRMER sign-off. At site 5, reviewers were just busy while, at another site, confusion was caused
by the R&D project information submitted to the Integrated Research Application System.
Peer review: one site (9) experienced delays in obtaining peer review. The trust in question required all
studies to be peer-reviewed. One of the reviewers was too busy to complete. The PI had to ask for another
peer reviewer to be found.
CSP: at two sites (6 and 7) delays due to central updates of the system meant delay in the transference of
site-specific information forms. The R&D department require these forms in order to progress local approvals.
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FIGURE 10 UK FASHIoN: time in days to R&D approval.
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Appendix 10 Pilot: qualitative recruitment
intervention study – trial management group and
recruiter interview schedule
Pre-pilot clinicians interviews schedule: UK FASHIoN
1. Greeting
Thank you for agreeing to take part in this study. As you know, we are seeking the advice of expert
clinicians like yourself, about randomising patients to clinical trials. We would like to talk to you
about this.
2. Verbal consent
Will it be OK with you if we audio record this conversation?
3. Explaining the trial
The context for this request is a new research project – the UK feasibility study of a trial of arthroscopic
surgery for hip impingement compared with non-operative care (the UK FASHIoN project).
We would like you to imagine that there is a randomised controlled trial currently taking place
comparing hip arthroscopy versus best conservative care (physiotherapy) for
femoroacetabular impingement.
The trial design is outlined in this information sheet.
As a recruiting clinician, it is up to you whether to send a patient to the randomised trial or continue
with usual care. If the patient is referred to be part of the trial, a researcher will discuss the trial with
the patient and obtain informed consent to the randomisation.
4. Case study introduction
These are the notes of a patient who may have hip impingement. I would like you to think aloud and
tell me what is going through your mind as you read this case. I am particularly interested in thoughts
you may have when considering an intervention including referring the patient to the randomised
control trial. So, can you tell me what it is in your mind about this patient?
Prompts:
i. What other interventions are you considering in this case?
ii. What concerns do you have about sending the patient to randomisation?
iii. What would make you decide one way or another?
iv. What would you do if the trial was not running?
v. Will you opt for operative or non-operative care?
vi. Which treatment do you think will help this patient more?
vii. What do you think about the control condition, conservative care?
viii. Are there any patients you would prefer not to randomise?
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5. Next case
‘Please have a look [at] the next case and just as before I would like you to think aloud and tell me
what is going through your mind as you read this case. I am particularly interested in thoughts you may
have when considering an intervention including referring the patient to the randomised control trial.
So, can you tell me what it is in your mind about this patient?’
(Prompts)
6. Closing
Thank you very much! Any other comments or thoughts?
Your contribution is much appreciated and extremely valuable to us. It will help us to improve the
information available to clinicians deciding whether or not to participate in the UK FASHIoN study in
the future.
Background
l How long have you recruited patients to RCTs?
l How did you become a recruiter?
l Have you recruited to other RCTs, before this one?
l How did you come to be working on this RCT?
l Have you received any training (a) as a recruiter; (b) for this RCT?
l When did you start recruiting to this trial?
l Please describe how recruitment has been for you in this RCT.
Introducing/explaining the trial
l How do you introduce/explain the trial to patients?
l Why do you think this RCT is needed?
l What is involved in taking part in this RCT; and in each arm?
l What happens to patients if they agree to take part?
Randomisation
l How do you explain to patients how the decision is made in the trial about which treatment they
will receive?
l How easy do you think the concept of randomisation is for patients to understand? Note: If this seems
threatening, acknowledge that this is a difficult and confusing concept for everybody and then
explore again.
l Does randomisation seem sensible and reasonable to you?
Uncertainty
l How do patients react to the idea that the specialist doctor does not know what the best treatment is?
l How do you describe the uncertainty?
l How do you feel about explaining uncertainty?
l Do you ever have a feeling during an appointment that a patient should really have one treatment
rather than another? Probe: Why? What do you do about that?
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Difficulties during recruitment
l What would you say are the main difficulties you face as a recruiter?
l Can you describe specific examples of ‘good’ and ‘bad’ recruitment experiences?
l Is recruitment organised well? Do other people explain the RCT to patients?
l Are there difficulties with any particular arm?
l Do patients have strong preferences?
l Do you think this RCT is the right thing for these patients?
Finally – improving recruitment
l What might, in your opinion, improve the recruitment appointments?
l Do you think you (or others) need more support or training?
OPTIONAL
Recruitment pathway
l How are patients recruited into this RCT? Is there a ‘recruitment’ appointment?
l Who undertakes the assessment of patient eligibility for this RCT? Are you involved in
eligibility assessment?
l How do you find out which patients to approach about the RCT?
Informed consent
l How easy do you think it is to obtain fully informed consent for patients participating in this RCT?
(Probe: what is informed consent; how do you know when you have reached it?)
l Are you ever concerned about the possibility of coercing patients into taking part in the trial?
Treatment preferences of patients
l Do patients express preferences for particular treatments?
l (Probe – what are their preferences; do you know why they express preferences?)
l What do you do when a patient expresses a preference?
l (Probe – do you accept it – what happens next? Or do you ever explore or challenge their preference?)
l What other reasons (not preferences) have patients given for not taking part in this RCT?
l What do you do when a patient gives a reason for not wanting to take part?
Personal views
l Do you think your work as a recruiter is similar or different from your usual work/practice? Probe: In
what ways it is (a) similar, (b) different?
l Do you think your work as a recruiter has changed the way you practise outside research?
l How do you feel about being a recruiter? Probe: Do you see yourself as a doctor/nurse/clinician,
scientist, or researcher (if nurse also add ‘patient advocate’); or all of these? Are there benefits or
problems that arise from these different roles?
l Do you know (or have a hunch) about what the outcome of the RCT will be?
l If you were a patient in this position today, would you agree to be recruited to the RCT and be
randomised? Or would you choose a treatment? Which one?
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Appendix 11 Examples of feedback letters to
principal investigators and research associates
Examples of feedback letters to PIs and research associates 
 
 
 
24th June 2013 
 
 
 
Dear  
 
I am writing to you with feedback from the integrative qualitative recruitment study of UK FASHIoN. 
The recruitment rate at your site is excellent and we hope more patients continue to be approached. 
Areas of concern derived from the shared learning from all sites are described in the attached 
document. 
 
Your efforts to improve communication between the research nurses and your team about upcoming 
recruitment opportunities are much appreciated. Approaches to eligible patients have resumed at your 
site and we recommend this system to be maintained as it will be essential for running the study 
effectively.    
 
We have noticed that research nurses/associates across the sites are becoming more effective at 
providing adequate study information to obtain patient informed consent, and we noted this 
specifically with your research nurse.  
 
Please do not hesitate to contact me or any of the team should you require more information or would 
like to discuss further our study. 
 
 
Yours sincerely,  
 
 
 
 
 
Alba Realpe 
Qualitative researcher 
T. 024761 51885 
a.x.realpe@warwick.ac.uk 
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UK Feasibility Study of a trial of Arthroscopic Surgery for 
Hip Impingement compared with PersoNalised Hip 
Therapy 
INTEGRATIVE QUALITATIVE STUDY OF RECRUITMENT (IQR) 
AUDIO RECORDING OF CONSULTATIONS ANALYSIS REPORT 
Participating site No.  
Feedback prepared by Alba Realpe 
No. audio recordings included in the analysis: 3 
Recruiter: SN374803 
12/06/2013 
Process of feedback 
This is individualised, confidential feedback to those involved in recruitment at the XXXX Hospital. 
We recognise that running recruitment appointments is incredibly difficult. We are all working 
together to improve the content and communication.  There are no right and wrong ways of recruiting. 
This feedback report is about sharing what we have learned from observing recruitment across the 
trial sites, and particularly what we have learned about how words and explanations are perceived by 
patients, and what might make a difference to improving recruitment and obtaining informed consent. 
Clinical service 
The xxxxxxxx hospital has shown to be successful at recruiting patients for the FASHIoN study. 
However:  
·  Recruitment opportunities have not been generated consistently due to time constraints and 
logistic challenges. 
 
Therefore it is essential that communication between the surgeons and your team improves, especially 
in relation to upcoming recruitment opportunities (i.e. FAI patients who may be eligible to join the 
study). Strategies that have been successful in other sites include: 
 
1. Liaising with surgeon’s secretary or other member of the team who is in charge of patient 
lists. Therefore patients with FAI can be identified in advance.  
2. Attending to a regular clinic at least once a week when possible. 
3. Developing an effective system to follow up FAI patients and carry out the recruitment 
consultation as close as possible to the diagnostic consultation.  
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Information provision  
Overall, during the consultations, patients are provided with the required information to achieve 
informed consent and you are demonstrating how your understanding and confidence in delivering 
information is improving as more opportunities to talk to patients arise.  
It is important to recognise that in most trials, despite all efforts to recruit patients, one in four people 
will not agree to participate in a randomised controlled trial. Nevertheless, you have been very 
successful recruiting patients to the study. They seem to understand and feel comfortable with the 
principles of equipoise and uncertainty about the treatments. Your approach to information giving 
follows a 6-step best practice recruitment model:  
 
1. Explain what FAI is to the patient 
2. Reassure the patient that they will receive treatment  
3. Explain that there is uncertainty about which treatment is best  
4. Explain the purpose of the trial  
5. Give the patient a balanced view about the pros and cons of each of the two treatments 
6. Explain the trial procedures 
 
During these consultations, patients are offered opportunities to ask questions and you delivered 
information with confidence and in a relaxed manner. A description of this model and some examples 
are attached to this letter for your reference. However, there are no concerns regarding your approach 
to patient recruitment so far in this study. Congratulations!  
 
Please do not hesitate to contact me or any of the team should you require more information or would 
like to discuss further our study. 
 
Kind regards,  
 
 
 
Alba Realpe 
Qualitative researcher 
T. 024761 51885 
a.x.realpe@warwick.ac.uk 
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